data_1h67_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h67 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.695 0.283 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.638 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 62' ' ' GLU . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.554 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' H ' HD21 ' A' ' 49' ' ' ASN . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.418 ' HE2' HG13 ' A' ' 120' ' ' VAL . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.512 ' HB3' HD13 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.595 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.554 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 38' ' ' ILE . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 65' ' ' ASN . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.43 ' N ' HG21 ' A' ' 64' ' ' ILE . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 131' ' ' ALA . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG12 ' HG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.546 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.657 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 84' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.701 HD13 HG22 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.575 HG21 HE21 ' A' ' 130' ' ' GLN . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.701 HG22 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.565 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.431 ' HG ' ' HA ' ' A' ' 119' ' ' GLN . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.431 HD12 HD23 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.575 HE21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.629 0.252 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 124' ' ' LEU . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.442 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.457 HG23 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HB2' HG22 ' A' ' 59' ' ' ILE . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.508 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 54' ' ' LEU . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.478 ' HE2' HG13 ' A' ' 120' ' ' VAL . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.592 HD21 HD13 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.626 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 57' ' ' GLY . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.592 HD13 HD21 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.484 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.557 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.2 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG23 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.62 ' HB2' HD22 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.536 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.558 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HA ' HG12 ' A' ' 95' ' ' ILE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 95' ' ' ILE . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 106' ' ' PHE . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.44 ' O ' ' HE3' ' A' ' 51' ' ' MET . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 51' ' ' MET . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.676 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.476 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 111.425 0.158 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 124' ' ' LEU . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.403 ' HG1' ' N ' ' A' ' 43' ' ' GLY . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.499 ' HB3' HD12 ' A' ' 59' ' ' ILE . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HA2' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.618 ' HE3' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.688 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 111' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 44' ' ' ARG . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 60' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 64' ' ' ILE . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' VAL . 2.0 m120 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.548 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.527 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.527 HG12 ' HA ' ' A' ' 92' ' ' LEU . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.634 HG13 HG13 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.61 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.634 HG13 HG13 ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.453 ' HB1' HG23 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.509 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.618 ' HB ' ' HE3' ' A' ' 51' ' ' MET . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 95' ' ' ILE . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.607 HE21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 36' ' ' VAL . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 34' ' ' LEU . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.623 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 HG21 HD21 ' A' ' 63' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 59' ' ' ILE . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.441 ' CG ' ' H ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.695 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.451 ' O ' HG21 ' A' ' 64' ' ' ILE . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 38' ' ' ILE . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.5 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 131' ' ' ALA . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.2 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.5 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 84' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.605 HG21 ' NE2' ' A' ' 130' ' ' GLN . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HE3' ' HD2' ' A' ' 103' ' ' HIS . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.473 ' HD2' ' HE3' ' A' ' 101' ' ' LYS . 89.5 m-70 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 101' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.756 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.425 ' O ' ' HE2' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.433 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.57 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.623 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 100' ' ' VAL . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.452 ' HB3' HD23 ' A' ' 67' ' ' LEU . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.537 0.208 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.475 HD23 ' HB3' ' A' ' 124' ' ' LEU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.534 ' NE1' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 63' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.541 ' HB3' HD12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 46' ' ' ILE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.85 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.44 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.85 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.613 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.646 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' NE1' ' A' ' 37' ' ' TRP . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.531 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' HG21 ' A' ' 64' ' ' ILE . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.623 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.458 HG21 ' HG3' ' A' ' 130' ' ' GLN . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.572 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 123' ' ' THR . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.815 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.815 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 105' ' ' ILE . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HB3' HD23 ' A' ' 34' ' ' LEU . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.458 ' HG3' HG21 ' A' ' 100' ' ' VAL . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.381 0.134 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.467 ' C ' HG21 ' A' ' 36' ' ' VAL . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 35' ' ' ARG . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.562 ' HE1' HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.594 HG22 HD21 ' A' ' 63' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' OE2' HD13 ' A' ' 46' ' ' ILE . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.404 ' OG1' HG21 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.514 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.609 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 44' ' ' ARG . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 38' ' ' ILE . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.535 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.588 HD22 ' H ' ' A' ' 73' ' ' GLN . 7.6 m-80 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.4 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' NE2' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.535 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.744 HG21 ' N ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.744 ' N ' HG21 ' A' ' 72' ' ' VAL . 97.0 mm-40 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG21 ' CG2' ' A' ' 72' ' ' VAL . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 74.0 m-20 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.543 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 84' ' ' LYS . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.501 ' HA ' HG12 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.696 HG21 HE21 ' A' ' 130' ' ' GLN . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.765 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 74.5 m-20 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.794 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.765 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.533 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 121' ' ' GLN . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.696 HE21 HG21 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.761 0.315 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 38' ' ' ILE . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.52 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 62' ' ' GLU . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.472 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.528 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 46' ' ' ILE . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.655 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 65' ' ' ASN . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' N ' HG21 ' A' ' 64' ' ' ILE . 73.1 m-20 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 8.1 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.527 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.655 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 109' ' ' ASN . 2.5 m120 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.881 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.8 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.881 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.8 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 68.1 tp60 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.571 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' ILE . 87.2 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 121' ' ' GLN . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 64' ' ' ILE . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.464 ' NE2' ' HA2' ' A' ' 99' ' ' GLY . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 62' ' ' GLU . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.605 HD12 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.618 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.617 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.574 HD12 ' HB3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 72' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG21 ' N ' ' A' ' 65' ' ' ASN . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.486 ' N ' HG21 ' A' ' 64' ' ' ILE . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HD3' HG22 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.469 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 75.7 m-20 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 64' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.554 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 90' ' ' ASN . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 105' ' ' ILE . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 127' ' ' LEU . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE3' ' NE2' ' A' ' 103' ' ' HIS . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.407 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 95' ' ' ILE . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 114' ' ' ASN . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.846 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 3.7 m120 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 6.8 m-80 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.846 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.576 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.613 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 100' ' ' VAL . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.783 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.627 HE21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.892 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.892 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.737 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.477 ' HE2' HG13 ' A' ' 120' ' ' VAL . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.56 HG21 ' OD1' ' A' ' 87' ' ' ASN . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.474 HD12 ' CB ' ' A' ' 44' ' ' ARG . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 91' ' ' PHE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.481 ' HG ' ' HB2' ' A' ' 91' ' ' PHE . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' A' ' 42' ' ' THR . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.526 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 HG23 ' OE2' ' A' ' 62' ' ' GLU . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.56 ' OD1' HG21 ' A' ' 58' ' ' VAL . 3.7 m120 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HG ' ' A' ' 61' ' ' CYS . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 92' ' ' LEU . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.687 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.665 HG21 HE21 ' A' ' 130' ' ' GLN . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.687 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.742 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.448 HD21 ' CE1' ' A' ' 106' ' ' PHE . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.404 ' HG1' ' H ' ' A' ' 119' ' ' GLN . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.404 ' H ' ' HG1' ' A' ' 118' ' ' THR . 69.3 tp60 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.477 HG13 ' HE2' ' A' ' 51' ' ' MET . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.665 HE21 HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.621 ' NZ ' ' HB2' ' A' ' 132' ' ' LYS . 4.2 ttmp? . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.69 0.281 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.672 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.704 HG21 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.704 HH12 HG21 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.536 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.587 ' HE3' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.626 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 60' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.565 ' HG ' ' HB2' ' A' ' 91' ' ' PHE . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' N ' HG21 ' A' ' 64' ' ' ILE . 5.0 m120 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.695 ' HG ' ' HB3' ' A' ' 131' ' ' ALA . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 75' ' ' VAL . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 72' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 58' ' ' VAL . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' CG2' ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 28.7 m170 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.503 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HB2' ' HG ' ' A' ' 61' ' ' CYS . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' HB ' HD12 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.777 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.519 HD11 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.647 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.576 ' HG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.672 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.51 HD13 HD21 ' A' ' 67' ' ' LEU . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.874 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.447 ' HG3' HG21 ' A' ' 100' ' ' VAL . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.695 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.874 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.59 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.836 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.836 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 52' ' ' ASP . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.607 HG23 ' HD3' ' A' ' 78' ' ' PRO . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HB3' HG23 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 60' ' ' LEU . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.548 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.607 ' HD3' HG23 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 3.9 m120 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 84' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.788 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG21 HE21 ' A' ' 130' ' ' GLN . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.788 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.486 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CE1' ' A' ' 106' ' ' PHE . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.53 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.479 HE22 ' HA ' ' A' ' 104' ' ' ASP . 3.8 tp-100 -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.623 HE21 HG21 ' A' ' 100' ' ' VAL . 45.4 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 HD12 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.674 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 HD12 HD23 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 62' ' ' GLU . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.865 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.589 ' O ' HD22 ' A' ' 54' ' ' LEU . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.586 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.865 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.46 ' HB3' HG23 ' A' ' 42' ' ' THR . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.419 HD23 ' NE1' ' A' ' 37' ' ' TRP . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.457 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' N ' HG21 ' A' ' 64' ' ' ILE . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' HA ' ' HB3' ' A' ' 90' ' ' ASN . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 84' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 77.5 m-20 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.629 HD13 HG22 ' A' ' 105' ' ' ILE . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.629 HG22 HD13 ' A' ' 95' ' ' ILE . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.622 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.622 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.723 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 105' ' ' ILE . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.674 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.648 HD12 HD22 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.755 0.312 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HA ' ' HE3' ' A' ' 37' ' ' TRP . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 63' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 62' ' ' GLU . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.561 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.52 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.463 ' HE2' HG13 ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.61 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 42' ' ' THR . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 38' ' ' ILE . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.53 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 84' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.663 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.621 ' HA ' ' HG1' ' A' ' 115' ' ' THR . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.493 HD22 ' NZ ' ' A' ' 55' ' ' LYS . 73.8 m-20 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.621 ' HG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.594 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.752 0.31 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD22 HD12 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.537 HG22 HD21 ' A' ' 63' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.496 ' CG2' ' HA2' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.57 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.6 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.606 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.496 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.612 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.57 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 38' ' ' ILE . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.598 ' HB2' HG22 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.495 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 131' ' ' ALA . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.539 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.417 ' HA ' HD21 ' A' ' 85' ' ' LEU . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 84' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.665 HD13 HG22 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.439 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.665 HG22 HD13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.445 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' LEU . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 117' ' ' HIS . 24.2 t-20 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.5 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.464 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.51 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.6 ' HB ' ' HE2' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 HD22 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.451 ' OE1' HG21 ' A' ' 100' ' ' VAL . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.682 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 84' ' ' LYS . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HB2' HG13 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 ' CD2' HG12 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 65' ' ' ASN . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' HG21 ' A' ' 64' ' ' ILE . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 73' ' ' GLN . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' N ' HG11 ' A' ' 72' ' ' VAL . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.584 ' HB2' HD22 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.584 HD22 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HA ' HG12 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HE21 ' A' ' 130' ' ' GLN . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.541 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.513 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.541 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 ' HG3' ' A' ' 96' ' ' LYS . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 109' ' ' ASN . 2.6 m120 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.485 ' HB2' HG22 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.487 HD22 ' HZ1' ' A' ' 55' ' ' LYS . 76.1 m-80 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.784 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HE2' ' A' ' 51' ' ' MET . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.784 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' HD11 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.682 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.486 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.598 HE21 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HA ' ' HE3' ' A' ' 37' ' ' TRP . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.618 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.634 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.614 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.634 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 54' ' ' LEU . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.61 ' HB2' HG22 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.1 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 72' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.567 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 90' ' ' ASN . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 95' ' ' ILE . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.546 HG21 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.614 ' HB ' ' HE2' ' A' ' 51' ' ' MET . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.618 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.595 0.236 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 37' ' ' TRP . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.639 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.619 HG12 ' HG ' ' A' ' 63' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.494 ' HB3' HD12 ' A' ' 59' ' ' ILE . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.964 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.964 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.603 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.59 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 44' ' ' ARG . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 60' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.619 ' HG ' HG12 ' A' ' 38' ' ' ILE . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.503 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.8 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.506 HG23 ' SG ' ' A' ' 61' ' ' CYS . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 84' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.522 ' HB ' HD13 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.522 HD13 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.632 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.632 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.628 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.571 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.564 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 63' ' ' LEU . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.603 0.239 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HG22 HD21 ' A' ' 60' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.681 ' HB2' HG22 ' A' ' 59' ' ' ILE . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.534 ' O ' HD22 ' A' ' 54' ' ' LEU . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.502 ' HE2' HG13 ' A' ' 120' ' ' VAL . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.612 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 50' ' ' PHE . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.612 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 38' ' ' ILE . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.564 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' HG21 ' A' ' 64' ' ' ILE . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.505 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.564 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.444 ' N ' ' HD2' ' A' ' 83' ' ' HIS . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.444 ' HD2' ' N ' ' A' ' 80' ' ' GLN . 95.6 m-70 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 92' ' ' LEU . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.527 HG21 ' NE2' ' A' ' 130' ' ' GLN . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.528 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 96' ' ' LYS . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.579 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.684 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.624 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.527 ' NE2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.594 ' NZ ' ' HB2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.694 0.283 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.406 ' HA ' HD21 ' A' ' 34' ' ' LEU . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' HG3' ' OE2' ' A' ' 39' ' ' GLU . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 62' ' ' GLU . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.559 ' HB3' HD12 ' A' ' 59' ' ' ILE . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 46' ' ' ILE . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 47.4 t30 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.45 ' HE2' HG13 ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.628 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.469 ' HB2' HD12 ' A' ' 111' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.628 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.602 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 44' ' ' ARG . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 91' ' ' PHE . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.537 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.51 ' N ' HG21 ' A' ' 64' ' ' ILE . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.503 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.415 ' HB3' ' HG ' ' A' ' 61' ' ' CYS . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 84' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 96' ' ' LYS . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.798 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 4.7 m120 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.704 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.798 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.662 0.268 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.565 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' HG ' ' A' ' 34' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' CB ' HD12 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 46' ' ' ILE . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.492 ' HE2' HG13 ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' ' 111' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' HD21 ' A' ' 60' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.557 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 HD22 ' CB ' ' A' ' 41' ' ' ALA . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.568 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.458 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.5 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.568 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.615 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.615 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.708 HD13 HG22 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.703 HG21 HE21 ' A' ' 130' ' ' GLN . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 95' ' ' ILE . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.619 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.519 HD22 ' NZ ' ' A' ' 55' ' ' LYS . 73.7 m-20 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.7 OUTLIER -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.429 HG21 ' ND2' ' A' ' 116' ' ' ASN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.619 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 106' ' ' PHE . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.674 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.703 HE21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.48 ' N ' ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.706 0.289 . . . . 0.0 111.154 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.88 -43.64 19.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.568 2.179 . . . . 0.0 112.286 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.492 ' HG3' ' H ' ' A' ' 30' ' ' THR . 3.6 tp-100 -171.09 -125.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.492 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 88.2 m -161.96 -42.37 0.04 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -168.79 -31.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.421 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -59.75 -47.47 85.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.462 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 53.7 tt0 -66.88 -34.76 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.638 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 HD11 HD22 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 62' ' ' GLU . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.554 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.871 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' H ' HD21 ' A' ' 49' ' ' ASN . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.418 ' HE2' HG13 ' A' ' 120' ' ' VAL . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.871 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.512 ' HB3' HD13 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.595 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.554 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 38' ' ' ILE . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.43 HG21 ' N ' ' A' ' 65' ' ' ASN . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.43 ' N ' HG21 ' A' ' 64' ' ' ILE . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' CD2' ' HB3' ' A' ' 131' ' ' ALA . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG12 ' HG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.546 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.546 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.657 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 84' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 96' ' ' LYS . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.701 HD13 HG22 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.543 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.575 HG21 HE21 ' A' ' 130' ' ' GLN . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.701 HG22 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.565 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.51 ' NE2' ' HB3' ' A' ' 31' ' ' GLU . 26.5 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.431 ' HG ' ' HA ' ' A' ' 119' ' ' GLN . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.638 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.431 HD12 HD23 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.575 HE21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.411 ' HB3' ' CD2' ' A' ' 67' ' ' LEU . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.02 -47.0 88.46 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.2 p -62.32 -43.97 97.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.338 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 66.8 mtm . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.5 Cg_endo -66.79 -45.06 4.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.163 1.909 . . . . 0.0 112.25 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.64 ' NE2' ' HB2' ' A' ' 33' ' ' GLN . 3.0 mm100 -61.04 150.8 32.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 t -161.57 -43.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.923 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' THR . 43.7 tp10 177.12 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 32' ' ' ARG . 31.5 tpt85 -75.46 -54.5 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.699 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.64 ' HB2' ' NE2' ' A' ' 29' ' ' GLN . 99.4 mm-40 -63.64 -29.91 71.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.405 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.595 ' N ' HE22 ' A' ' 29' ' ' GLN . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.442 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.457 HG23 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.536 ' HB2' HG22 ' A' ' 59' ' ' ILE . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.508 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 54' ' ' LEU . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.478 ' HE2' HG13 ' A' ' 120' ' ' VAL . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.592 HD21 HD13 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.626 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 57' ' ' GLY . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG22 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.592 HD13 HD21 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' HG22 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' ILE . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.484 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.557 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.2 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG22 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG23 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.62 ' HB2' HD22 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.536 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.558 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.62 HD22 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' HA ' HG12 ' A' ' 95' ' ' ILE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.5 ' HB ' HD12 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 95' ' ' ILE . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 106' ' ' PHE . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.44 ' O ' ' HE3' ' A' ' 51' ' ' MET . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.478 HG13 ' HE2' ' A' ' 51' ' ' MET . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.676 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.547 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.94 -56.03 3.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t 179.6 46.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.547 ' HE3' ' OE1' ' A' ' 130' ' ' GLN . 75.1 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.0 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.612 0.244 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.58 ' HB2' HD12 ' A' ' 125' ' ' ILE . 32.1 Cg_exo -58.59 131.48 42.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.475 2.117 . . . . 0.0 112.167 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.2 -46.86 72.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 t -174.65 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 16.1 pt-20 -142.43 -40.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 47.3 ttm-85 -59.92 156.92 13.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 85.2 mt-30 76.45 -33.07 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.425 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 32' ' ' ARG . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.635 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.403 ' HG1' ' N ' ' A' ' 43' ' ' GLY . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.499 ' HB3' HD12 ' A' ' 59' ' ' ILE . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HA2' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.618 ' HE3' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.688 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HB2' HD12 ' A' ' 111' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.586 HG23 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 44' ' ' ARG . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 60' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 64' ' ' ILE . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HD3' HG23 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' VAL . 2.0 m120 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.548 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.527 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.527 HG12 ' HA ' ' A' ' 92' ' ' LEU . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.634 HG13 HG13 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.61 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.634 HG13 HG13 ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.453 ' HB1' HG23 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.656 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.509 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.4 ' O ' ' HE3' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.618 ' HB ' ' HE3' ' A' ' 51' ' ' MET . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 31' ' ' GLU . 26.2 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.635 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 28' ' ' PRO . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.417 HD11 HG23 ' A' ' 95' ' ' ILE . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.607 HE21 HG21 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.45 -47.32 84.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.6 p -62.19 -44.42 96.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.02 -40.59 26.5 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.472 2.115 . . . . 0.0 112.332 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.656 ' HB2' HD13 ' A' ' 125' ' ' ILE . 66.1 tp60 -57.37 121.58 10.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p -155.73 23.66 0.39 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.843 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' H ' HE21 ' A' ' 29' ' ' GLN . 56.1 mt-10 49.32 47.76 21.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' O ' HG22 ' A' ' 36' ' ' VAL . 40.7 ttt85 -168.74 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.715 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -59.88 -41.45 91.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD13 ' OE1' ' A' ' 29' ' ' GLN . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 32' ' ' ARG . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.623 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 HG21 HD21 ' A' ' 63' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 59' ' ' ILE . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.441 ' CG ' ' H ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.695 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.695 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.523 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.451 ' O ' HG21 ' A' ' 64' ' ' ILE . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 38' ' ' ILE . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.5 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 131' ' ' ALA . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.2 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.5 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 84' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.55 HG12 ' HA ' ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.605 HG21 ' NE2' ' A' ' 130' ' ' GLN . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HE3' ' HD2' ' A' ' 103' ' ' HIS . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.473 ' HD2' ' HE3' ' A' ' 101' ' ' LYS . 89.5 m-70 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 101' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.57 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.756 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.756 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.425 ' O ' ' HE2' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.433 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.57 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.623 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 29' ' ' GLN . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.605 ' NE2' HG21 ' A' ' 100' ' ' VAL . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.452 ' HB3' HD23 ' A' ' 67' ' ' LEU . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -72.6 -44.11 62.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.8 p -61.63 -49.24 77.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.867 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 73.7 mmtt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.962 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.622 0.249 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.79 -46.45 26.45 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.577 2.185 . . . . 0.0 112.631 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.897 ' HG2' ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -172.43 -133.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.25 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' H ' ' HB2' ' A' ' 29' ' ' GLN . 84.8 m -157.22 -47.28 0.07 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.508 0.194 . . . . 0.0 111.449 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -170.95 -30.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.7 ttm-85 -56.57 -45.86 81.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.897 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 4.2 tp-100 -69.21 -33.67 73.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 31' ' ' GLU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.534 ' NE1' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 63' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.541 ' HB3' HD12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 46' ' ' ILE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.85 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.44 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.85 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.613 ' CD ' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.646 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD23 ' NE1' ' A' ' 37' ' ' TRP . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.531 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' HG21 ' A' ' 64' ' ' ILE . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.623 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.623 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.646 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.572 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' OH ' ' HG3' ' A' ' 134' ' ' LYS . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.458 HG21 ' HG3' ' A' ' 130' ' ' GLN . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.572 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 123' ' ' THR . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.799 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.815 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.799 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.815 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.516 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' OE1' ' HB3' ' A' ' 31' ' ' GLU . 8.1 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 105' ' ' ILE . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HB3' HD23 ' A' ' 34' ' ' LEU . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.585 HG12 HE22 ' A' ' 29' ' ' GLN . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.596 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -70.68 -46.91 62.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.6 p -64.39 -47.97 77.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.9 mmtp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.626 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 27' ' ' MET . 32.2 Cg_exo -59.37 134.05 56.21 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.212 1.941 . . . . 0.0 112.289 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' H ' HE21 ' A' ' 33' ' ' GLN . 25.0 mt-30 -61.39 139.62 58.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.713 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.2 m -61.04 -50.99 71.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 32' ' ' ARG . 15.0 pt-20 -72.13 -52.95 14.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.467 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.674 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 32.8 ttt85 -75.46 178.21 6.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.674 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 0.8 OUTLIER 73.68 -46.79 0.64 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.203 0.315 . . . . 0.0 111.319 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' C ' HG21 ' A' ' 36' ' ' VAL . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG21 ' C ' ' A' ' 35' ' ' ARG . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.562 ' HE1' HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.594 HG22 HD21 ' A' ' 63' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' OE2' HD13 ' A' ' 46' ' ' ILE . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.404 ' OG1' HG21 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.514 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.609 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 44' ' ' ARG . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.467 HD21 HG23 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 38' ' ' ILE . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.535 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.588 HD22 ' H ' ' A' ' 73' ' ' GLN . 7.6 m-80 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.4 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.627 ' HA3' ' NE2' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.535 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.744 HG21 ' N ' ' A' ' 73' ' ' GLN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.744 ' N ' HG21 ' A' ' 72' ' ' VAL . 97.0 mm-40 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG21 ' CG2' ' A' ' 72' ' ' VAL . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 74.0 m-20 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.543 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 84' ' ' LYS . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.543 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.501 ' HA ' HG12 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.696 HG21 HE21 ' A' ' 130' ' ' GLN . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.49 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.765 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 74.5 m-20 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.794 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.765 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.533 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 121' ' ' GLN . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.696 HE21 HG21 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -71.82 -48.82 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.1 p -153.72 36.07 0.45 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.1 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.946 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.62 0.248 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.722 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 36.8 Cg_exo -60.39 127.1 21.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.563 2.175 . . . . 0.0 112.237 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 30' ' ' THR . 3.0 pm0 -76.64 -47.41 22.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.563 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 75.9 m -101.28 143.39 31.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' N ' HG21 ' A' ' 30' ' ' THR . 24.2 pt-20 -55.7 -19.73 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' H ' HG21 ' A' ' 30' ' ' THR . 39.1 ttm180 -56.38 -48.49 76.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.722 ' HB2' ' HB3' ' A' ' 28' ' ' PRO . 11.5 mm100 -60.14 -25.66 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.41 HD13 HD13 ' A' ' 38' ' ' ILE . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.52 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.419 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 62' ' ' GLU . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.472 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.604 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.528 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 46' ' ' ILE . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.57 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.655 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.504 HG21 ' N ' ' A' ' 65' ' ' ASN . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' N ' HG21 ' A' ' 64' ' ' ILE . 73.1 m-20 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 8.1 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.527 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.655 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.578 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' N ' ' CD1' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.584 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.462 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HD12 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.465 HD11 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.533 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 109' ' ' ASN . 2.5 m120 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.881 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.8 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.881 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.8 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 68.1 tp60 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.571 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' ILE . 87.2 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 121' ' ' GLN . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.469 HD12 HD11 ' A' ' 64' ' ' ILE . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.662 ' HG3' ' HE3' ' A' ' 134' ' ' LYS . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -76.52 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.419 HG22 ' HE2' ' A' ' 134' ' ' LYS . 8.0 t -179.31 47.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.061 0.458 . . . . 0.0 110.904 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.662 ' HE3' ' HG3' ' A' ' 130' ' ' GLN . 70.7 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 22.8 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.617 0.246 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HA ' ' HB3' ' A' ' 33' ' ' GLN . 18.6 Cg_exo -66.09 -142.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.701 2.267 . . . . 0.0 112.271 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' A' ' 30' ' ' THR . 7.4 tt0 -176.16 -128.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.124 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.546 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 74.2 p -64.25 -47.43 79.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 110.878 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -177.19 31.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.689 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -83.35 -94.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.2 tt0 -56.17 -34.64 66.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.613 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.605 ' HB ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 62' ' ' GLU . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HB3' HD12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.605 HD12 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.618 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.617 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.574 HD12 ' HB3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 72' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG21 ' N ' ' A' ' 65' ' ' ASN . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.486 ' N ' HG21 ' A' ' 64' ' ' ILE . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.463 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG22 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.539 ' HD3' HG22 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.469 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 75.7 m-20 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 64' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.554 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 90' ' ' ASN . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 105' ' ' ILE . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 127' ' ' LEU . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HE3' ' NE2' ' A' ' 103' ' ' HIS . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.407 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 95' ' ' ILE . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 114' ' ' ASN . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.846 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 3.7 m120 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 6.8 m-80 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.846 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.645 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.576 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.613 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 100' ' ' VAL . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.783 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.627 HE21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt -78.22 39.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -160.24 -44.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.71 0.291 . . . . 0.0 111.23 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 47.4 mmtm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.413 ' HB2' ' HE1' ' A' ' 27' ' ' MET . 51.7 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.708 0.289 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.5 136.66 55.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.497 2.131 . . . . 0.0 112.24 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -66.92 -137.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -174.12 49.09 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 111.48 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 5.5 tp10 -172.12 -54.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.303 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -77.31 -50.39 12.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.282 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.21 -37.08 83.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.557 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.892 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.892 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.737 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.48 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.477 ' HE2' HG13 ' A' ' 120' ' ' VAL . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.737 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.56 HG21 ' OD1' ' A' ' 87' ' ' ASN . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.474 HD12 ' CB ' ' A' ' 44' ' ' ARG . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 91' ' ' PHE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.481 ' HG ' ' HB2' ' A' ' 91' ' ' PHE . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' A' ' 42' ' ' THR . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.526 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 HG23 ' OE2' ' A' ' 62' ' ' GLU . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' HG23 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.56 ' OD1' HG21 ' A' ' 58' ' ' VAL . 3.7 m120 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 84' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HG ' ' A' ' 61' ' ' CYS . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.555 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 92' ' ' LEU . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.687 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.665 HG21 HE21 ' A' ' 130' ' ' GLN . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.687 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.742 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.448 HD21 ' CE1' ' A' ' 106' ' ' PHE . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.404 ' HG1' ' H ' ' A' ' 119' ' ' GLN . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' H ' ' HG1' ' A' ' 118' ' ' THR . 69.3 tp60 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.477 HG13 ' HE2' ' A' ' 51' ' ' MET . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.491 ' O ' HD22 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.681 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.665 HE21 HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.621 ' NZ ' ' HB2' ' A' ' 132' ' ' LYS . 4.2 ttmp? -58.17 -49.78 75.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.2 p -69.06 -43.54 74.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.453 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.7 mmtp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.929 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.429 ' HB2' ' HE1' ' A' ' 27' ' ' MET . 25.3 ptm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.715 0.293 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 33.5 Cg_exo -58.13 -46.14 27.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.565 2.177 . . . . 0.0 112.225 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HB3' ' HE3' ' A' ' 27' ' ' MET . 16.5 pt20 39.31 -137.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 t -56.45 152.17 12.0 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.841 0.353 . . . . 0.0 111.28 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 34' ' ' LEU . 40.7 mp0 -51.26 -23.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.461 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 32' ' ' ARG . 41.4 ttt85 -49.68 -45.44 48.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 3.3 mm100 -75.44 -33.78 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 31' ' ' GLU . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.672 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.704 HG21 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.704 HH12 HG21 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.536 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.587 ' HE3' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.626 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 60' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.565 ' HG ' ' HB2' ' A' ' 91' ' ' PHE . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.626 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.505 HD13 ' HB2' ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' N ' HG21 ' A' ' 64' ' ' ILE . 5.0 m120 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.695 ' HG ' ' HB3' ' A' ' 131' ' ' ALA . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.443 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.83 HG13 HG21 ' A' ' 75' ' ' VAL . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.83 HG21 HG13 ' A' ' 72' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 58' ' ' VAL . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD3' ' CG2' ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.403 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 28.7 m170 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.539 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.503 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HB2' ' HG ' ' A' ' 61' ' ' CYS . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.777 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' HB ' HD12 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.777 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.519 HD11 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.647 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.576 ' HG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.664 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.672 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.51 HD13 HD21 ' A' ' 67' ' ' LEU . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.874 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.532 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.695 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.874 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp -167.21 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 84.8 m -65.96 -38.11 87.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.05 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 35.2 mmtp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.943 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 50.8 ttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.597 0.237 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 32.5 Cg_exo -58.27 135.36 67.63 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.684 ' HG3' ' HE ' ' A' ' 32' ' ' ARG . 12.4 mm100 -61.03 135.12 57.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.609 ' HB ' ' NE2' ' A' ' 121' ' ' GLN . 80.1 p -78.94 34.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' GLN . 2.0 pp20? 179.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.753 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.684 ' HE ' ' HG3' ' A' ' 29' ' ' GLN . 57.6 ttp180 -84.02 159.78 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 74.74 -35.27 0.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.734 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.572 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.59 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.501 ' HB3' HD12 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.836 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.836 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.482 ' O ' HG22 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 52' ' ' ASP . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HE2' ' O ' ' A' ' 52' ' ' ASP . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.679 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.607 HG23 ' HD3' ' A' ' 78' ' ' PRO . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.597 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HB3' HG23 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 60' ' ' LEU . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.548 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.584 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG13 HG12 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.607 ' HD3' HG23 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.679 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 3.9 m120 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 84' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.788 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG21 HE21 ' A' ' 130' ' ' GLN . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.788 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.486 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD21 ' CE1' ' A' ' 106' ' ' PHE . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.53 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.479 HE22 ' HA ' ' A' ' 104' ' ' ASP . 3.8 tp-100 -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.596 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.609 ' NE2' ' HB ' ' A' ' 30' ' ' THR . 40.3 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.438 ' HB3' HD23 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.623 HE21 HG21 ' A' ' 100' ' ' VAL . 45.4 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt -76.61 -47.23 23.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.1 m -164.54 45.43 0.1 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.069 0.461 . . . . 0.0 110.656 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 130' ' ' GLN . 75.0 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.498 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 2.7 tpt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 74.0 Cg_endo -76.8 45.59 1.69 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 112.629 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -59.39 -32.76 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.019 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.441 HG23 ' HG3' ' A' ' 33' ' ' GLN . 85.8 m -43.05 101.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.681 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -67.99 -28.17 67.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.068 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -53.39 -43.32 67.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' A' ' 30' ' ' THR . 73.8 mt-30 -61.29 -37.08 81.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 HD12 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.674 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 HD12 HD23 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 62' ' ' GLU . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.865 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.92 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.589 ' O ' HD22 ' A' ' 54' ' ' LEU . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.92 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD22 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.627 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.586 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.865 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.46 ' HB3' HG23 ' A' ' 42' ' ' THR . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.419 HD23 ' NE1' ' A' ' 37' ' ' TRP . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.457 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' N ' HG21 ' A' ' 64' ' ' ILE . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.517 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' HA ' ' HB3' ' A' ' 90' ' ' ASN . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.439 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.586 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 84' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 77.5 m-20 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 60' ' ' LEU . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.629 HD13 HG22 ' A' ' 105' ' ' ILE . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.629 HG22 HD13 ' A' ' 95' ' ' ILE . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.622 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.723 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.622 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.723 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.421 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 105' ' ' ILE . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.674 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.648 HD12 HD22 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? -62.75 -47.72 82.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.412 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 86.2 m -68.6 -36.93 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 15.3 tppt? . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.027 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 66.3 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.556 0.217 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.51 134.72 62.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.602 2.201 . . . . 0.0 112.327 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.472 ' NE2' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.59 -170.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.289 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' NE2' ' A' ' 29' ' ' GLN . 66.8 p 42.04 -121.18 0.55 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.572 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -147.42 -23.75 0.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -55.62 -43.44 76.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.75 -37.98 79.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HA ' ' HE3' ' A' ' 37' ' ' TRP . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 63' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 62' ' ' GLU . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.583 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.561 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.52 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.463 ' HE2' HG13 ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.61 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 42' ' ' THR . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 38' ' ' ILE . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.53 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.53 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 84' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.663 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.663 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 96' ' ' LYS . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.621 ' HA ' ' HG1' ' A' ' 115' ' ' THR . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.493 HD22 ' NZ ' ' A' ' 55' ' ' LYS . 73.8 m-20 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.621 ' HG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.573 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.594 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.684 ' NE2' ' HE3' ' A' ' 134' ' ' LYS . 57.8 tp60 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -77.36 -72.55 0.35 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -156.59 45.89 0.42 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.684 ' HE3' ' NE2' ' A' ' 130' ' ' GLN . 75.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.657 0.265 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.99 133.27 52.39 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.58 2.186 . . . . 0.0 112.205 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -64.03 131.25 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 3.7 t -69.23 120.93 15.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 4.5 tp10 176.18 -127.77 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 39.4 ttm180 -57.84 -36.63 72.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.642 0.258 . . . . 0.0 111.226 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -49.99 -41.6 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.984 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD22 HD12 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.549 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.537 HG22 HD21 ' A' ' 63' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.496 ' CG2' ' HA2' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.57 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.6 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.606 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.496 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.606 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.555 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.612 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.57 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 38' ' ' ILE . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.598 ' HB2' HG22 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD21 HG22 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.495 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 131' ' ' ALA . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.539 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.539 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG23 HG13 ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.417 ' HA ' HD21 ' A' ' 85' ' ' LEU . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 84' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.541 ' HD3' ' O ' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.665 HD13 HG22 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.439 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.665 HG22 HD13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.445 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 111' ' ' LEU . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 117' ' ' HIS . 24.2 t-20 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.5 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.464 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.51 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.6 ' HB ' ' HE2' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.481 HD12 HD22 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.608 ' O ' ' HD3' ' A' ' 134' ' ' LYS . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 67' ' ' LEU . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -56.73 -55.35 35.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.467 HG21 ' N ' ' A' ' 134' ' ' LYS . 3.4 t -69.69 -43.84 71.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.329 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.608 ' HD3' ' O ' ' A' ' 130' ' ' GLN . 4.9 mptp? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.586 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 mpt? . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.6 Cg_endo -66.88 133.15 30.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.21 1.94 . . . . 0.0 112.217 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 30' ' ' THR . 17.9 pt20 -64.04 -48.99 74.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.702 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.741 ' HG1' ' HB2' ' A' ' 33' ' ' GLN . 10.2 t 36.23 42.25 0.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.833 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -69.03 -47.93 64.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.547 ' HA ' HH12 ' A' ' 35' ' ' ARG . 39.5 ttm180 -68.82 -42.52 77.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.275 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.741 ' HB2' ' HG1' ' A' ' 30' ' ' THR . 84.5 mt-30 -60.48 -18.85 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.842 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 30' ' ' THR . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.547 HH12 ' HA ' ' A' ' 32' ' ' ARG . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.682 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.455 HG12 ' CD2' ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.531 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 84' ' ' LYS . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.517 HD12 ' CB ' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HB2' HG13 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 ' CD2' HG12 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 65' ' ' ASN . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' HG21 ' A' ' 64' ' ' ILE . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.46 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.46 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 73' ' ' GLN . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' N ' HG11 ' A' ' 72' ' ' VAL . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.584 ' HB2' HD22 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.584 HD22 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HA ' HG12 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HE21 ' A' ' 130' ' ' GLN . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.541 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.513 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.541 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 ' HG3' ' A' ' 96' ' ' LYS . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 109' ' ' ASN . 2.6 m120 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.504 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.427 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.485 ' HB2' HG22 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.487 HD22 ' HZ1' ' A' ' 55' ' ' LYS . 76.1 m-80 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.784 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.435 ' O ' ' HE2' ' A' ' 51' ' ' MET . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.784 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.602 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' HD11 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.682 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.486 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.598 HE21 HG21 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.514 ' HB3' ' NZ ' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -167.7 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.0 m -63.47 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.953 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.829 0.347 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.613 ' HB2' HE22 ' A' ' 33' ' ' GLN . 25.8 Cg_endo -61.96 -49.56 6.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.39 2.06 . . . . 0.0 112.346 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -177.46 130.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.442 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -91.38 135.92 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 66.6 mm-40 65.49 145.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.391 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 79.2 ttt180 75.47 -51.15 0.64 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.613 HE22 ' HB2' ' A' ' 28' ' ' PRO . 54.2 tt0 -68.25 -43.89 76.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HA ' ' HE3' ' A' ' 37' ' ' TRP . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.618 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.634 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.705 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.614 ' HE2' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 111' ' ' LEU . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.634 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD13 HD21 ' A' ' 54' ' ' LEU . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.61 ' HB2' HG22 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.567 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.536 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.1 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.61 HG22 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 72' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 84' ' ' LYS . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG22 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.567 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 90' ' ' ASN . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.567 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.527 HD12 HG13 ' A' ' 95' ' ' ILE . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.668 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.546 HG21 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.668 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.614 ' HB ' ' HE2' ' A' ' 51' ' ' MET . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.618 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.557 HG22 ' HD2' ' A' ' 28' ' ' PRO . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.565 ' NE2' ' HE3' ' A' ' 134' ' ' LYS . 51.8 tp60 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt -73.52 -47.03 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.4 m -70.16 -46.44 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.133 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.565 ' HE3' ' NE2' ' A' ' 130' ' ' GLN . 72.8 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.982 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.571 0.224 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.587 ' HA ' HE22 ' A' ' 33' ' ' GLN . 36.3 Cg_exo -57.63 135.06 67.18 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.524 HE22 ' HD2' ' A' ' 32' ' ' ARG . 25.9 mt-30 -69.27 -143.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 57.5 p -152.43 136.36 16.35 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.323 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' H ' HD13 ' A' ' 34' ' ' LEU . 4.8 mm-40 73.39 -52.46 0.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.015 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.524 ' HD2' HE22 ' A' ' 29' ' ' GLN . 39.2 ttm180 -63.81 -52.54 59.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.587 HE22 ' HA ' ' A' ' 28' ' ' PRO . 25.3 mt-30 -77.84 -37.94 47.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.563 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD13 ' H ' ' A' ' 31' ' ' GLU . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.639 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.619 HG12 ' HG ' ' A' ' 63' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.494 ' HB3' HD12 ' A' ' 59' ' ' ILE . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.964 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.964 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.482 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.603 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.59 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 44' ' ' ARG . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.446 ' HA ' HD21 ' A' ' 60' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.619 ' HG ' HG12 ' A' ' 38' ' ' ILE . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.503 HG21 ' N ' ' A' ' 65' ' ' ASN . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.8 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.506 HG23 ' SG ' ' A' ' 61' ' ' CYS . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.542 ' HD3' HG22 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 84' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.522 ' HB ' HD13 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.522 HD13 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.632 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.632 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.628 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.571 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.628 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.564 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 63' ' ' LEU . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt -169.41 44.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -171.63 -36.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.883 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.63 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 27.8 ttt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 35.5 Cg_exo -59.63 -47.2 17.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.194 1.929 . . . . 0.0 112.18 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.68 ' HG3' ' H ' ' A' ' 30' ' ' THR . 60.0 tp60 -175.23 -135.27 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.943 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.68 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 9.6 t 178.88 38.02 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.901 0.381 . . . . 0.0 110.974 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -176.57 -54.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -77.48 -45.86 24.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.217 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.461 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 99.2 mm-40 -68.62 -40.55 80.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.622 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.624 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HG22 HD21 ' A' ' 60' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.681 ' HB2' HG22 ' A' ' 59' ' ' ILE . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.534 ' O ' HD22 ' A' ' 54' ' ' LEU . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.502 ' HE2' HG13 ' A' ' 120' ' ' VAL . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.612 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 50' ' ' PHE . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.612 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 HG22 ' A' ' 38' ' ' ILE . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.564 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' HG21 ' A' ' 64' ' ' ILE . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.505 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.564 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.444 ' N ' ' HD2' ' A' ' 83' ' ' HIS . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.444 ' HD2' ' N ' ' A' ' 80' ' ' GLN . 95.6 m-70 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.538 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 92' ' ' LEU . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.527 HG21 ' NE2' ' A' ' 130' ' ' GLN . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.528 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 96' ' ' LYS . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.579 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.684 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.608 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.624 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.527 ' NE2' HG21 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.594 ' NZ ' ' HB2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -68.53 -43.82 75.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.4 t -176.07 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 130' ' ' GLN . 35.3 mmtp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.858 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.477 ' N ' ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 29' ' ' GLN . 43.1 Cg_endo -67.58 -137.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.543 2.162 . . . . 0.0 112.25 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 17.9 pt20 -171.78 -139.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.612 ' HA ' ' HG ' ' A' ' 34' ' ' LEU . 69.2 p -147.8 -149.13 0.28 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.944 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 32' ' ' ARG . 88.4 tt0 54.48 -110.76 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.655 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.518 HH11 ' NH2' ' A' ' 35' ' ' ARG . 30.0 tpt180 -56.9 -40.34 76.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -58.34 -48.27 81.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.612 ' HG ' ' HA ' ' A' ' 30' ' ' THR . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.518 ' NH2' HH11 ' A' ' 32' ' ' ARG . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 32' ' ' ARG . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 62' ' ' GLU . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.559 ' HB3' HD12 ' A' ' 59' ' ' ILE . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 46' ' ' ILE . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 47.4 t30 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.45 ' HE2' HG13 ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.628 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.469 ' HB2' HD12 ' A' ' 111' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.628 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.602 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 44' ' ' ARG . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 91' ' ' PHE . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.537 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.51 ' N ' HG21 ' A' ' 64' ' ' ILE . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.503 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.471 ' HD3' HG23 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.415 ' HB3' ' HG ' ' A' ' 61' ' ' CYS . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 84' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.566 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 96' ' ' LYS . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.435 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.798 ' HB3' ' HE2' ' A' ' 117' ' ' HIS . 4.7 m120 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.704 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.798 ' HE2' ' HB3' ' A' ' 114' ' ' ASN . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.637 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt -67.57 -58.56 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.604 HG21 ' H ' ' A' ' 134' ' ' LYS . 2.4 t -67.63 -50.3 58.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.138 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.604 ' H ' HG21 ' A' ' 133' ' ' THR . 48.0 mmtm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.878 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.563 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 51.0 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 27' ' ' MET . 50.5 Cg_endo -68.39 -138.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.235 1.957 . . . . 0.0 112.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.631 HE22 ' HG2' ' A' ' 31' ' ' GLU . 70.8 tp60 -173.05 127.47 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.641 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 t -179.82 44.08 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.298 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.631 ' HG2' HE22 ' A' ' 29' ' ' GLN . 65.7 mm-40 -60.76 -54.55 43.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.667 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.597 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 79.7 ttt180 -81.12 -45.14 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -55.95 -12.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.142 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.565 ' C ' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD13 ' HG ' ' A' ' 34' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD22 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' CB ' HD12 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 46' ' ' ILE . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.492 ' HE2' HG13 ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.589 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' ' 111' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' HD21 ' A' ' 60' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.557 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 HD22 ' CB ' ' A' ' 41' ' ' ALA . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.568 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.458 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.5 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.568 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.615 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.615 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.545 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.708 HD13 HG22 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.673 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.703 HG21 HE21 ' A' ' 130' ' ' GLN . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.673 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 95' ' ' ILE . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.619 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.519 HD22 ' NZ ' ' A' ' 55' ' ' LYS . 73.7 m-20 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.469 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.7 OUTLIER -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.429 HG21 ' ND2' ' A' ' 116' ' ' ASN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.619 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.587 ' HG1' ' HD2' ' A' ' 106' ' ' PHE . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.674 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.703 HE21 HG21 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt -57.06 -41.32 78.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.404 ' HB ' ' HD3' ' A' ' 134' ' ' LYS . 91.0 m -64.87 -35.78 82.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.596 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.695 0.283 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.646 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.452 HD12 HD23 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 46' ' ' ILE . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.898 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 50.9 t-20 -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.898 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.649 HD22 HD11 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.649 HD11 HD22 ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.589 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 71' ' ' SER . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.6 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 64' ' ' ILE . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.437 HG11 ' SG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.537 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 55' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' CE1' ' A' ' 106' ' ' PHE . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.551 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD21 ' A' ' 92' ' ' LEU . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.507 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.569 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HA ' HD13 ' A' ' 124' ' ' LEU . 89.1 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.56 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.629 0.252 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 124' ' ' LEU . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG12 HD22 ' A' ' 63' ' ' LEU . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.875 HG21 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.645 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.94 HD22 HD11 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.94 HD11 HD22 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.619 ' SG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.875 ' HB3' HG21 ' A' ' 42' ' ' THR . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.749 HD22 HG12 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.508 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.553 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.1 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG21 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.619 HG22 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB2' HD21 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 77' ' ' ASP . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.656 HD21 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 95' ' ' ILE . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 106' ' ' PHE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.609 HG13 HD13 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE1' HD21 ' A' ' 92' ' ' LEU . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CB ' HG23 ' A' ' 115' ' ' THR . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 113' ' ' GLU . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.698 HD22 HD11 ' A' ' 38' ' ' ILE . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 111.425 0.158 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 60' ' ' LEU . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.718 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.58 HD22 HD11 ' A' ' 60' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.718 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD22 ' A' ' 54' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 64' ' ' ILE . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 61' ' ' CYS . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.643 HD22 ' HB1' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.5 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.914 ' HD3' HG21 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.578 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 112' ' ' PHE . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.452 ' ND2' HG22 ' A' ' 58' ' ' VAL . 10.7 m-20 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.746 HG13 HD13 ' A' ' 105' ' ' ILE . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HD21 ' A' ' 85' ' ' LEU . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' HE1' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 119' ' ' GLN . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.47 ' NE2' ' N ' ' A' ' 130' ' ' GLN . 0.0 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.643 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD13 ' A' ' 125' ' ' ILE . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' LEU . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD22 ' A' ' 124' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 53' ' ' GLY . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 53.9 t-20 -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.898 HD22 HD11 ' A' ' 60' ' ' LEU . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.898 HD11 HD22 ' A' ' 54' ' ' LEU . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD13 ' CB ' ' A' ' 41' ' ' ALA . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.528 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.474 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.3 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.528 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 61' ' ' CYS . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' SG ' ' A' ' 61' ' ' CYS . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.649 HD11 ' O ' ' A' ' 55' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.55 HD21 ' C ' ' A' ' 54' ' ' LEU . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CB ' HG23 ' A' ' 115' ' ' THR . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.63 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.451 HD13 HD21 ' A' ' 34' ' ' LEU . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.537 0.208 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 124' ' ' LEU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 124' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 50' ' ' PHE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.883 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.832 HD22 HD11 ' A' ' 60' ' ' LEU . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.877 HG13 HG21 ' A' ' 75' ' ' VAL . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 HD22 ' A' ' 54' ' ' LEU . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.492 ' CD2' HG12 ' A' ' 38' ' ' ILE . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 131' ' ' ALA . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.2 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.6 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 58' ' ' VAL . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 112' ' ' PHE . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.528 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.583 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 54' ' ' LEU . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CG ' HD21 ' A' ' 85' ' ' LEU . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.491 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.8 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 38' ' ' ILE . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.381 0.134 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 34' ' ' LEU . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 60' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.507 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.803 HD22 HD11 ' A' ' 60' ' ' LEU . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.517 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HE1' ' A' ' 37' ' ' TRP . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.558 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 72' ' ' VAL . 2.3 m120 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 131' ' ' ALA . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.9 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.485 ' HA2' ' OE1' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.485 ' OE1' ' HA2' ' A' ' 70' ' ' GLY . 30.5 mm100 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG21 ' OE2' ' A' ' 62' ' ' GLU . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 30.4 m120 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 108' ' ' ALA . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.614 HD11 HD23 ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.479 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 100' ' ' VAL . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.604 ' HA ' HD13 ' A' ' 92' ' ' LEU . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.459 HD22 ' HD2' ' A' ' 55' ' ' LYS . 32.4 m120 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 116' ' ' ASN . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 121' ' ' GLN . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.562 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.586 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.5 mm100 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.761 0.315 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD12 ' A' ' 124' ' ' LEU . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HE1' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' CD1' HD13 ' A' ' 124' ' ' LEU . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 59' ' ' ILE . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.498 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.547 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 60' ' ' LEU . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 54' ' ' LEU . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.66 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 61' ' ' CYS . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 72' ' ' VAL . 24.6 m120 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 131' ' ' ALA . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 64.0 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' H ' HD21 ' A' ' 65' ' ' ASN . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.66 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 112' ' ' PHE . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.419 ' HB3' HG22 ' A' ' 72' ' ' VAL . 32.3 m120 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.461 ' HA3' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.772 HD13 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.531 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 85' ' ' LEU . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.49 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.799 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 12.1 tp-100 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 116' ' ' ASN . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 125' ' ' ILE . 32.7 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 105' ' ' ILE . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.681 HD12 HD21 ' A' ' 34' ' ' LEU . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 121' ' ' GLN . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.489 ' HB2' ' CH2' ' A' ' 37' ' ' TRP . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.461 ' NE2' ' HA3' ' A' ' 99' ' ' GLY . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 124' ' ' LEU . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 46' ' ' ILE . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 60' ' ' LEU . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 54' ' ' LEU . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 75' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD13 ' CB ' ' A' ' 41' ' ' ALA . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.784 HD22 ' HB1' ' A' ' 131' ' ' ALA . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG21 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 72' ' ' VAL . 31.0 m120 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 95' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 92' ' ' LEU . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.659 ' HG2' HD12 ' A' ' 105' ' ' ILE . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.659 HD12 ' HG2' ' A' ' 96' ' ' LYS . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 115' ' ' THR . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 55.6 m-20 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 113' ' ' GLU . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 1.8 m120 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.678 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 105' ' ' ILE . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.548 HE21 HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.784 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 124' ' ' LEU . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.909 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.909 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB2' HD11 ' A' ' 111' ' ' LEU . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' HD11 ' A' ' 88' ' ' ILE . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.702 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.479 HG23 ' OG1' ' A' ' 42' ' ' THR . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 38' ' ' ILE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' OE2' HG21 ' A' ' 75' ' ' VAL . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD21 ' NE1' ' A' ' 37' ' ' TRP . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 58' ' ' VAL . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' CE2' ' A' ' 112' ' ' PHE . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.426 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 40.8 m-20 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 55' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 105' ' ' ILE . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 105' ' ' ILE . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.688 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.732 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 92' ' ' LEU . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' HD21 ' A' ' 85' ' ' LEU . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 116' ' ' ASN . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' HD23 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.683 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.596 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.627 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 4.2 ttmp? . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.69 0.281 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.408 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.679 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.856 HG22 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.888 ' CZ ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.968 HG21 ' HD3' ' A' ' 78' ' ' PRO . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.888 HG23 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 54' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.0 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 58' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.968 ' HD3' HG21 ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' TRP . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 55' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.654 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.766 ' HA ' HD13 ' A' ' 124' ' ' LEU . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 121' ' ' GLN . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.885 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.591 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.658 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.851 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 60' ' ' LEU . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' O ' HD11 ' A' ' 88' ' ' ILE . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 75' ' ' VAL . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 54' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HB3' HG21 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.658 HD11 ' HE1' ' A' ' 37' ' ' TRP . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.572 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.2 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' HG13 ' A' ' 64' ' ' ILE . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD3' HG21 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.568 ' HA ' HD12 ' A' ' 85' ' ' LEU . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 82' ' ' TRP . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 51.4 m-20 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 55' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.593 HD11 HD23 ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.613 ' HB ' HD11 ' A' ' 105' ' ' ILE . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 100' ' ' VAL . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 54' ' ' LEU . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.533 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.4 OUTLIER -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HB3' HD22 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.453 ' OE1' HG23 ' A' ' 100' ' ' VAL . 26.6 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD21 HD13 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.724 HD11 HD22 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.945 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 50.3 t-20 -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 54' ' ' LEU . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.945 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.857 HG21 ' HD3' ' A' ' 78' ' ' PRO . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.852 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' HG11 ' A' ' 75' ' ' VAL . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD22 HG12 ' A' ' 38' ' ' ILE . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG13 ' OG ' ' A' ' 71' ' ' SER . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 131' ' ' ALA . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.5 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.517 HG21 ' SG ' ' A' ' 61' ' ' CYS . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.605 ' CG2' HG13 ' A' ' 58' ' ' VAL . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.857 ' HD3' HG21 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.53 ' HA ' HD12 ' A' ' 85' ' ' LEU . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 82' ' ' TRP . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 31.4 m120 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 95' ' ' ILE . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.605 HD11 ' HB ' ' A' ' 100' ' ' VAL . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.63 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 115' ' ' THR . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.63 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 119' ' ' GLN . 54.8 t-20 -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.532 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.581 ' HB2' ' ND2' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 38' ' ' ILE . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.755 0.312 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 124' ' ' LEU . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.593 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.645 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.593 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.474 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.634 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.012 HD22 HD11 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD11 HD22 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 41' ' ' ALA . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG22 ' SG ' ' A' ' 61' ' ' CYS . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 83' ' ' HIS . 24.9 m-70 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 112' ' ' PHE . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.627 HD11 ' O ' ' A' ' 55' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.592 HD11 HD23 ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 105' ' ' ILE . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 100' ' ' VAL . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 85' ' ' LEU . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.444 ' HB2' HG23 ' A' ' 115' ' ' THR . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 m120 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.599 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.645 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 127' ' ' LEU . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.752 0.31 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.737 HD21 HD13 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.554 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.642 HG21 HD23 ' A' ' 60' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.662 ' HE2' ' HB3' ' A' ' 117' ' ' HIS . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.064 HD22 HD11 ' A' ' 60' ' ' LEU . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.064 HD11 HD22 ' A' ' 54' ' ' LEU . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.836 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.565 HD22 HG12 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.519 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.537 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 61.3 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG22 ' CG1' ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 75' ' ' VAL . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' ILE . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.64 HD23 HD11 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB1' ' OE1' ' A' ' 68' ' ' GLN . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.657 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.657 HD13 HG13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' C ' ' A' ' 54' ' ' LEU . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 113' ' ' GLU . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.509 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.526 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.612 HD22 HD11 ' A' ' 38' ' ' ILE . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD13 HD21 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.445 ' OE1' HG22 ' A' ' 100' ' ' VAL . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.658 HG23 HD22 ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HB2' HD13 ' A' ' 59' ' ' ILE . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.497 ' O ' HD11 ' A' ' 111' ' ' LEU . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HD3' HD22 ' A' ' 114' ' ' ASN . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 54' ' ' LEU . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.54 ' HB2' HG11 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.658 HD22 HG23 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 95' ' ' ILE . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 61.8 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' HB2' ' A' ' 61' ' ' CYS . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.599 ' HB2' HD21 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.599 HD21 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 108' ' ' ALA . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HG3' HD12 ' A' ' 105' ' ' ILE . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.638 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.511 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.544 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.638 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 92' ' ' LEU . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 54' ' ' LEU . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.696 HD22 ' HD3' ' A' ' 55' ' ' LYS . 34.8 m120 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.609 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.731 ' HA ' HD13 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 121' ' ' GLN . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.626 HE21 HG22 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 124' ' ' LEU . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 53' ' ' GLY . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.482 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 60' ' ' LEU . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.669 ' O ' HD11 ' A' ' 88' ' ' ILE . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.649 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 38' ' ' ILE . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 64.9 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.828 HG21 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 75' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 112' ' ' PHE . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.837 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 102' ' ' PRO . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 92' ' ' LEU . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 85' ' ' LEU . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.56 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.603 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.635 HD22 HD11 ' A' ' 38' ' ' ILE . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.595 0.236 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 124' ' ' LEU . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.647 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.641 HD11 HD22 ' A' ' 124' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.694 HG22 ' HA3' ' A' ' 53' ' ' GLY . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.966 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.522 ' HE3' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 60' ' ' LEU . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.852 HG13 HG11 ' A' ' 75' ' ' VAL . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 54' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB3' HG21 ' A' ' 42' ' ' THR . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' HE1' ' A' ' 37' ' ' TRP . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG13 ' OG ' ' A' ' 71' ' ' SER . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' ALA . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.532 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 62.3 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.852 HG11 HG13 ' A' ' 58' ' ' VAL . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HD3' HG21 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 55' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.583 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 53.5 t-20 -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 51' ' ' MET . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.468 ' HB2' HD22 ' A' ' 116' ' ' ASN . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.603 0.239 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.633 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.648 HD11 HD22 ' A' ' 124' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' HA3' ' A' ' 53' ' ' GLY . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.538 ' O ' HD23 ' A' ' 54' ' ' LEU . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 60' ' ' LEU . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.575 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 54' ' ' LEU . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.588 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.7 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.588 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD3' HG21 ' A' ' 58' ' ' VAL . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 51.1 m80 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 90' ' ' ASN . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 91' ' ' PHE . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.78 HD11 ' HB ' ' A' ' 100' ' ' VAL . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.586 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.447 HD21 ' C ' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.7 m120 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.417 HG23 HG12 ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD22 HD11 ' A' ' 38' ' ' ILE . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.694 0.283 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG3' ' OE2' ' A' ' 39' ' ' GLU . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 HD22 ' A' ' 63' ' ' LEU . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 18.0 t-20 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.847 HG21 ' HD3' ' A' ' 78' ' ' PRO . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 72' ' ' VAL . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD13 ' CB ' ' A' ' 41' ' ' ALA . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.565 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 131' ' ' ALA . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.0 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.565 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG21 ' SG ' ' A' ' 61' ' ' CYS . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 58' ' ' VAL . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 55' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.616 HG13 HD13 ' A' ' 105' ' ' ILE . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.597 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.454 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.662 0.268 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 124' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HB2' HD13 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.466 ' CE ' ' HB ' ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 60' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.687 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG13 HG11 ' A' ' 75' ' ' VAL . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 54' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.561 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.592 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 131' ' ' ALA . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.4 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.592 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.589 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 HG13 ' A' ' 58' ' ' VAL . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 112' ' ' PHE . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.687 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.744 ' HB ' HD11 ' A' ' 105' ' ' ILE . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.744 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.504 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CD2' HD21 ' A' ' 85' ' ' LEU . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 115' ' ' THR . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.558 HD22 ' HE3' ' A' ' 55' ' ' LYS . 33.1 m120 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 51.9 t-20 -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.491 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 119' ' ' GLN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 118' ' ' THR . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.676 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.789 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.706 0.289 . . . . 0.0 111.154 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' HG23 ' A' ' 125' ' ' ILE . 28.7 Cg_endo -62.88 -43.64 19.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.568 2.179 . . . . 0.0 112.286 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 3.6 tp-100 -171.09 -125.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.476 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 88.2 m -161.96 -42.37 0.04 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HA ' HD12 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -168.79 -31.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.421 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -59.75 -47.47 85.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 53.7 tt0 -66.88 -34.76 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.646 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.452 HD12 HD23 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 46' ' ' ILE . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.898 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 50.9 t-20 -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.898 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.649 HD22 HD11 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.649 HD11 HD22 ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.589 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 71' ' ' SER . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.6 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 64' ' ' ILE . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.437 HG11 ' SG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.537 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 55' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' CE1' ' A' ' 106' ' ' PHE . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.551 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD21 ' A' ' 92' ' ' LEU . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.507 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HA ' HD13 ' A' ' 124' ' ' LEU . 89.1 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 133' ' ' THR . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.56 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.02 -47.0 88.46 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 129' ' ' SER . 82.2 p -62.32 -43.97 97.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.338 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.583 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 66.8 mtm . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.5 Cg_endo -66.79 -45.06 4.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.163 1.909 . . . . 0.0 112.25 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.51 ' OE1' ' HB2' ' A' ' 33' ' ' GLN . 42.4 mm-40 -61.04 150.8 32.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 t -161.57 -43.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.923 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.743 ' HA ' HD12 ' A' ' 34' ' ' LEU . 43.7 tp10 177.12 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 32' ' ' ARG . 31.5 tpt85 -75.46 -54.5 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.699 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HB2' ' OE1' ' A' ' 29' ' ' GLN . 99.4 mm-40 -63.64 -29.91 71.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.405 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 31' ' ' GLU . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG12 HD22 ' A' ' 63' ' ' LEU . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.875 HG21 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.645 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.94 HD22 HD11 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.94 HD11 HD22 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.619 ' SG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.875 ' HB3' HG21 ' A' ' 42' ' ' THR . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.749 HD22 HG12 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.508 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.553 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.1 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG21 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.619 HG22 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB2' HD21 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 77' ' ' ASP . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.656 HD21 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 95' ' ' ILE . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 106' ' ' PHE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.609 HG13 HD13 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE1' HD21 ' A' ' 92' ' ' LEU . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CB ' HG23 ' A' ' 115' ' ' THR . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 113' ' ' GLU . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.698 HD22 HD11 ' A' ' 38' ' ' ILE . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HB2' ' HG3' ' A' ' 29' ' ' GLN . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.553 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.94 -56.03 3.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t 179.6 46.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.553 ' HE3' ' OE1' ' A' ' 130' ' ' GLN . 75.1 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.0 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.612 0.244 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 32.1 Cg_exo -58.59 131.48 42.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.475 2.117 . . . . 0.0 112.167 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -67.2 -46.86 72.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' HG2' ' A' ' 31' ' ' GLU . 7.0 t -174.65 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.569 ' HA ' HD12 ' A' ' 34' ' ' LEU . 16.1 pt-20 -142.43 -40.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 47.3 ttm-85 -59.92 156.92 13.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 85.2 mt-30 76.45 -33.07 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.425 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 31' ' ' GLU . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 60' ' ' LEU . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.718 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.58 HD22 HD11 ' A' ' 60' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.718 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD22 ' A' ' 54' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 64' ' ' ILE . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 61' ' ' CYS . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.643 HD22 ' HB1' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.5 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.914 ' HD3' HG21 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.578 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 112' ' ' PHE . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.452 ' ND2' HG22 ' A' ' 58' ' ' VAL . 10.7 m-20 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.746 HG13 HD13 ' A' ' 105' ' ' ILE . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HD21 ' A' ' 85' ' ' LEU . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' HE1' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 119' ' ' GLN . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 28' ' ' PRO . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 133' ' ' THR . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.643 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.45 -47.32 84.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 129' ' ' SER . 81.6 p -62.19 -44.42 96.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 125' ' ' ILE . 31.3 Cg_endo -64.02 -40.59 26.5 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.472 2.115 . . . . 0.0 112.332 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' OE1' HD11 ' A' ' 125' ' ' ILE . 66.1 tp60 -57.37 121.58 10.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p -155.73 23.66 0.39 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.843 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' H ' HE21 ' A' ' 29' ' ' GLN . 56.1 mt-10 49.32 47.76 21.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 32' ' ' ARG . 40.7 ttt85 -168.74 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.715 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -59.88 -41.45 91.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD13 ' A' ' 125' ' ' ILE . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' LEU . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD22 ' A' ' 124' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 53' ' ' GLY . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 53.9 t-20 -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.898 HD22 HD11 ' A' ' 60' ' ' LEU . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.898 HD11 HD22 ' A' ' 54' ' ' LEU . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD13 ' CB ' ' A' ' 41' ' ' ALA . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.528 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.474 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.3 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.528 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 61' ' ' CYS . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' SG ' ' A' ' 61' ' ' CYS . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.649 HD11 ' O ' ' A' ' 55' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.55 HD21 ' C ' ' A' ' 54' ' ' LEU . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CB ' HG23 ' A' ' 115' ' ' THR . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.63 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.553 HD11 ' OE1' ' A' ' 29' ' ' GLN . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 133' ' ' THR . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.641 ' HG3' ' HE2' ' A' ' 134' ' ' LYS . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -72.6 -44.11 62.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 129' ' ' SER . 68.8 p -61.63 -49.24 77.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.867 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.641 ' HE2' ' HG3' ' A' ' 130' ' ' GLN . 73.7 mmtt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.962 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.622 0.249 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.79 -46.45 26.45 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.577 2.185 . . . . 0.0 112.631 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.905 ' HG2' ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -172.43 -133.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.25 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 29' ' ' GLN . 84.8 m -157.22 -47.28 0.07 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.508 0.194 . . . . 0.0 111.449 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.606 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 0.9 OUTLIER -170.95 -30.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 32' ' ' ARG . 46.7 ttm-85 -56.57 -45.86 81.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.905 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 4.2 tp-100 -69.21 -33.67 73.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 31' ' ' GLU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 124' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 50' ' ' PHE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.883 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.832 HD22 HD11 ' A' ' 60' ' ' LEU . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.877 HG13 HG21 ' A' ' 75' ' ' VAL . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 HD22 ' A' ' 54' ' ' LEU . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.492 ' CD2' HG12 ' A' ' 38' ' ' ILE . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 131' ' ' ALA . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.2 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.6 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 58' ' ' VAL . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 112' ' ' PHE . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.528 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.493 ' OH ' ' HG3' ' A' ' 134' ' ' LYS . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.583 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 54' ' ' LEU . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CG ' HD21 ' A' ' 85' ' ' LEU . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.491 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.8 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.606 ' NE2' ' HB3' ' A' ' 31' ' ' GLU . 65.3 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 38' ' ' ILE . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.588 HG12 HE22 ' A' ' 29' ' ' GLN . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 133' ' ' THR . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.61 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -70.68 -46.91 62.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 129' ' ' SER . 61.6 p -64.39 -47.97 77.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.9 mmtp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 27' ' ' MET . 32.2 Cg_exo -59.37 134.05 56.21 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.212 1.941 . . . . 0.0 112.289 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.605 ' H ' HE21 ' A' ' 33' ' ' GLN . 82.2 mt-30 -61.39 139.62 58.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.713 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 125' ' ' ILE . 86.2 m -61.04 -50.99 71.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 32' ' ' ARG . 15.0 pt-20 -72.13 -52.95 14.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.467 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 32.8 ttt85 -75.46 178.21 6.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.675 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 0.8 OUTLIER 73.68 -46.79 0.64 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.203 0.315 . . . . 0.0 111.319 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 34' ' ' LEU . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 60' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.507 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.803 HD22 HD11 ' A' ' 60' ' ' LEU . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.517 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HE1' ' A' ' 37' ' ' TRP . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.558 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 72' ' ' VAL . 2.3 m120 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 131' ' ' ALA . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.434 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.9 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.485 ' HA2' ' OE1' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.485 ' OE1' ' HA2' ' A' ' 70' ' ' GLY . 30.5 mm100 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG21 ' OE2' ' A' ' 62' ' ' GLU . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 30.4 m120 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 108' ' ' ALA . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.614 HD11 HD23 ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.479 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 100' ' ' VAL . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.604 ' HA ' HD13 ' A' ' 92' ' ' LEU . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.459 HD22 ' HD2' ' A' ' 55' ' ' LYS . 32.4 m120 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 116' ' ' ASN . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 30' ' ' THR . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.562 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.586 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 133' ' ' THR . 14.5 ptmm? -71.82 -48.82 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 56.1 p -153.72 36.07 0.45 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.946 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.445 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.62 0.248 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.758 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 36.8 Cg_exo -60.39 127.1 21.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.563 2.175 . . . . 0.0 112.237 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.533 ' CD ' ' H ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -76.64 -47.41 22.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 32' ' ' ARG . 75.9 m -101.28 143.39 31.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 24.2 pt-20 -55.7 -19.73 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.801 ' H ' HG22 ' A' ' 30' ' ' THR . 39.1 ttm180 -56.38 -48.49 76.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.758 ' HB2' ' HB3' ' A' ' 28' ' ' PRO . 11.5 mm100 -60.14 -25.66 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD12 ' A' ' 124' ' ' LEU . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HE1' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' CD1' HD13 ' A' ' 124' ' ' LEU . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 59' ' ' ILE . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.498 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.547 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 60' ' ' LEU . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 54' ' ' LEU . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.66 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 61' ' ' CYS . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 72' ' ' VAL . 24.6 m120 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 131' ' ' ALA . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 64.0 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' H ' HD21 ' A' ' 65' ' ' ASN . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.66 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 112' ' ' PHE . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.419 ' HB3' HG22 ' A' ' 72' ' ' VAL . 32.3 m120 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.461 ' HA3' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.772 HD13 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.531 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 85' ' ' LEU . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.49 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.799 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 12.1 tp-100 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 116' ' ' ASN . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 125' ' ' ILE . 32.7 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 105' ' ' ILE . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.681 HD12 HD21 ' A' ' 34' ' ' LEU . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.602 HG23 ' HD2' ' A' ' 28' ' ' PRO . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.489 ' HB2' ' CH2' ' A' ' 37' ' ' TRP . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.678 ' HG3' ' HE3' ' A' ' 134' ' ' LYS . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -76.52 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.537 HG23 ' HE2' ' A' ' 134' ' ' LYS . 8.0 t -179.31 47.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.061 0.458 . . . . 0.0 110.904 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.678 ' HE3' ' HG3' ' A' ' 130' ' ' GLN . 70.7 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 22.8 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.617 0.246 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 33' ' ' GLN . 18.6 Cg_exo -66.09 -142.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.701 2.267 . . . . 0.0 112.271 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 30' ' ' THR . 55.6 tt0 -176.16 -128.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.124 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.529 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 74.2 p -64.25 -47.43 79.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 110.878 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -177.19 31.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.689 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.6 ttt-85 -83.35 -94.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.2 tt0 -56.17 -34.64 66.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 124' ' ' LEU . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 46' ' ' ILE . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' ARG . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 60' ' ' LEU . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 54' ' ' LEU . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 75' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD13 ' CB ' ' A' ' 41' ' ' ALA . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.784 HD22 ' HB1' ' A' ' 131' ' ' ALA . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG21 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 72' ' ' VAL . 31.0 m120 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 95' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 92' ' ' LEU . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.659 ' HG2' HD12 ' A' ' 105' ' ' ILE . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.659 HD12 ' HG2' ' A' ' 96' ' ' LYS . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 115' ' ' THR . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 55.6 m-20 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 113' ' ' GLU . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 1.8 m120 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.678 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 105' ' ' ILE . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.548 HE21 HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.784 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt -78.22 39.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -160.24 -44.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.71 0.291 . . . . 0.0 111.23 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 47.4 mmtm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.708 0.289 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.5 136.66 55.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.497 2.131 . . . . 0.0 112.24 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -66.92 -137.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.608 ' HB ' HD11 ' A' ' 125' ' ' ILE . 6.9 t -174.12 49.09 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 111.48 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -172.12 -54.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.303 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -77.31 -50.39 12.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.282 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.21 -37.08 83.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.557 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 124' ' ' LEU . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.909 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.909 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB2' HD11 ' A' ' 111' ' ' LEU . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' HD11 ' A' ' 88' ' ' ILE . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.702 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.479 HG23 ' OG1' ' A' ' 42' ' ' THR . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 38' ' ' ILE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' OE2' HG21 ' A' ' 75' ' ' VAL . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD21 ' NE1' ' A' ' 37' ' ' TRP . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 HG13 ' OG ' ' A' ' 71' ' ' SER . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 58' ' ' VAL . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' CE2' ' A' ' 112' ' ' PHE . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.426 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 40.8 m-20 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 55' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 105' ' ' ILE . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 105' ' ' ILE . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.688 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.732 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 92' ' ' LEU . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' HD21 ' A' ' 85' ' ' LEU . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 116' ' ' ASN . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' HD23 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.683 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 30' ' ' THR . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.596 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.627 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 4.2 ttmp? -58.17 -49.78 75.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.2 p -69.06 -43.54 74.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.453 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.7 mmtp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.929 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.3 ptm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.715 0.293 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.616 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 33.5 Cg_exo -58.13 -46.14 27.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.565 2.177 . . . . 0.0 112.225 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 39.31 -137.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.54 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 32' ' ' ARG . 8.1 t -56.45 152.17 12.0 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.841 0.353 . . . . 0.0 111.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HA ' HD12 ' A' ' 34' ' ' LEU . 40.7 mp0 -51.26 -23.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.461 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 30' ' ' THR . 41.4 ttt85 -49.68 -45.44 48.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 48.3 mm-40 -75.44 -33.78 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 31' ' ' GLU . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.408 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.679 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.856 HG22 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.888 ' CZ ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.968 HG21 ' HD3' ' A' ' 78' ' ' PRO . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.888 HG23 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 54' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.0 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 58' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.968 ' HD3' HG21 ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' TRP . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 55' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.654 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.766 ' HA ' HD13 ' A' ' 124' ' ' LEU . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 121' ' ' GLN . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.616 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.885 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp -167.21 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 84.8 m -65.96 -38.11 87.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.05 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 35.2 mmtp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.943 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 50.8 ttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.597 0.237 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' A' ' 125' ' ' ILE . 32.5 Cg_exo -58.27 135.36 67.63 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.734 ' HG3' ' HE ' ' A' ' 32' ' ' ARG . 12.4 mm100 -61.03 135.12 57.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.46 ' HB ' ' OE1' ' A' ' 121' ' ' GLN . 80.1 p -78.94 34.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? 179.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.734 ' HE ' ' HG3' ' A' ' 29' ' ' GLN . 57.6 ttp180 -84.02 159.78 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 50.0 tt0 74.74 -35.27 0.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.734 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.591 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.658 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.851 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 60' ' ' LEU . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' O ' HD11 ' A' ' 88' ' ' ILE . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 75' ' ' VAL . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 54' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HB3' HG21 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.658 HD11 ' HE1' ' A' ' 37' ' ' TRP . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.572 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.2 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' HG13 ' A' ' 64' ' ' ILE . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD3' HG21 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.568 ' HA ' HD12 ' A' ' 85' ' ' LEU . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 82' ' ' TRP . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 51.4 m-20 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 55' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.593 HD11 HD23 ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.613 ' HB ' HD11 ' A' ' 105' ' ' ILE . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 100' ' ' VAL . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 54' ' ' LEU . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.533 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.4 OUTLIER -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' OE1' ' HB ' ' A' ' 30' ' ' THR . 17.5 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HB3' HD22 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 28' ' ' PRO . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.453 ' OE1' HG23 ' A' ' 100' ' ' VAL . 26.6 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt -76.61 -47.23 23.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 133' ' ' THR . 20.1 m -164.54 45.43 0.1 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.069 0.461 . . . . 0.0 110.656 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 130' ' ' GLN . 75.0 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 2.7 tpt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 74.0 Cg_endo -76.8 45.59 1.69 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 112.629 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -59.39 -32.76 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.019 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 33' ' ' GLN . 85.8 m -43.05 101.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.681 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -67.99 -28.17 67.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.068 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -53.39 -43.32 67.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.476 ' H ' HG22 ' A' ' 30' ' ' THR . 35.4 mt-30 -61.29 -37.08 81.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD21 HD13 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.724 HD11 HD22 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.945 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 50.3 t-20 -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 54' ' ' LEU . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.945 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.857 HG21 ' HD3' ' A' ' 78' ' ' PRO . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.852 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' HG11 ' A' ' 75' ' ' VAL . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD22 HG12 ' A' ' 38' ' ' ILE . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG13 ' OG ' ' A' ' 71' ' ' SER . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 131' ' ' ALA . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.512 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 63.5 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.517 HG21 ' SG ' ' A' ' 61' ' ' CYS . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.605 ' CG2' HG13 ' A' ' 58' ' ' VAL . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.857 ' HD3' HG21 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.53 ' HA ' HD12 ' A' ' 85' ' ' LEU . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 82' ' ' TRP . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 31.4 m120 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 95' ' ' ILE . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.605 HD11 ' HB ' ' A' ' 100' ' ' VAL . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.63 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 115' ' ' THR . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.63 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.581 ' ND2' ' HB2' ' A' ' 119' ' ' GLN . 54.8 t-20 -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.532 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.581 ' HB2' ' ND2' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 38' ' ' ILE . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.53 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? -62.75 -47.72 82.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 86.2 m -68.6 -36.93 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 15.3 tppt? . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.027 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 66.3 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.556 0.217 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 32.3 Cg_exo -58.51 134.72 62.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.602 2.201 . . . . 0.0 112.327 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.59 -170.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.289 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.8 p 42.04 -121.18 0.55 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.572 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -147.42 -23.75 0.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 36' ' ' VAL . 39.4 ttm180 -55.62 -43.44 76.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.75 -37.98 79.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 124' ' ' LEU . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.593 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 32' ' ' ARG . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.645 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.593 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.474 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.634 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.012 HD22 HD11 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD11 HD22 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 41' ' ' ALA . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG22 ' SG ' ' A' ' 61' ' ' CYS . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.526 ' H ' ' CD2' ' A' ' 83' ' ' HIS . 24.9 m-70 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 112' ' ' PHE . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.627 HD11 ' O ' ' A' ' 55' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.592 HD11 HD23 ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 105' ' ' ILE . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 100' ' ' VAL . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 85' ' ' LEU . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.444 ' HB2' HG23 ' A' ' 115' ' ' THR . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 m120 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.599 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.645 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 127' ' ' LEU . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.557 ' CD ' ' HE3' ' A' ' 134' ' ' LYS . 8.0 tp-100 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -77.36 -72.55 0.35 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -156.59 45.89 0.42 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.557 ' HE3' ' CD ' ' A' ' 130' ' ' GLN . 75.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.657 0.265 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 31.1 Cg_exo -58.99 133.27 52.39 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.58 2.186 . . . . 0.0 112.205 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -64.03 131.25 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.556 ' HB ' HD11 ' A' ' 125' ' ' ILE . 3.7 t -69.23 120.93 15.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' THR . 4.5 tp10 176.18 -127.77 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.51 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 39.4 ttm180 -57.84 -36.63 72.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.642 0.258 . . . . 0.0 111.226 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -49.99 -41.6 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.984 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.737 HD21 HD13 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.554 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.642 HG21 HD23 ' A' ' 60' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.662 ' HE2' ' HB3' ' A' ' 117' ' ' HIS . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.064 HD22 HD11 ' A' ' 60' ' ' LEU . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.064 HD11 HD22 ' A' ' 54' ' ' LEU . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.836 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.565 HD22 HG12 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.519 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.537 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 61.3 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG22 ' CG1' ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 75' ' ' VAL . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' ILE . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.64 HD23 HD11 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.4 ' HB1' ' OE1' ' A' ' 68' ' ' GLN . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.657 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 134' ' ' LYS . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.657 HD13 HG13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' C ' ' A' ' 54' ' ' LEU . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.501 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 0.3 OUTLIER 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 113' ' ' GLU . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.509 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.526 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD22 HD11 ' A' ' 38' ' ' ILE . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD13 HD21 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.624 ' O ' ' HD3' ' A' ' 134' ' ' LYS . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -56.73 -55.35 35.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.675 HG23 ' HD2' ' A' ' 134' ' ' LYS . 3.4 t -69.69 -43.84 71.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.329 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.675 ' HD2' HG23 ' A' ' 133' ' ' THR . 4.9 mptp? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.596 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 mpt? . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.6 Cg_endo -66.88 133.15 30.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.21 1.94 . . . . 0.0 112.217 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 30' ' ' THR . 17.9 pt20 -64.04 -48.99 74.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.702 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 33' ' ' GLN . 10.2 t 36.23 42.25 0.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.833 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -69.03 -47.93 64.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HA ' HH12 ' A' ' 35' ' ' ARG . 39.5 ttm180 -68.82 -42.52 77.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.275 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 84.5 mt-30 -60.48 -18.85 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.842 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 30' ' ' THR . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH12 ' HA ' ' A' ' 32' ' ' ARG . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.658 HG23 HD22 ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HB2' HD13 ' A' ' 59' ' ' ILE . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.497 ' O ' HD11 ' A' ' 111' ' ' LEU . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.696 ' HD3' HD22 ' A' ' 114' ' ' ASN . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 54' ' ' LEU . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.54 ' HB2' HG11 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.658 HD22 HG23 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 95' ' ' ILE . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 61.8 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' HB2' ' A' ' 61' ' ' CYS . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.599 ' HB2' HD21 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.599 HD21 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 108' ' ' ALA . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HG3' HD12 ' A' ' 105' ' ' ILE . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.638 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.511 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.544 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.638 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 92' ' ' LEU . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 54' ' ' LEU . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.696 HD22 ' HD3' ' A' ' 55' ' ' LYS . 34.8 m120 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.609 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.731 ' HA ' HD13 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 121' ' ' GLN . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.626 HE21 HG22 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -167.7 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.0 m -63.47 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.4 mmtt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.953 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.829 0.347 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 125' ' ' ILE . 25.8 Cg_endo -61.96 -49.56 6.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.39 2.06 . . . . 0.0 112.346 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -177.46 130.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.442 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -91.38 135.92 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 66.6 mm-40 65.49 145.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.391 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 79.2 ttt180 75.47 -51.15 0.64 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.629 HE22 ' HB2' ' A' ' 28' ' ' PRO . 54.2 tt0 -68.25 -43.89 76.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 124' ' ' LEU . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 53' ' ' GLY . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.482 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 60' ' ' LEU . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.669 ' O ' HD11 ' A' ' 88' ' ' ILE . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.649 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 38' ' ' ILE . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 64.9 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.828 HG21 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 75' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 112' ' ' PHE . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.837 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 102' ' ' PRO . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 92' ' ' LEU . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 85' ' ' LEU . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.56 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.603 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.635 HD22 HD11 ' A' ' 38' ' ' ILE . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 28' ' ' PRO . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.551 ' NE2' ' HE3' ' A' ' 134' ' ' LYS . 9.9 tp-100 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt -73.52 -47.03 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.408 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 77.4 m -70.16 -46.44 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.133 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' HE3' ' NE2' ' A' ' 130' ' ' GLN . 72.8 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.982 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.6 mmt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.571 0.224 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 36.3 Cg_exo -57.63 135.06 67.18 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -69.27 -143.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.738 HG22 HD11 ' A' ' 125' ' ' ILE . 57.5 p -152.43 136.36 16.35 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.323 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' H ' HD12 ' A' ' 34' ' ' LEU . 4.8 mm-40 73.39 -52.46 0.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.015 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -63.81 -52.54 59.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.84 -37.94 47.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.563 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 31' ' ' GLU . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.647 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.641 HD11 HD22 ' A' ' 124' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.694 HG22 ' HA3' ' A' ' 53' ' ' GLY . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.966 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.522 ' HE3' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 60' ' ' LEU . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.852 HG13 HG11 ' A' ' 75' ' ' VAL . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 54' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB3' HG21 ' A' ' 42' ' ' THR . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' HE1' ' A' ' 37' ' ' TRP . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG13 ' OG ' ' A' ' 71' ' ' SER . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' ALA . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.532 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 62.3 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.852 HG11 HG13 ' A' ' 58' ' ' VAL . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HD3' HG21 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 55' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.583 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 53.5 t-20 -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.522 ' O ' ' HE3' ' A' ' 51' ' ' MET . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.468 ' HB2' HD22 ' A' ' 116' ' ' ASN . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 HG22 ' A' ' 30' ' ' THR . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt -169.41 44.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -171.63 -36.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.883 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 27.8 ttt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 35.5 Cg_exo -59.63 -47.2 17.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.194 1.929 . . . . 0.0 112.18 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.692 ' HG3' ' H ' ' A' ' 30' ' ' THR . 60.0 tp60 -175.23 -135.27 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.943 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.692 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 9.6 t 178.88 38.02 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.901 0.381 . . . . 0.0 110.974 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -176.57 -54.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HG3' HH21 ' A' ' 35' ' ' ARG . 79.1 ttt180 -77.48 -45.86 24.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.217 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 99.2 mm-40 -68.62 -40.55 80.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.622 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.633 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.648 HD11 HD22 ' A' ' 124' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' HA3' ' A' ' 53' ' ' GLY . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.539 ' HE2' HE21 ' A' ' 121' ' ' GLN . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 60' ' ' LEU . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.575 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 54' ' ' LEU . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.588 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.5 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 65.7 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.588 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD3' HG21 ' A' ' 58' ' ' VAL . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.477 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 51.1 m80 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 90' ' ' ASN . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 91' ' ' PHE . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.78 HD11 ' HB ' ' A' ' 100' ' ' VAL . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.586 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.447 HD21 ' C ' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.7 m120 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.539 HE21 ' HE2' ' A' ' 50' ' ' PHE . 89.5 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.417 HG23 HG12 ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD22 HD11 ' A' ' 38' ' ' ILE . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -68.53 -43.82 75.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 132' ' ' LYS . 8.4 t -176.07 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.858 179.84 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 29' ' ' GLN . 43.1 Cg_endo -67.58 -137.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.543 2.162 . . . . 0.0 112.25 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 17.9 pt20 -171.78 -139.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.606 ' HA ' ' HG ' ' A' ' 34' ' ' LEU . 69.2 p -147.8 -149.13 0.28 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.944 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 32' ' ' ARG . 88.4 tt0 54.48 -110.76 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.655 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.535 HH11 ' NH2' ' A' ' 35' ' ' ARG . 30.0 tpt180 -56.9 -40.34 76.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.34 -48.27 81.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' A' ' 30' ' ' THR . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.535 ' NH2' HH11 ' A' ' 32' ' ' ARG . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 HD22 ' A' ' 63' ' ' LEU . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 18.0 t-20 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.847 HG21 ' HD3' ' A' ' 78' ' ' PRO . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 72' ' ' VAL . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD13 ' CB ' ' A' ' 41' ' ' ALA . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.565 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 131' ' ' ALA . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 66.0 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.565 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG21 ' SG ' ' A' ' 61' ' ' CYS . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 58' ' ' VAL . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 55' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.616 HG13 HD13 ' A' ' 105' ' ' ILE . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.597 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.454 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt -67.57 -58.56 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 134' ' ' LYS . 2.4 t -67.63 -50.3 58.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.138 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 48.0 mmtm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.878 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 51.0 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 27' ' ' MET . 50.5 Cg_endo -68.39 -138.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.235 1.957 . . . . 0.0 112.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.463 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 12.0 tp-100 -173.05 127.47 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.641 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 t -179.82 44.08 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.298 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HG2' ' OE1' ' A' ' 29' ' ' GLN . 65.7 mm-40 -60.76 -54.55 43.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.667 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.616 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 79.7 ttt180 -81.12 -45.14 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -55.95 -12.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.142 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 124' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HB2' HD13 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.466 ' CE ' ' HB ' ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 60' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.687 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG13 HG11 ' A' ' 75' ' ' VAL . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 54' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.561 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.592 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 131' ' ' ALA . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.455 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 60.4 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.592 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.589 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 HG13 ' A' ' 58' ' ' VAL . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.4 mm-40 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 112' ' ' PHE . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.687 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.744 ' HB ' HD11 ' A' ' 105' ' ' ILE . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.744 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.504 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CD2' HD21 ' A' ' 85' ' ' LEU . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 115' ' ' THR . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.558 HD22 ' HE3' ' A' ' 55' ' ' LYS . 33.1 m120 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 51.9 t-20 -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.491 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 119' ' ' GLN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 118' ' ' THR . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.676 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.789 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt -57.06 -41.32 78.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 134' ' ' LYS . 91.0 m -64.87 -35.78 82.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.695 0.283 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.646 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.452 HD12 HD23 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 46' ' ' ILE . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.898 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.592 ' H ' HD22 ' A' ' 49' ' ' ASN . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.898 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.649 HD22 HD11 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.649 HD11 HD22 ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.589 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 71' ' ' SER . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 64' ' ' ILE . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.437 HG11 ' SG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.537 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 55' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' CE1' ' A' ' 106' ' ' PHE . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.551 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD21 ' A' ' 92' ' ' LEU . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.507 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.569 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.402 ' HA ' HD13 ' A' ' 124' ' ' LEU . 26.5 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.56 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.629 0.252 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 124' ' ' LEU . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG12 HD22 ' A' ' 63' ' ' LEU . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.875 HG21 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.645 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.94 HD22 HD11 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.94 HD11 HD22 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.619 ' SG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.875 ' HB3' HG21 ' A' ' 42' ' ' THR . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.749 HD22 HG12 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.641 HD11 HE21 ' A' ' 68' ' ' GLN . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.641 HE21 HD11 ' A' ' 64' ' ' ILE . 8.2 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG21 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.619 HG22 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB2' HD21 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 77' ' ' ASP . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.656 HD21 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 95' ' ' ILE . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 106' ' ' PHE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.609 HG13 HD13 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE1' HD21 ' A' ' 92' ' ' LEU . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CB ' HG23 ' A' ' 115' ' ' THR . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 113' ' ' GLU . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.698 HD22 HD11 ' A' ' 38' ' ' ILE . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 127' ' ' LEU . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 111.425 0.158 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 60' ' ' LEU . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.718 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.58 HD22 HD11 ' A' ' 60' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.718 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD22 ' A' ' 54' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 64' ' ' ILE . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 61' ' ' CYS . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.643 HD22 ' HB1' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.914 ' HD3' HG21 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.578 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 112' ' ' PHE . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 87' ' ' ASN . 2.0 m120 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.746 HG13 HD13 ' A' ' 105' ' ' ILE . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HD21 ' A' ' 85' ' ' LEU . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' HE1' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 119' ' ' GLN . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.528 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.643 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD13 ' A' ' 125' ' ' ILE . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' LEU . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD22 ' A' ' 124' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 53' ' ' GLY . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.898 HD22 HD11 ' A' ' 60' ' ' LEU . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.898 HD11 HD22 ' A' ' 54' ' ' LEU . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD13 ' CB ' ' A' ' 41' ' ' ALA . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 HD11 HE21 ' A' ' 68' ' ' GLN . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.553 HE21 HD11 ' A' ' 64' ' ' ILE . 8.2 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.528 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 61' ' ' CYS . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' SG ' ' A' ' 61' ' ' CYS . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.649 HD11 ' O ' ' A' ' 55' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.495 ' HE3' ' HD2' ' A' ' 103' ' ' HIS . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.495 ' HD2' ' HE3' ' A' ' 101' ' ' LYS . 89.5 m-70 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.55 HD21 ' C ' ' A' ' 54' ' ' LEU . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CB ' HG23 ' A' ' 115' ' ' THR . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.63 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.451 HD13 HD21 ' A' ' 34' ' ' LEU . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.537 0.208 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 124' ' ' LEU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 124' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 50' ' ' PHE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.883 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.832 HD22 HD11 ' A' ' 60' ' ' LEU . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.877 HG13 HG21 ' A' ' 75' ' ' VAL . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 HD22 ' A' ' 54' ' ' LEU . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.492 ' CD2' HG12 ' A' ' 38' ' ' ILE . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 131' ' ' ALA . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.539 HE21 HD11 ' A' ' 64' ' ' ILE . 8.3 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.6 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 58' ' ' VAL . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 112' ' ' PHE . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.528 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.583 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 54' ' ' LEU . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CG ' HD21 ' A' ' 85' ' ' LEU . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.491 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.8 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 38' ' ' ILE . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.381 0.134 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 34' ' ' LEU . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 60' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.507 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.803 HD22 HD11 ' A' ' 60' ' ' LEU . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.517 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HE1' ' A' ' 37' ' ' TRP . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.576 HD11 HE21 ' A' ' 68' ' ' GLN . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.676 ' ND2' HG22 ' A' ' 72' ' ' VAL . 7.6 m-80 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 131' ' ' ALA . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.576 HE21 HD11 ' A' ' 64' ' ' ILE . 8.4 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.676 HG22 ' ND2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 70' ' ' GLY . 97.0 mm-40 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG21 ' OE2' ' A' ' 62' ' ' GLU . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 74.0 m-20 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 108' ' ' ALA . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.614 HD11 HD23 ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.479 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 100' ' ' VAL . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.604 ' HA ' HD13 ' A' ' 92' ' ' LEU . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.544 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 74.5 m-20 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 116' ' ' ASN . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 121' ' ' GLN . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.562 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.586 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HA ' HG12 ' A' ' 36' ' ' VAL . 11.5 mm100 . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.761 0.315 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD12 ' A' ' 124' ' ' LEU . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HE1' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' CD1' HD13 ' A' ' 124' ' ' LEU . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 59' ' ' ILE . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.498 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.547 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 60' ' ' LEU . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 54' ' ' LEU . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.66 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 61' ' ' CYS . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 131' ' ' ALA . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 8.1 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.66 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 112' ' ' PHE . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.419 ' HB3' HG22 ' A' ' 72' ' ' VAL . 78.8 m-20 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.461 ' HA3' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.772 HD13 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.531 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 109' ' ' ASN . 2.5 m120 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 85' ' ' LEU . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.49 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.799 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 68.1 tp60 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 116' ' ' ASN . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 125' ' ' ILE . 87.2 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 105' ' ' ILE . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.681 HD12 HD21 ' A' ' 34' ' ' LEU . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 121' ' ' GLN . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.489 ' HB2' ' CH2' ' A' ' 37' ' ' TRP . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.461 ' NE2' ' HA3' ' A' ' 99' ' ' GLY . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? . . . . . 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 124' ' ' LEU . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 46' ' ' ILE . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 60' ' ' LEU . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 54' ' ' LEU . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 75' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.594 HD13 ' CB ' ' A' ' 41' ' ' ALA . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.784 HD22 ' HB1' ' A' ' 131' ' ' ALA . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.537 HG21 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 72' ' ' VAL . 75.7 m-20 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 95' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 92' ' ' LEU . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.659 ' HG2' HD12 ' A' ' 105' ' ' ILE . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.659 HD12 ' HG2' ' A' ' 96' ' ' LYS . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 115' ' ' THR . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 3.7 m120 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 113' ' ' GLU . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 6.8 m-80 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.678 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 105' ' ' ILE . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.548 HE21 HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.784 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 C--O 1.231 0.084 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 124' ' ' LEU . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.909 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.909 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB2' HD11 ' A' ' 111' ' ' LEU . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' HD11 ' A' ' 88' ' ' ILE . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.702 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.479 HG23 ' OG1' ' A' ' 42' ' ' THR . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 38' ' ' ILE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' OE2' HG21 ' A' ' 75' ' ' VAL . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD21 ' NE1' ' A' ' 37' ' ' TRP . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HE21 ' A' ' 68' ' ' GLN . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.593 HE21 HD11 ' A' ' 64' ' ' ILE . 8.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 58' ' ' VAL . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' CE2' ' A' ' 112' ' ' PHE . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.426 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 3.7 m120 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 55' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 105' ' ' ILE . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 105' ' ' ILE . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.688 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.732 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 92' ' ' LEU . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' HD21 ' A' ' 85' ' ' LEU . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 116' ' ' ASN . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' HD23 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.683 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.596 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.627 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 4.2 ttmp? . . . . . 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.69 0.281 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.408 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.679 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.856 HG22 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.888 ' CZ ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.968 HG21 ' HD3' ' A' ' 78' ' ' PRO . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.888 HG23 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 54' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 58' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.968 ' HD3' HG21 ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.412 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 28.7 m170 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' TRP . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 55' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.654 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.766 ' HA ' HD13 ' A' ' 124' ' ' LEU . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 121' ' ' GLN . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.885 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.591 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.658 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.851 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 60' ' ' LEU . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' O ' HD11 ' A' ' 88' ' ' ILE . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 75' ' ' VAL . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 54' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HB3' HG21 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.658 HD11 ' HE1' ' A' ' 37' ' ' TRP . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.572 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' HG13 ' A' ' 64' ' ' ILE . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 HD21 ' CD ' ' A' ' 86' ' ' GLU . 69.5 m-20 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD3' HG21 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.568 ' HA ' HD12 ' A' ' 85' ' ' LEU . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 82' ' ' TRP . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' CD ' HD21 ' A' ' 76' ' ' ASN . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 3.9 m120 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 55' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.593 HD11 HD23 ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.613 ' HB ' HD11 ' A' ' 105' ' ' ILE . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.522 ' HA ' HE22 ' A' ' 119' ' ' GLN . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 100' ' ' VAL . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 54' ' ' LEU . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.533 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 104' ' ' ASP . 3.8 tp-100 -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HB3' HD22 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.587 ' NE2' HG23 ' A' ' 100' ' ' VAL . 45.4 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD21 HD13 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.724 HD11 HD22 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.945 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.595 ' H ' HD22 ' A' ' 49' ' ' ASN . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.945 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.857 HG21 ' HD3' ' A' ' 78' ' ' PRO . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.852 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' HG11 ' A' ' 75' ' ' VAL . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.537 HD22 HG12 ' A' ' 38' ' ' ILE . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.648 HD11 HE21 ' A' ' 68' ' ' GLN . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 131' ' ' ALA . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.648 HE21 HD11 ' A' ' 64' ' ' ILE . 8.0 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.517 HG21 ' SG ' ' A' ' 61' ' ' CYS . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.605 ' CG2' HG13 ' A' ' 58' ' ' VAL . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.857 ' HD3' HG21 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.53 ' HA ' HD12 ' A' ' 85' ' ' LEU . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 82' ' ' TRP . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 77.5 m-20 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 95' ' ' ILE . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.605 HD11 ' HB ' ' A' ' 100' ' ' VAL . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.63 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 115' ' ' THR . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.63 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.532 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 38' ' ' ILE . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.755 0.312 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 124' ' ' LEU . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.593 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.645 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.593 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.474 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.634 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.012 HD22 HD11 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD11 HD22 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 41' ' ' ALA . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG22 ' SG ' ' A' ' 61' ' ' CYS . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 HD21 ' HG2' ' A' ' 86' ' ' GLU . 75.5 m-20 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 112' ' ' PHE . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 76' ' ' ASN . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.627 HD11 ' O ' ' A' ' 55' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.592 HD11 HD23 ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 105' ' ' ILE . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 100' ' ' VAL . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 85' ' ' LEU . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.444 ' HB2' HG23 ' A' ' 115' ' ' THR . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.538 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 73.8 m-20 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.599 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.645 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 127' ' ' LEU . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.752 0.31 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.737 HD21 HD13 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.554 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.642 HG21 HD23 ' A' ' 60' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.506 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.662 ' HE2' ' HB3' ' A' ' 117' ' ' HIS . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.064 HD22 HD11 ' A' ' 60' ' ' LEU . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.064 HD11 HD22 ' A' ' 54' ' ' LEU . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.836 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.565 HD22 HG12 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HE21 ' A' ' 68' ' ' GLN . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 64' ' ' ILE . 7.6 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.469 HG22 ' CG1' ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 75' ' ' VAL . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' ILE . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.64 HD23 HD11 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB1' ' NE2' ' A' ' 68' ' ' GLN . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.657 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.657 HD13 HG13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' C ' ' A' ' 54' ' ' LEU . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 113' ' ' GLU . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.509 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.526 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.612 HD22 HD11 ' A' ' 38' ' ' ILE . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.737 HD13 HD21 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.445 ' OE1' HG22 ' A' ' 100' ' ' VAL . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.658 HG23 HD22 ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HB2' HD13 ' A' ' 59' ' ' ILE . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.497 ' O ' HD11 ' A' ' 111' ' ' LEU . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 84' ' ' LYS . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 54' ' ' LEU . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.54 ' HB2' HG11 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.658 HD22 HG23 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 95' ' ' ILE . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' HB2' ' A' ' 61' ' ' CYS . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.599 ' HB2' HD21 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.599 HD21 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 108' ' ' ALA . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HG3' HD12 ' A' ' 105' ' ' ILE . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.638 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.511 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.544 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.638 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 92' ' ' LEU . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 109' ' ' ASN . 2.6 m120 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 54' ' ' LEU . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.418 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 76.1 m-80 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.609 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.731 ' HA ' HD13 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 121' ' ' GLN . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.626 HE21 HG22 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 124' ' ' LEU . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 53' ' ' GLY . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.482 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 60' ' ' LEU . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.669 ' O ' HD11 ' A' ' 88' ' ' ILE . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.649 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 38' ' ' ILE . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.559 HD11 HE21 ' A' ' 68' ' ' GLN . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.559 HE21 HD11 ' A' ' 64' ' ' ILE . 8.1 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.828 HG21 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 75' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.43 ' C ' HD22 ' A' ' 81' ' ' ASN . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 80' ' ' GLN . 4.6 m120 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 112' ' ' PHE . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.837 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 68' ' ' GLN . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 102' ' ' PRO . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 92' ' ' LEU . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 85' ' ' LEU . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.56 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.603 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.635 HD22 HD11 ' A' ' 38' ' ' ILE . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.595 0.236 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD22 ' HB3' ' A' ' 124' ' ' LEU . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.647 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.641 HD11 HD22 ' A' ' 124' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.694 HG22 ' HA3' ' A' ' 53' ' ' GLY . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.966 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.522 ' HE3' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 60' ' ' LEU . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.852 HG13 HG11 ' A' ' 75' ' ' VAL . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 54' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB3' HG21 ' A' ' 42' ' ' THR . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' HE1' ' A' ' 37' ' ' TRP . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.649 HD11 HE21 ' A' ' 68' ' ' GLN . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' ALA . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.649 HE21 HD11 ' A' ' 64' ' ' ILE . 7.8 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.852 HG11 HG13 ' A' ' 58' ' ' VAL . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HD3' HG21 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 55' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.583 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.531 ' N ' HD22 ' A' ' 116' ' ' ASN . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.603 0.239 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.633 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.648 HD11 HD22 ' A' ' 124' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' HA3' ' A' ' 53' ' ' GLY . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.538 ' O ' HD23 ' A' ' 54' ' ' LEU . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 60' ' ' LEU . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.575 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 54' ' ' LEU . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.588 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 64' ' ' ILE . 8.3 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.588 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD3' HG21 ' A' ' 58' ' ' VAL . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' HIS . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' GLN . 95.6 m-70 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 90' ' ' ASN . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 91' ' ' PHE . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.78 HD11 ' HB ' ' A' ' 100' ' ' VAL . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.586 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.447 HD21 ' C ' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.417 HG23 HG12 ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.648 HD22 HD11 ' A' ' 38' ' ' ILE . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.694 0.283 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.415 ' HG3' ' OE2' ' A' ' 39' ' ' GLU . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 HD22 ' A' ' 63' ' ' LEU . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.531 HD22 ' H ' ' A' ' 52' ' ' ASP . 47.4 t30 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.847 HG21 ' HD3' ' A' ' 78' ' ' PRO . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 72' ' ' VAL . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD13 ' CB ' ' A' ' 41' ' ' ALA . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.565 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 131' ' ' ALA . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.565 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG21 ' SG ' ' A' ' 61' ' ' CYS . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 58' ' ' VAL . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.406 HD21 ' CD ' ' A' ' 86' ' ' GLU . 72.5 m-20 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.406 ' CD ' HD21 ' A' ' 76' ' ' ASN . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 55' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.616 HG13 HD13 ' A' ' 105' ' ' ILE . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.597 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.454 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m120 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.662 0.268 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 124' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HB2' HD13 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.466 ' CE ' ' HB ' ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 60' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.687 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG13 HG11 ' A' ' 75' ' ' VAL . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 54' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.561 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.592 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 131' ' ' ALA . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.487 HE21 HD11 ' A' ' 64' ' ' ILE . 7.5 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.592 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.589 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 HG13 ' A' ' 58' ' ' VAL . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.417 ' C ' HD22 ' A' ' 81' ' ' ASN . 3.4 mm100 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.417 HD22 ' C ' ' A' ' 80' ' ' GLN . 4.8 m120 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 112' ' ' PHE . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.687 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.744 ' HB ' HD11 ' A' ' 105' ' ' ILE . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.744 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.504 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CD2' HD21 ' A' ' 85' ' ' LEU . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 115' ' ' THR . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.559 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 73.7 m-20 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.7 OUTLIER -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.491 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 HD22 ' A' ' 116' ' ' ASN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 118' ' ' THR . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.676 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.789 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.706 0.289 . . . . 0.0 111.154 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' CG ' HG23 ' A' ' 125' ' ' ILE . 28.7 Cg_endo -62.88 -43.64 19.33 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.568 2.179 . . . . 0.0 112.286 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 3.6 tp-100 -171.09 -125.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.509 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.476 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 88.2 m -161.96 -42.37 0.04 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.677 0.275 . . . . 0.0 111.109 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 1.0 OUTLIER -168.79 -31.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.421 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -59.75 -47.47 85.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.757 0.313 . . . . 0.0 110.861 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 53.7 tt0 -66.88 -34.76 78.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 125' ' ' ILE . 66.1 mt -50.8 -43.3 58.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.379 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 39' ' ' GLU . 99.1 mtt180 -64.54 -68.09 0.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.767 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.7 t -48.68 -37.53 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.904 0.383 . . . . 0.0 111.796 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.646 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 1.7 t90 -60.42 -76.12 0.05 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.452 HD12 HD23 ' A' ' 124' ' ' LEU . 83.2 mt -62.92 -43.5 99.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE1' ' HB3' ' A' ' 35' ' ' ARG . 60.1 mt-10 -49.76 -41.88 45.17 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.74 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.94 -37.39 94.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.429 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.92 -57.41 12.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.767 0.318 . . . . 0.0 111.474 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.8 p -79.13 -67.61 0.74 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.25 -35.91 0.89 Allowed Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB2' HG12 ' A' ' 59' ' ' ILE . 14.1 mmt-85 -65.4 128.5 36.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.686 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HG3' HH11 ' A' ' 45' ' ' ARG . 43.0 mmm-85 -94.91 38.62 1.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 46' ' ' ILE . 71.3 mt 39.41 72.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 121.064 0.459 . . . . 0.0 110.429 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.98 49.68 1.16 Allowed Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.684 -0.689 . . . . 0.0 113.719 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -176.92 -147.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.598 0.237 . . . . 0.0 110.433 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.898 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -68.19 138.62 55.77 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.592 ' H ' HD22 ' A' ' 49' ' ' ASN . 19.6 t80 -60.46 -48.57 81.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.439 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.8 mmm -75.13 -50.49 16.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.145 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.898 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 8.2 t70 -57.34 -40.01 77.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.007 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.34 -37.21 64.86 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.921 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.649 HD22 HD11 ' A' ' 60' ' ' LEU . 49.8 mt -71.96 -30.62 65.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.812 0.339 . . . . 0.0 110.808 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.697 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 55.9 mtpt -51.8 -49.24 63.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.746 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 2.7 p30 -60.02 -31.71 70.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.847 0.356 . . . . 0.0 110.673 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.53 103.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.541 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.592 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.5 t -156.0 -60.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.01 0.433 . . . . 0.0 109.999 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.8 mp -68.01 -43.5 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.923 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.649 HD11 HD22 ' A' ' 54' ' ' LEU . 75.4 mt -61.11 -45.87 92.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 110.261 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 92.6 m -60.79 -41.01 94.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.22 0.533 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 48.2 mt-10 -68.77 -30.83 69.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.325 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.589 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -68.16 -51.71 42.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.515 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 71' ' ' SER . 7.7 tp -57.93 -39.02 69.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.416 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -51.21 -27.82 9.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.85 0.357 . . . . 0.0 110.547 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.561 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.42 -50.2 34.23 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.345 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.1 mt -72.59 -57.82 3.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -106.25 114.2 62.58 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.694 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.34 133.58 56.77 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 123.158 2.572 . . . . 0.0 113.501 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 47.85 79.84 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.105 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' HG23 ' A' ' 64' ' ' ILE . 74.6 m -82.87 -50.08 9.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.055 0.427 . . . . 0.0 111.005 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.437 HG11 ' SG ' ' A' ' 61' ' ' CYS . 13.0 t -144.49 48.38 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.401 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.489 ' HG3' ' HG3' ' A' ' 74' ' ' LYS . 25.1 pt20 -58.14 -43.58 87.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 73' ' ' GLN . 55.0 mtpt -80.54 43.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.171 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.02 123.96 16.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 0.0 111.046 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -89.48 139.5 30.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.452 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.5 t0 -62.73 126.92 89.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.537 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -69.26 43.27 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.885 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.91 -53.05 18.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.995 0.426 . . . . 0.0 110.53 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.08 -124.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.782 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -142.83 -46.89 0.32 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.691 0.282 . . . . 0.0 110.793 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -65.5 -25.37 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.768 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -55.72 -45.39 77.94 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.503 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 95.1 mttt -58.82 -44.16 90.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.578 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -57.64 -34.0 68.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.199 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -71.29 -50.75 29.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.049 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.668 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 70.8 m-20 -59.87 -41.44 91.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.659 HD11 ' O ' ' A' ' 55' ' ' LYS . 77.1 mt -65.96 -43.47 92.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.131 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.03 -48.83 84.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.752 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.19 -43.18 98.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.73 0.3 . . . . 0.0 111.338 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.1 t80 -60.68 -48.73 80.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.797 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' CE1' ' A' ' 106' ' ' PHE . 96.7 mt -68.83 -49.37 58.96 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.4 ptm180 -56.65 -39.19 73.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.069 0.462 . . . . 0.0 110.437 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.32 -45.67 75.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.847 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.533 HG13 HD13 ' A' ' 105' ' ' ILE . 33.6 pt -71.61 -39.03 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 58.4 mtpt -57.7 -41.02 80.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 110.657 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -85.85 -34.28 21.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.569 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.9 t80 -51.36 -44.0 61.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.06 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.23 -44.59 0.16 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.971 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.9 t -58.05 127.89 17.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 110.853 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -68.22 139.68 92.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.125 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.551 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 52.3 Cg_exo -53.99 -38.8 86.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.607 2.205 . . . . 0.0 112.093 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -56.48 -26.24 53.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.696 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -110.24 37.29 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.571 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.0 mt -146.39 130.41 10.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.231 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD21 ' A' ' 92' ' ' LEU . 45.7 p90 -71.8 142.19 49.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.003 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -84.45 153.82 23.13 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.319 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -47.39 -42.76 22.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.703 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -67.67 -37.71 82.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.875 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 66.5 m-20 -60.33 -51.24 70.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 63.4 tp -68.42 -48.06 65.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.612 0.244 . . . . 0.0 111.169 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.507 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 30.1 t80 -57.45 -52.96 63.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.207 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -74.8 -14.15 60.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.533 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.0 t30 63.42 30.98 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.298 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.1 p -72.94 -56.86 4.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.823 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.1 m120 -90.38 123.15 33.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.793 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -100.58 -49.84 4.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.727 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.5 m -65.2 -41.06 94.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.1 tp60 -58.54 -37.97 76.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.569 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 56.0 t -61.12 -53.62 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.505 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.523 ' NE2' ' HB3' ' A' ' 31' ' ' GLU . 26.5 mt-30 -64.01 -43.39 95.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.3 p -52.81 -35.78 57.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.746 0.308 . . . . 0.0 111.14 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 105' ' ' ILE . 64.3 m -57.11 -50.78 71.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.19 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.646 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 5.6 mp -56.9 -39.75 75.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 34' ' ' LEU . 47.3 mm -55.22 -46.99 78.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.42 -42.2 83.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.22 -31.19 65.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -46.11 90.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.561 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 133' ' ' THR . 80.7 p -60.09 -40.11 88.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.56 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -64.3 -49.41 71.91 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.037 0.446 . . . . 0.0 111.097 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.19 91.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.432 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -61.02 -47.0 88.46 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.332 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 129' ' ' SER . 82.2 p -62.32 -43.97 97.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.338 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.583 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 66.8 mtm . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.5 Cg_endo -66.79 -45.06 4.83 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.163 1.909 . . . . 0.0 112.25 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.66 ' NE2' ' HB2' ' A' ' 33' ' ' GLN . 3.0 mm100 -61.04 150.8 32.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.523 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 t -161.57 -43.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.923 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.743 ' HA ' HD12 ' A' ' 34' ' ' LEU . 43.7 tp10 177.12 -34.93 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.157 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 32' ' ' ARG . 31.5 tpt85 -75.46 -54.5 6.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.699 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.66 ' HB2' ' NE2' ' A' ' 29' ' ' GLN . 99.4 mm-40 -63.64 -29.91 71.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.405 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 31' ' ' GLU . 96.2 mt -53.17 -43.26 66.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 40.9 ttt85 -64.03 -57.27 10.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.642 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.61 -35.5 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 111.702 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -59.39 -73.22 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG12 HD22 ' A' ' 63' ' ' LEU . 66.3 mt -65.0 -50.99 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -59.08 -44.78 91.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 0.0 110.682 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.18 -31.03 74.06 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.558 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.37 -55.0 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 111.517 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.875 HG21 ' HB3' ' A' ' 62' ' ' GLU . 74.5 p -101.89 -51.01 3.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.193 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.9 43.27 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 19.5 mmt85 -130.9 128.86 41.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.828 0.347 . . . . 0.0 111.314 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HD2' ' NH2' ' A' ' 35' ' ' ARG . 20.6 mmt85 -84.22 131.14 34.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.56 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 72.2 mt -63.79 -56.67 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 111.015 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.1 -146.06 13.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.517 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.04 -51.1 6.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 0.0 110.833 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -71.95 -133.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -168.63 -51.18 0.02 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.762 0.315 . . . . 0.0 110.708 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.9 mmm -74.42 -49.61 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.175 0.512 . . . . 0.0 110.25 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.645 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.25 -33.64 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.854 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.33 -41.74 98.54 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.733 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.94 HD22 HD11 ' A' ' 60' ' ' LEU . 64.1 mt -61.35 -28.69 69.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.753 0.311 . . . . 0.0 111.608 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.1 mtpt -49.27 -44.31 43.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.489 ' HA ' ' CD ' ' A' ' 84' ' ' LYS . 55.0 p30 -55.23 -34.84 64.31 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.46 79.39 0.14 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.134 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 47.6 t -145.62 -56.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.937 0.398 . . . . 0.0 110.329 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 44' ' ' ARG . 42.4 mt -69.33 -41.87 81.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.406 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.94 HD11 HD22 ' A' ' 54' ' ' LEU . 79.9 mt -60.25 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.619 ' SG ' HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.17 -40.36 73.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.206 178.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.875 ' HB3' HG21 ' A' ' 42' ' ' THR . 59.7 mm-40 -64.5 -37.26 86.93 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.147 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.749 HD22 HG12 ' A' ' 38' ' ' ILE . 33.8 tp -59.01 -64.02 1.09 Allowed 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.268 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.641 HD11 HE21 ' A' ' 68' ' ' GLN . 8.1 tp -59.78 -33.19 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 22.2 t-20 -55.11 -30.41 59.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.181 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 35.7 mmtp -81.29 -51.23 8.6 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.971 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.2 -60.12 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.641 HE21 HD11 ' A' ' 64' ' ' ILE . 8.2 tt0 -98.59 114.32 65.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.726 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.71 128.62 26.94 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.196 2.597 . . . . 0.0 113.493 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 50.06 49.96 34.89 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.98 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 66.5 m -70.45 -57.69 4.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.036 0.418 . . . . 0.0 110.818 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG21 ' SG ' ' A' ' 61' ' ' CYS . 72.5 t -94.19 139.04 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -57.67 -48.45 79.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -174.06 135.59 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.619 HG22 ' SG ' ' A' ' 61' ' ' CYS . 47.2 t -69.01 130.28 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.656 ' HB2' HD21 ' A' ' 87' ' ' ASN . 72.2 m-20 -107.18 133.19 52.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.085 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 65.3 t0 -63.88 125.94 88.89 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 77' ' ' ASP . 54.5 Cg_endo -70.13 44.57 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.681 2.254 . . . . 0.0 113.742 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 77' ' ' ASP . 91.9 t -75.43 -57.96 5.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.401 . . . . 0.0 110.754 179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -77.86 -123.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.796 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -145.26 -47.11 0.22 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.516 0.198 . . . . 0.0 111.351 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -66.54 -17.95 65.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.594 0.235 . . . . 0.0 111.151 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.81 -46.29 84.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.5 mttt -59.21 -43.36 92.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.855 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -52.61 -37.05 57.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.062 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -69.65 -50.36 44.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.698 0.285 . . . . 0.0 111.163 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.656 HD21 ' HB2' ' A' ' 76' ' ' ASN . 74.4 m-20 -61.25 -39.61 90.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.777 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 84' ' ' LYS . 63.3 mt -65.45 -42.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.46 -46.23 94.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.431 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -67.57 -40.99 84.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.671 0.272 . . . . 0.0 111.068 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' O ' HG23 ' A' ' 95' ' ' ILE . 23.1 t80 -58.69 -52.56 65.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.244 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.566 HD21 ' CE1' ' A' ' 106' ' ' PHE . 92.1 mt -68.82 -42.74 76.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.272 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.18 -38.97 81.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.092 0.472 . . . . 0.0 110.232 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.68 -45.48 71.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.682 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.609 HG13 HD13 ' A' ' 105' ' ' ILE . 31.0 pt -71.25 -40.55 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 54.8 mtpt -60.61 -42.53 96.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 110.463 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -78.82 -35.54 43.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.259 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 49.0 t80 -51.59 -43.82 62.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.828 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.05 -41.57 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.964 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 105' ' ' ILE . 23.2 t -55.82 127.88 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.073 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -68.82 142.23 93.4 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.239 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 -37.41 90.07 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.64 2.226 . . . . 0.0 112.125 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -55.46 -27.23 46.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -110.22 37.4 2.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.271 0.558 . . . . 0.0 109.644 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.8 mt -147.91 130.19 6.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.189 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE1' HD21 ' A' ' 92' ' ' LEU . 27.3 p90 -73.42 143.52 46.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.646 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.6 mp0 -84.03 149.56 26.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.268 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.73 -38.44 33.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.42 -39.12 81.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.24 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.0 m-20 -61.31 -48.78 79.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.31 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.646 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -70.6 -46.51 63.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.29 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -59.51 -54.56 45.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.189 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CB ' HG23 ' A' ' 115' ' ' THR . 57.2 mm-40 -73.49 -14.54 61.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.996 0.427 . . . . 0.0 110.481 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.22 31.23 17.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.958 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 113' ' ' GLU . 74.6 p -75.48 -56.03 5.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.661 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.5 m120 -86.66 121.91 29.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -102.19 -48.12 4.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.021 0.439 . . . . 0.0 110.515 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.1 m -65.19 -38.71 91.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.036 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -61.49 -45.7 93.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.245 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.1 t -62.4 -47.94 90.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.391 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -63.94 -44.24 93.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.7 p -60.91 -38.41 85.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.248 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.464 HG23 ' HA ' ' A' ' 105' ' ' ILE . 88.6 m -52.87 -45.3 67.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.188 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.698 HD22 HD11 ' A' ' 38' ' ' ILE . 82.8 mt -60.11 -39.59 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.667 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 43.1 mm -60.57 -46.95 94.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.171 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.59 85.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.654 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 130' ' ' GLN . 41.5 tp -57.94 -31.96 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.071 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HB2' ' HG3' ' A' ' 29' ' ' GLN . . . -53.04 -45.46 68.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.5 m -61.61 -33.66 74.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.669 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.553 ' OE1' ' HE3' ' A' ' 134' ' ' LYS . 4.3 tp-100 -65.53 -52.05 55.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.711 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.61 39.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.94 -56.03 3.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.664 0.269 . . . . 0.0 111.246 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t 179.6 46.43 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.553 ' HE3' ' OE1' ' A' ' 130' ' ' GLN . 75.1 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.948 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.0 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.612 0.244 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 32.1 Cg_exo -58.59 131.48 42.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.475 2.117 . . . . 0.0 112.167 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.2 -46.86 72.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 HG23 ' HG2' ' A' ' 31' ' ' GLU . 7.0 t -174.65 -37.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.171 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.569 ' HA ' HD12 ' A' ' 34' ' ' LEU . 16.1 pt-20 -142.43 -40.14 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 47.3 ttm-85 -59.92 156.92 13.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.573 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 32' ' ' ARG . 85.2 mt-30 76.45 -33.07 0.2 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.425 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.569 HD12 ' HA ' ' A' ' 31' ' ' GLU . 95.0 mt -56.27 -47.08 79.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.867 0.365 . . . . 0.0 110.748 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 15.0 ptp180 -67.66 -50.74 56.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.295 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 57.9 t -56.03 -37.3 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.023 0.44 . . . . 0.0 111.063 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.644 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -63.82 -66.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.122 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.533 HD13 ' CD2' ' A' ' 60' ' ' LEU . 90.4 mt -63.71 -47.62 90.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -54.92 -46.38 74.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.41 -32.09 71.61 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.498 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -53.39 -67.59 0.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.715 0.293 . . . . 0.0 111.657 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 56.9 p -82.57 -50.01 9.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.375 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 122.19 40.64 0.5 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.648 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 32.4 mmt180 -130.85 130.05 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 0.0 110.718 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -80.8 31.46 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.432 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.2 mt 58.03 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.594 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 156.15 -133.86 3.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.232 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -67.55 -123.6 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.4 m120 -53.5 143.63 19.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.684 0.278 . . . . 0.0 110.486 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.6 t80 -55.41 -48.28 74.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.412 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.52 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.9 mmm -70.91 -48.38 53.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.926 0.393 . . . . 0.0 111.035 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.718 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 8.1 t70 -54.73 -40.23 69.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -64.59 -49.08 66.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.583 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.58 HD22 HD11 ' A' ' 60' ' ' LEU . 89.2 mt -53.2 -29.6 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.864 0.364 . . . . 0.0 111.214 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.718 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 57.6 mtpt -49.69 -35.32 21.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.473 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -55.17 -40.53 70.77 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.44 -30.07 2.51 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.042 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.5 t -52.45 -60.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.5 mt -55.71 -48.01 78.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.925 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD22 ' A' ' 54' ' ' LEU . 82.8 mt -61.35 -36.06 79.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' O ' HG22 ' A' ' 64' ' ' ILE . 14.7 m -65.63 -33.34 75.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.187 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 94.7 mt-10 -70.4 -37.88 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.163 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -68.71 -47.52 66.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.616 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 61' ' ' CYS . 9.3 tp -56.1 -36.8 46.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.237 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -59.9 -36.81 77.75 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.776 0.322 . . . . 0.0 110.479 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.54 -50.48 69.37 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.643 HD22 ' HB1' ' A' ' 131' ' ' ALA . 59.1 mt -65.02 -45.45 85.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.0 tt0 -121.86 118.33 29.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.65 125.36 13.99 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.934 2.423 . . . . 0.0 112.985 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.72 50.75 48.2 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.117 -0.564 . . . . 0.0 113.447 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 68.2 m -63.2 -64.82 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.895 0.348 . . . . 0.0 110.788 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.9 t -86.36 133.66 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.039 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -61.6 -42.58 99.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -172.15 121.86 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.361 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' A' ' 58' ' ' VAL . 5.8 p -93.31 130.69 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.997 0.427 . . . . 0.0 111.765 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -92.61 142.52 27.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.938 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.07 138.84 87.87 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.479 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.914 ' HD3' HG21 ' A' ' 58' ' ' VAL . 73.2 Cg_endo -76.48 39.48 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.471 2.114 . . . . 0.0 112.841 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.59 -55.69 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.903 0.382 . . . . 0.0 110.883 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -76.32 -130.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.79 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -138.12 -46.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 110.71 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.9 p-90 -65.9 -24.71 66.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -55.22 -46.66 75.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.759 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.578 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.8 mttt -59.39 -44.4 92.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 112' ' ' PHE . 92.0 mt -55.91 -34.44 65.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 5.5 tp10 -75.8 -45.71 34.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.739 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 87' ' ' ASN . 2.0 m120 -58.38 -44.2 88.79 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.435 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.725 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.6 mt -63.27 -38.82 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.746 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -57.75 -48.38 82.21 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -62.71 -42.45 99.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.008 0.432 . . . . 0.0 110.699 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.506 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.5 t80 -60.1 -46.2 90.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.279 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.9 mt -66.56 -49.84 65.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.63 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 17.7 mmt85 -58.08 -37.2 74.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 110.291 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.36 -45.66 68.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.763 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.746 HG13 HD13 ' A' ' 105' ' ' ILE . 36.0 pt -73.08 -39.23 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.7 mtpt -58.92 -39.78 82.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 110.483 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -84.05 -34.93 24.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.361 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 34.1 t80 -52.7 -45.09 66.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.093 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.87 -43.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.841 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.3 t -56.39 128.61 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 111.005 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 67.1 mttm -68.93 139.07 90.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.288 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.614 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 39.1 Cg_exo -56.2 -39.17 92.99 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.749 2.299 . . . . 0.0 112.127 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -54.9 -32.22 60.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.59 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -88.69 -34.97 17.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 109.638 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.841 HD11 ' HB ' ' A' ' 100' ' ' VAL . 73.1 mt -71.81 131.67 34.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.793 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 10.3 p90 -73.15 -150.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.365 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 55.3 mt-10 -148.51 154.56 39.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.725 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -50.44 -26.35 4.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -76.72 -41.84 43.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.283 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 56.9 m-20 -60.06 -46.8 88.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.232 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 54' ' ' LEU . 61.2 tp -73.95 -47.62 36.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' CD2' HD21 ' A' ' 85' ' ' LEU . 34.0 t80 -61.0 -52.16 66.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.268 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 67.8 mm-40 -74.97 -12.11 60.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.552 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.21 31.12 15.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.664 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.52 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 76.8 p -73.25 -51.96 15.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.1 m120 -95.88 119.94 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.838 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' HE1' ' A' ' 51' ' ' MET . 44.1 m170 -100.35 -52.86 3.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.67 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 119' ' ' GLN . 8.9 t -66.57 -41.64 88.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.78 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 62.3 tp60 -54.65 -40.86 69.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.043 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 51.1 t -61.07 -46.65 96.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.493 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 31' ' ' GLU . 26.2 mt-30 -65.96 -44.26 85.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.374 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 81.4 p -59.16 -42.24 90.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.3 m -59.05 -42.85 91.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.996 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.644 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 97.1 mt -56.78 -41.99 78.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.438 HG23 ' HG2' ' A' ' 28' ' ' PRO . 59.5 mt -60.19 -44.15 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.43 98.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.427 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.7 tp -56.03 -37.45 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.21 97.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.248 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.539 ' O ' HG23 ' A' ' 133' ' ' THR . 47.2 t -59.23 -41.38 88.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.244 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.528 HE21 HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -67.24 -51.19 56.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.002 0.43 . . . . 0.0 111.65 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.643 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -58.9 -39.51 81.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.399 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.45 -47.32 84.54 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.321 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 129' ' ' SER . 81.6 p -62.19 -44.42 96.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.3 mmtt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.889 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.3 tpp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 125' ' ' ILE . 31.3 Cg_endo -64.02 -40.59 26.5 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.472 2.115 . . . . 0.0 112.332 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' OE1' HD11 ' A' ' 125' ' ' ILE . 66.1 tp60 -57.37 121.58 10.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.984 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.5 p -155.73 23.66 0.39 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.843 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' H ' HE21 ' A' ' 29' ' ' GLN . 56.1 mt-10 49.32 47.76 21.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 32' ' ' ARG . 40.7 ttt85 -168.74 -43.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.715 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -59.88 -41.45 91.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD21 HD13 ' A' ' 125' ' ' ILE . 95.5 mt -63.62 -47.32 81.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.243 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.48 36.34 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.265 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' LEU . 72.1 t -154.0 -37.82 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.905 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.63 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.68 -65.36 0.7 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.332 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD22 ' A' ' 124' ' ' LEU . 87.2 mt -63.62 -47.99 88.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.744 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -59.48 -43.94 93.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 0.0 110.632 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.67 91.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.469 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.3 -58.53 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.313 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.0 p -86.02 -66.26 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.057 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 149.77 -33.91 1.05 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.812 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.527 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 19.7 mmt180 -67.9 133.83 49.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.743 0.306 . . . . 0.0 111.459 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' A' ' 45' ' ' ARG . 38.6 mmt-85 -82.66 132.52 35.18 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 53' ' ' GLY . 77.8 mt -53.44 -50.75 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.765 0.316 . . . . 0.0 110.748 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.75 -150.49 22.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.478 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 49' ' ' ASN . 2.4 p30 -83.4 -43.79 15.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 0.0 110.602 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -74.83 -125.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.257 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.531 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.5 t80 -169.24 -45.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 13.8 mmt -80.81 -40.55 24.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.139 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 65.0 t0 -50.37 -48.88 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.031 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -60.39 -31.64 74.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.056 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.898 HD22 HD11 ' A' ' 60' ' ' LEU . 53.4 mt -75.74 -34.05 60.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.954 0.406 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.6 mtpt -53.44 -55.37 25.81 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.309 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 6.6 p-10 -59.2 -36.94 76.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.703 0.287 . . . . 0.0 111.038 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.26 111.09 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.548 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 58.8 t -159.2 -58.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.171 0.51 . . . . 0.0 109.907 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.5 mp -72.87 -41.25 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.898 HD11 HD22 ' A' ' 54' ' ' LEU . 85.1 mt -57.17 -43.88 83.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.373 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.7 p -63.74 -39.26 93.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.551 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.3 mt-10 -69.24 -34.42 74.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.396 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD13 ' CB ' ' A' ' 41' ' ' ALA . 36.6 tp -67.45 -48.07 68.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.277 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 HD11 HE21 ' A' ' 68' ' ' GLN . 8.0 tp -59.21 -38.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.433 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -56.34 -28.35 58.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 110.435 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.576 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -70.37 -54.04 14.14 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.446 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.6 mt -70.86 -58.46 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.386 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.553 HE21 HD11 ' A' ' 64' ' ' ILE . 8.2 tt0 -96.99 111.47 57.84 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.428 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.73 130.34 36.68 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.09 2.526 . . . . 0.0 113.462 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.56 51.59 37.25 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.896 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.528 ' OG ' HG13 ' A' ' 64' ' ' ILE . 68.3 m -75.58 -80.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.967 0.384 . . . . 0.0 111.087 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 61' ' ' CYS . 59.5 t -85.79 137.2 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.355 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -69.68 -140.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -65.31 129.95 41.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.779 0.323 . . . . 0.0 110.913 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' SG ' ' A' ' 61' ' ' CYS . 52.8 t -71.47 127.25 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.007 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -94.56 130.85 40.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.003 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.76 126.93 90.41 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.98 118.28 5.36 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.176 1.917 . . . . 0.0 112.329 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 79.4 t -154.36 -57.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -79.66 -125.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.764 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.45 -46.86 0.9 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.691 0.282 . . . . 0.0 111.252 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -70.03 -18.55 63.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.544 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.9 m170 -58.99 -55.65 32.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.866 0.365 . . . . 0.0 110.84 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.6 mttt -63.17 -46.25 88.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.043 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.585 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -57.34 -34.91 69.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.419 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.09 -44.51 60.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.71 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -60.5 -41.35 94.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.411 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.649 HD11 ' O ' ' A' ' 55' ' ' LYS . 56.7 mt -69.58 -42.71 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.915 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.14 -45.89 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.816 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -65.4 -40.4 93.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.7 t80 -60.32 -51.93 67.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.087 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.58 HD23 HD11 ' A' ' 95' ' ' ILE . 91.0 mt -67.38 -43.53 81.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.157 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -57.8 -39.59 77.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.973 0.415 . . . . 0.0 110.313 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.8 -46.02 69.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.58 HD11 HD23 ' A' ' 92' ' ' LEU . 30.7 pt -70.66 -40.29 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 92' ' ' LEU . 56.2 mtpt -60.17 -41.99 94.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 110.462 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -79.43 -35.49 40.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.296 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -52.53 -43.73 65.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.972 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.58 -44.23 0.2 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.253 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 36.2 t -55.01 127.47 13.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.33 . . . . 0.0 111.044 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.495 ' HE3' ' HD2' ' A' ' 103' ' ' HIS . 28.2 mtpp -74.41 145.6 82.82 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.54 -34.69 73.76 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.07 2.513 . . . . 0.0 112.36 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.495 ' HD2' ' HE3' ' A' ' 101' ' ' LYS . 89.5 m-70 -53.94 -29.09 41.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.019 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -113.06 39.09 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 82.7 mt -146.21 132.1 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.31 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 47.2 p90 -72.94 -154.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.255 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -147.41 148.08 30.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 110.909 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.22 -24.33 4.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.348 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -77.4 -43.27 33.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 60.0 m-20 -61.18 -46.93 88.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 111.033 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.55 HD21 ' C ' ' A' ' 54' ' ' LEU . 58.6 tp -69.44 -45.18 69.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.482 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -67.59 -56.55 9.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 112.075 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CB ' HG23 ' A' ' 115' ' ' THR . 68.6 mm-40 -68.51 -7.8 35.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 114' ' ' ASN . 19.2 t-20 61.74 31.8 18.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.403 0.621 . . . . 0.0 109.585 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.589 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 73.5 p -84.38 -27.47 27.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.625 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 26.7 t-20 -139.15 143.01 38.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.828 0.347 . . . . 0.0 110.626 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 9.1 m80 -132.13 -43.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.2 m -56.35 -44.67 80.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.734 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.0 tp60 -59.92 -39.68 86.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.527 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 92.4 t -61.58 -45.43 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.108 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.19 -46.5 86.75 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.309 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -61.2 -39.79 91.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.142 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 89.1 m -54.26 -42.86 70.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.961 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.63 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.6 mt -59.92 -39.05 84.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.804 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.553 HD11 ' OE1' ' A' ' 29' ' ' GLN . 49.9 mm -58.7 -47.28 89.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.175 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.54 96.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.166 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.25 -39.42 93.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.42 72.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.239 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 133' ' ' THR . 47.4 t -65.87 -39.72 90.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.746 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.641 ' HG3' ' HE2' ' A' ' 134' ' ' LYS . 51.2 tt0 -52.18 -49.28 64.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.816 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.19 -42.0 63.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.392 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -72.6 -44.11 62.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.73 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 129' ' ' SER . 68.8 p -61.63 -49.24 77.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.867 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.641 ' HE2' ' HG3' ' A' ' 130' ' ' GLN . 73.7 mmtt . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.962 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.622 0.249 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.79 -46.45 26.45 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.577 2.185 . . . . 0.0 112.631 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.905 ' HG2' ' HB3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -172.43 -133.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.25 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 29' ' ' GLN . 84.8 m -157.22 -47.28 0.07 Allowed 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.508 0.194 . . . . 0.0 111.449 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.605 ' HA ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -170.95 -30.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 32' ' ' ARG . 46.7 ttm-85 -56.57 -45.86 81.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.905 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 4.2 tp-100 -69.21 -33.67 73.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.277 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 31' ' ' GLU . 97.3 mt -50.78 -44.94 58.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.505 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 39.3 ttm180 -60.6 -51.31 69.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.602 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.4 t -63.89 -40.12 87.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -62.49 -71.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.633 HD11 HD22 ' A' ' 124' ' ' LEU . 83.8 mt -57.31 -52.85 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 96.4 mt-10 -62.12 -44.0 97.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.768 0.318 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.72 87.98 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.674 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.87 -66.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 111.475 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -83.8 -62.75 1.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.75 -30.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.473 ' HG3' HG12 ' A' ' 59' ' ' ILE . 15.5 mmt85 -58.05 131.62 51.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.435 -0.383 . . . . 0.0 111.314 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.3 mmm180 -90.39 36.15 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.704 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 50' ' ' PHE . 31.3 mm 59.36 -76.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.474 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 157.22 -144.16 10.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.439 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -75.41 -52.14 11.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.56 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.883 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.6 m120 -109.54 140.9 42.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.4 t80 -61.75 -51.4 68.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.355 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' HE3' ' HB3' ' A' ' 117' ' ' HIS . 17.9 mmt -70.13 -54.2 14.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.092 0.472 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.883 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 35.7 t70 -52.2 -36.92 53.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.88 -44.92 90.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.645 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.832 HD22 HD11 ' A' ' 60' ' ' LEU . 69.5 mt -60.9 -27.4 68.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.727 0.299 . . . . 0.0 111.603 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.64 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.8 mtpt -48.34 -45.3 35.12 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 6.4 p-10 -49.8 -38.99 36.88 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.69 72.35 0.9 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.298 -0.954 . . . . 0.0 112.037 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.877 HG13 HG21 ' A' ' 75' ' ' VAL . 64.4 t -151.31 -53.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.908 0.385 . . . . 0.0 110.073 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' A' ' 44' ' ' ARG . 57.9 mt -62.24 -47.32 93.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.731 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.832 HD11 HD22 ' A' ' 54' ' ' LEU . 83.3 mt -63.86 -45.57 88.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.003 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 96.6 m -58.56 -39.43 80.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 5.2 mm-40 -66.36 -38.01 86.61 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.492 ' CD2' HG12 ' A' ' 38' ' ' ILE . 23.9 tp -67.97 -48.8 64.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.999 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -59.09 -36.46 62.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 121.16 -0.216 . . . . 0.0 111.254 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -54.8 -27.63 43.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.854 0.359 . . . . 0.0 110.512 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -68.85 -53.45 21.3 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.635 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.612 HD13 ' HB2' ' A' ' 131' ' ' ALA . 68.7 mt -75.72 -57.58 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.539 HE21 HD11 ' A' ' 64' ' ' ILE . 8.3 tt0 -95.61 111.36 55.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.045 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.16 131.61 47.37 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 123.029 2.486 . . . . 0.0 113.046 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.05 48.68 66.26 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.88 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.557 ' OG ' HG13 ' A' ' 64' ' ' ILE . 67.5 m -74.71 -44.35 50.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -143.15 130.56 18.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.696 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.6 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 43.2 tt0 -70.59 -133.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.6 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 22.0 pttp -72.86 122.31 21.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 110.586 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG21 HG13 ' A' ' 58' ' ' VAL . 27.2 m -80.08 129.92 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.359 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -72.05 132.64 44.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.28 127.97 91.8 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.325 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.45 117.04 4.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.344 2.029 . . . . 0.0 112.474 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.9 t -153.93 -54.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.222 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -75.53 -124.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.496 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -138.14 -46.06 0.52 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.787 0.327 . . . . 0.0 110.916 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -73.64 -21.69 60.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.512 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -55.77 -49.55 72.85 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.893 0.377 . . . . 0.0 110.851 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.1 mttt -62.38 -47.82 82.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 112' ' ' PHE . 97.6 mt -58.6 -31.29 67.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.654 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -59.88 -54.81 41.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.817 0.341 . . . . 0.0 110.998 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.528 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 78.0 m-20 -67.56 -36.45 80.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.97 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 84' ' ' LYS . 79.3 mt -59.06 -43.21 88.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.73 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.73 -44.01 98.12 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -65.18 -42.78 93.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.976 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 26.0 t80 -61.35 -51.12 70.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.558 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.1 mt -64.6 -45.13 88.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.197 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -58.95 -36.87 75.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.09 0.471 . . . . 0.0 110.185 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.16 -43.79 70.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.693 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 92' ' ' LEU . 28.3 pt -71.29 -39.98 73.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 120.667 0.27 . . . . 0.0 111.27 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.0 mtpt -60.31 -40.07 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.177 0.513 . . . . 0.0 110.057 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -79.72 -35.33 39.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.192 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.493 ' OH ' ' HG3' ' A' ' 134' ' ' LYS . 39.9 t80 -51.25 -44.05 61.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.854 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.22 -42.14 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.732 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.42 129.44 16.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HG13 ' A' ' 105' ' ' ILE . 17.7 ptpt -73.62 145.33 84.55 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.124 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.583 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 12.0 Cg_endo -53.8 -36.51 82.75 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 123.123 2.548 . . . . 0.0 112.236 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -53.6 -27.57 27.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -115.11 40.09 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.224 0.535 . . . . 0.0 109.632 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 96' ' ' LYS . 92.1 mt -145.41 129.59 11.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.303 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.6 p90 -78.28 143.42 37.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.751 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -83.18 156.99 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.12 -23.53 3.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -82.42 -38.32 24.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.41 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.8 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -57.57 -50.23 73.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.588 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 54' ' ' LEU . 63.5 tp -70.99 -47.28 59.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.554 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.535 ' CG ' HD21 ' A' ' 85' ' ' LEU . 31.0 t80 -60.16 -45.46 93.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.618 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -78.23 -19.52 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.485 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.491 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 5.5 m120 64.45 33.75 10.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.428 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.5 p -89.06 -49.79 6.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.273 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.8 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -91.78 59.97 3.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.774 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.491 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 48.1 m170 -53.71 -50.28 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.822 0.344 . . . . 0.0 111.137 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.5 p -59.37 -42.96 92.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.389 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.6 tp60 -56.2 -42.18 76.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.659 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.522 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 88.6 t -61.75 -43.66 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.98 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 31' ' ' GLU . 8.1 tt0 -60.47 -47.19 87.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.166 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.402 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.8 m -54.51 -47.01 73.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.587 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD22 HD11 ' A' ' 38' ' ' ILE . 84.8 mt -59.05 -43.13 91.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.998 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.588 HG12 HE22 ' A' ' 29' ' ' GLN . 54.4 mt -59.48 -43.73 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.17 95.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 tp -60.41 -39.53 87.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.739 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.24 91.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.866 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 133' ' ' THR . 47.6 t -58.31 -39.77 80.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.786 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.61 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 8.5 mm100 -63.21 -49.58 73.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.503 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.88 -40.02 41.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.614 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -70.68 -46.91 62.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.311 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 129' ' ' SER . 61.6 p -64.39 -47.97 77.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.9 mmtp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.904 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.637 ' HB2' ' HD3' ' A' ' 28' ' ' PRO . 26.5 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 27' ' ' MET . 32.2 Cg_exo -59.37 134.05 56.21 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.212 1.941 . . . . 0.0 112.289 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.605 ' H ' HE21 ' A' ' 33' ' ' GLN . 25.0 mt-30 -61.39 139.62 58.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.713 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.422 ' HA ' HD11 ' A' ' 125' ' ' ILE . 86.2 m -61.04 -50.99 71.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.601 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 32' ' ' ARG . 15.0 pt-20 -72.13 -52.95 14.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.467 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 32.8 ttt85 -75.46 178.21 6.1 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.675 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 0.8 OUTLIER 73.68 -46.79 0.64 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.203 0.315 . . . . 0.0 111.319 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 36' ' ' VAL . 81.9 mt -70.17 -46.3 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 111.085 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -77.29 33.64 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.235 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' A' ' 34' ' ' LEU . 98.8 t -154.03 -39.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.224 0.535 . . . . 0.0 110.091 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -63.69 -71.46 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.9 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 60' ' ' LEU . 4.6 mp -56.18 -45.01 80.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.49 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -60.39 -40.7 91.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.876 0.369 . . . . 0.0 110.673 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.13 -39.68 98.27 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.006 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.72 -61.01 2.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.743 0.306 . . . . 0.0 111.68 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.517 ' OG1' HG23 ' A' ' 59' ' ' ILE . 69.0 p -79.07 -54.58 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.342 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.616 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.57 40.0 1.16 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 31.1 mmt-85 -134.41 137.76 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 110.934 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.5 mmt85 -79.9 28.31 0.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.233 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ARG . 69.8 mt 58.42 -76.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.426 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 162.2 -140.01 6.31 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.487 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -70.53 138.69 51.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.657 0.265 . . . . 0.0 110.783 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 59.32 -126.32 1.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 25.0 t80 -158.72 -49.93 0.06 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.677 0.275 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.507 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 60.4 mmm -71.4 -49.21 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.114 0.483 . . . . 0.0 110.272 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -60.03 -33.98 72.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.661 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.0 -42.39 98.24 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.419 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.803 HD22 HD11 ' A' ' 60' ' ' LEU . 82.4 mt -60.43 -27.31 67.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.686 0.279 . . . . 0.0 111.583 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.2 mtpt -48.88 -45.12 40.6 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -55.06 -32.36 61.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 62.3 88.39 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.123 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 59.3 t -153.29 -56.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 0.0 110.322 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.517 HG23 ' OG1' ' A' ' 42' ' ' THR . 32.9 mm -66.44 -45.24 89.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.846 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 38' ' ' ILE . 88.5 mt -61.44 -45.26 95.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.043 0.449 . . . . 0.0 109.801 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 82.8 m -59.2 -43.35 92.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.775 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 57.9 mm-40 -65.65 -34.81 79.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.93 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 HD11 ' HE1' ' A' ' 37' ' ' TRP . 20.6 tp -60.54 -55.47 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.825 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.576 HD11 HE21 ' A' ' 68' ' ' GLN . 7.8 tp -60.71 -38.58 79.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.676 ' ND2' HG22 ' A' ' 72' ' ' VAL . 7.6 m-80 -58.42 -25.46 62.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.642 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 32.7 mmmt -75.31 -51.14 13.92 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.077 0.465 . . . . 0.0 110.416 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' A' ' 131' ' ' ALA . 79.8 mt -71.59 -60.64 2.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.727 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.576 HE21 HD11 ' A' ' 64' ' ' ILE . 8.4 tt0 -89.03 113.77 57.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.62 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.71 127.27 20.51 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.991 2.46 . . . . 0.0 112.891 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.638 ' HA2' ' NE2' ' A' ' 73' ' ' GLN . . . 53.41 55.86 22.59 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.361 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.558 ' OG ' HG13 ' A' ' 64' ' ' ILE . 69.9 m -72.54 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.891 0.377 . . . . 0.0 111.009 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG22 ' ND2' ' A' ' 65' ' ' ASN . 0.7 OUTLIER -89.4 -46.26 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.437 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.638 ' NE2' ' HA2' ' A' ' 70' ' ' GLY . 97.0 mm-40 61.63 146.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.605 ' NZ ' ' HB3' ' A' ' 74' ' ' LYS . 7.6 mtpm? 71.23 -67.64 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.489 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG21 ' OE2' ' A' ' 62' ' ' GLU . 58.6 t 65.42 122.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 83' ' ' HIS . 74.0 m-20 -88.32 136.39 33.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -66.38 135.87 94.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.48 44.74 0.92 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.194 . . . . 0.0 112.987 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.84 -60.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.828 0.346 . . . . 0.0 110.968 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -81.02 -116.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.845 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -145.64 -41.57 0.22 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.688 0.28 . . . . 0.0 111.107 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -62.26 -30.39 71.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.924 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 47.1 m80 -52.16 -46.49 65.5 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.835 0.35 . . . . 0.0 110.361 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.7 mttt -57.08 -48.47 78.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.35 -30.95 65.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -75.05 -49.25 20.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.018 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 74.1 m-20 -60.99 -44.51 97.3 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.618 HG21 ' HA ' ' A' ' 108' ' ' ALA . 67.6 mt -59.13 -40.22 80.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -61.98 -42.52 99.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.218 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.572 ' HB3' ' HB ' ' A' ' 72' ' ' VAL . 80.7 m-20 -62.09 -44.03 97.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.376 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.566 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.0 t80 -63.87 -49.05 74.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.616 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD23 HD11 ' A' ' 95' ' ' ILE . 67.1 mt -68.05 -44.41 76.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 16.5 ptm180 -60.32 -39.1 85.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.074 0.464 . . . . 0.0 110.256 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.79 -46.87 67.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.0 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.614 HD11 HD23 ' A' ' 92' ' ' LEU . 27.0 pt -72.42 -40.58 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 62.5 tttm -58.82 -35.98 73.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.482 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -90.33 -32.79 16.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.463 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 39.6 t80 -51.63 -44.18 62.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.387 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.99 -42.87 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.437 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 105' ' ' ILE . 12.2 t -54.82 121.45 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.985 0.422 . . . . 0.0 110.785 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 96.4 mttt -68.33 142.95 95.15 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.678 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.479 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 25.7 Cg_exo -62.16 76.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.028 2.485 . . . . 0.0 112.152 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.67 -31.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.918 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.55 38.13 2.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.03 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 100' ' ' VAL . 56.0 mt -140.8 130.3 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.504 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 32.4 p90 -79.57 -153.25 0.08 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.604 ' HA ' HD13 ' A' ' 92' ' ' LEU . 54.6 mt-10 -150.47 164.28 36.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 110.382 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.34 -25.87 2.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -79.58 -40.43 29.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.667 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 31.7 m-20 -58.29 -51.95 67.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.4 tp -70.05 -46.39 65.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -61.06 -47.93 84.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.561 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -76.78 -15.67 59.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.544 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 74.5 m-20 64.61 36.02 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.379 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 69.8 p -88.46 -51.22 5.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.609 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.798 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -91.71 63.64 4.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.118 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.415 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 52.3 m170 -55.85 -48.49 75.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 111.068 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.0 m -63.58 -44.02 95.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.536 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.776 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.5 tp60 -59.15 -36.71 75.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.327 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 116' ' ' ASN . 53.4 t -54.46 -49.5 64.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.311 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' HG13 ' A' ' 125' ' ' ILE . 74.1 mt-30 -71.99 -40.84 68.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -56.05 -42.8 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.192 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.5 m -59.34 -45.66 90.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.102 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 37' ' ' TRP . 90.9 mt -61.2 -46.74 89.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.974 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 30' ' ' THR . 67.4 mt -56.37 -44.6 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.251 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.99 94.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 47.8 tp -61.53 -33.19 73.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.066 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -40.35 65.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -58.03 -35.65 71.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.81 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.562 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -63.57 -52.75 59.65 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.501 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.586 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.3 40.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.4 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 133' ' ' THR . 14.5 ptmm? -71.82 -48.82 43.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.905 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 56.1 p -153.72 36.07 0.45 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.1 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.946 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.445 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 66.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.62 0.248 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.758 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 36.8 Cg_exo -60.39 127.1 21.82 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.563 2.175 . . . . 0.0 112.237 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.601 ' NE2' ' H ' ' A' ' 30' ' ' THR . 3.0 pm0 -76.64 -47.41 22.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.801 HG22 ' H ' ' A' ' 32' ' ' ARG . 75.9 m -101.28 143.39 31.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 24.2 pt-20 -55.7 -19.73 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.801 ' H ' HG22 ' A' ' 30' ' ' THR . 39.1 ttm180 -56.38 -48.49 76.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.758 ' HB2' ' HB3' ' A' ' 28' ' ' PRO . 11.5 mm100 -60.14 -25.66 65.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD21 HD12 ' A' ' 124' ' ' LEU . 52.3 tp -71.14 -51.09 26.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.067 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 35' ' ' ARG . 7.7 ptm180 -65.45 -46.48 79.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.181 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' TRP . 9.7 p -56.76 -44.17 81.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.347 0.594 . . . . 0.0 110.413 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HE1' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -61.55 -70.2 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.61 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' CD1' HD13 ' A' ' 124' ' ' LEU . 62.7 mt -53.71 -51.68 41.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.482 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HG2' HG13 ' A' ' 46' ' ' ILE . 52.8 mt-10 -60.41 -44.21 95.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.863 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -36.76 93.9 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.81 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -55.27 -58.56 7.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.801 0.334 . . . . 0.0 111.406 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.421 ' CG2' HG23 ' A' ' 59' ' ' ILE . 70.8 p -83.62 -65.98 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.319 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.75 -36.45 0.91 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HB2' HG12 ' A' ' 59' ' ' ILE . 21.1 mmt180 -63.94 134.02 54.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.914 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 38.0 mmt180 -83.54 31.61 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.498 HG13 ' HG2' ' A' ' 39' ' ' GLU . 67.4 mt 70.42 -42.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.077 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.38 137.56 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.8 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.06 -144.53 0.52 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.738 0.304 . . . . 0.0 111.235 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 5.3 m120 -65.98 146.99 54.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 30.5 t80 -58.0 -47.43 83.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.547 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.0 mmm -76.46 -47.3 23.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.269 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 65.3 t0 -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.415 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.4 57.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.585 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 60' ' ' LEU . 82.7 mt -69.33 -36.65 77.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HG2' ' HG ' ' A' ' 111' ' ' LEU . 40.8 mtmt -54.21 -51.87 63.08 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.9 p30 -53.4 -32.81 51.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.839 0.352 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.04 107.45 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.863 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.538 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 62.0 t -156.52 -57.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.208 0.528 . . . . 0.0 109.806 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.4 mp -74.7 -41.67 47.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.301 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 54' ' ' LEU . 74.3 mt -56.95 -46.16 82.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.326 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.66 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -61.7 -47.27 86.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.091 0.472 . . . . 0.0 109.761 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 56.8 mt-10 -60.71 -33.4 72.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.666 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.8 tm? -66.94 -49.27 66.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.352 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 61' ' ' CYS . 7.1 tp -64.57 -38.16 81.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.554 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -58.77 -24.75 62.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.887 0.375 . . . . 0.0 110.337 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.65 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 49.0 mmtm -72.74 -50.25 25.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.335 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 131' ' ' ALA . 42.1 mt -70.92 -59.31 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.507 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 8.1 tt0 -80.98 137.78 49.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.583 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.551 ' HD2' ' HG3' ' A' ' 68' ' ' GLN . 55.3 Cg_exo -37.56 -42.17 1.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.633 2.889 . . . . 0.0 113.61 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 178.75 91.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.365 -0.922 . . . . 0.0 112.819 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.1 m -81.94 -83.36 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.931 0.396 . . . . 0.0 111.192 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.66 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 39.3 t -78.22 138.73 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.231 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -67.94 -49.59 60.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.133 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -174.28 133.59 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.571 ' HA ' ' OD1' ' A' ' 87' ' ' ASN . 27.9 m -75.53 132.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.818 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -87.28 138.14 31.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.174 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -58.52 120.6 46.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.463 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 48.1 Cg_endo -67.69 130.42 21.97 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.572 2.181 . . . . 0.0 112.427 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -150.28 -57.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -86.75 -75.67 0.38 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.166 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 179.78 -46.06 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.422 ' CD1' ' N ' ' A' ' 82' ' ' TRP . 0.2 OUTLIER -55.61 -35.99 66.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.405 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -58.9 -43.53 91.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.895 0.379 . . . . 0.0 110.66 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 88' ' ' ILE . 94.1 mttt -64.95 -52.66 55.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 112' ' ' PHE . 90.9 mt -57.54 -31.11 65.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.473 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -65.92 -53.34 40.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.96 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 74.6 m-20 -61.52 -37.38 83.51 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.744 0.307 . . . . 0.0 110.662 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.7 mt -63.19 -49.74 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.965 0.412 . . . . 0.0 110.544 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -56.43 -46.22 87.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.399 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.419 ' HB3' HG22 ' A' ' 72' ' ' VAL . 78.8 m-20 -59.43 -39.27 82.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.729 0.3 . . . . 0.0 110.905 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -64.01 -57.53 9.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.62 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 88' ' ' ILE . 8.5 mp -60.91 -48.46 81.71 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.3 mmt180 -60.24 -40.28 89.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.054 0.454 . . . . 0.0 111.047 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -46.89 84.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.675 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.772 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -73.14 -37.95 53.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.3 mtpm? -55.47 -41.01 72.37 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.07 0.462 . . . . 0.0 110.114 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -84.95 -34.52 22.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.118 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 95' ' ' ILE . 36.2 t80 -50.55 -44.76 56.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.07 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.461 ' HA3' ' NE2' ' A' ' 130' ' ' GLN . . . 171.37 -42.98 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.167 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' HB ' HD11 ' A' ' 105' ' ' ILE . 59.7 t -54.54 126.57 11.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.895 0.378 . . . . 0.0 111.069 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -67.86 137.4 92.51 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.766 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 104' ' ' ASP . 50.4 Cg_exo -52.69 -24.52 23.41 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.48 2.12 . . . . 0.0 112.159 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.52 40.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.957 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 102' ' ' PRO . 9.9 t0 -159.44 -42.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.319 0.581 . . . . 0.0 109.656 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.772 HD13 HG13 ' A' ' 95' ' ' ILE . 52.6 mt -74.9 135.03 28.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.184 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 4.7 p90 -73.9 -147.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.372 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.531 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 49.2 mt-10 -143.58 151.62 40.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.706 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.94 -22.16 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 109' ' ' ASN . 2.5 m120 -82.32 -39.95 22.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.177 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.887 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 34.8 m-20 -57.14 -49.23 76.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.554 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.586 ' HG ' ' HG2' ' A' ' 55' ' ' LYS . 61.1 tp -71.8 -47.51 52.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.635 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CG ' HD21 ' A' ' 85' ' ' LEU . 36.5 t80 -61.05 -43.9 98.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.696 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -76.45 -16.94 59.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.639 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.49 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 6.2 m120 64.81 33.12 10.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.448 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.9 t -92.5 -45.2 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.806 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.887 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.9 m120 -94.49 57.4 2.24 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.49 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 51.9 m170 -53.95 -48.68 70.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 111.235 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.3 m -62.35 -44.29 96.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.251 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.799 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 68.1 tp60 -60.82 -36.13 78.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 116' ' ' ASN . 60.9 t -53.66 -48.29 60.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.506 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.466 ' O ' HG13 ' A' ' 125' ' ' ILE . 87.2 mt-30 -68.02 -41.34 82.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.162 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -57.24 -44.41 83.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.276 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 105' ' ' ILE . 96.9 m -59.57 -46.48 88.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.193 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.681 HD12 HD21 ' A' ' 34' ' ' LEU . 94.5 mt -57.5 -42.25 82.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.747 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.602 HG23 ' HD2' ' A' ' 28' ' ' PRO . 69.1 mt -56.94 -42.62 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.22 -42.41 90.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.1 tp -59.98 -43.69 94.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.994 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.489 ' HB2' ' CH2' ' A' ' 37' ' ' TRP . . . -58.81 -45.96 88.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.1 m -59.51 -37.49 78.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.805 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.678 ' HG3' ' HE3' ' A' ' 134' ' ' LYS . 4.8 tp60 -64.07 -46.78 82.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.075 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -61.18 -42.07 97.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.164 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -76.52 43.93 0.34 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.537 HG23 ' HE2' ' A' ' 134' ' ' LYS . 8.0 t -179.31 47.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.061 0.458 . . . . 0.0 110.904 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.678 ' HE3' ' HG3' ' A' ' 130' ' ' GLN . 70.7 mmtt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 22.8 ptp . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.617 0.246 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 33' ' ' GLN . 18.6 Cg_exo -66.09 -142.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.701 2.267 . . . . 0.0 112.271 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.529 ' HG2' ' H ' ' A' ' 30' ' ' THR . 7.4 tt0 -176.16 -128.48 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.124 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.529 ' H ' ' HG2' ' A' ' 29' ' ' GLN . 74.2 p -64.25 -47.43 79.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.85 0.357 . . . . 0.0 110.878 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -177.19 31.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.689 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.6 ttt-85 -83.35 -94.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.568 ' HB3' ' HA ' ' A' ' 28' ' ' PRO . 41.2 tt0 -56.17 -34.64 66.37 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.021 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 124' ' ' LEU . 52.3 tp -55.48 -52.54 63.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HG3' HD12 ' A' ' 46' ' ' ILE . 79.6 ttt180 -69.76 -44.84 69.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.174 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' ARG . 99.0 t -54.59 -32.91 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.47 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.703 -179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.765 ' HB ' HD11 ' A' ' 46' ' ' ILE . 4.4 mp -60.9 -43.69 96.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.633 0.254 . . . . 0.0 111.451 -178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 55.7 mt-10 -56.01 -45.18 79.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.904 0.383 . . . . 0.0 110.895 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.97 -35.32 84.05 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.602 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -53.68 -62.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.665 0.269 . . . . 0.0 111.639 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.3 p -99.03 -63.18 1.15 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.934 0.397 . . . . 0.0 111.441 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.45 -30.18 0.57 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.548 ' HG3' HG12 ' A' ' 59' ' ' ILE . 23.3 mmm180 -55.8 131.96 48.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.02 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -81.44 19.37 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.811 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.765 HD11 ' HB ' ' A' ' 38' ' ' ILE . 76.2 mt 55.78 -77.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.625 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 158.89 144.44 3.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.103 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -54.92 -36.74 65.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.349 . . . . 0.0 110.321 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 6.2 m120 -63.7 -30.84 71.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.401 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t80 78.15 -46.85 0.45 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.016 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.0 mmt -87.3 -50.81 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.217 0.532 . . . . 0.0 110.522 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.63 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.5 m-20 -53.74 -37.2 63.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.289 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.59 96.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.271 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 60' ' ' LEU . 81.1 mt -64.15 -23.81 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.672 0.272 . . . . 0.0 111.527 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.3 mtpt -49.63 -41.77 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.093 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.564 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.6 p-10 -55.16 -32.66 62.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.032 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.6 -33.18 1.62 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.638 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 61.3 t -51.64 -53.52 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 HG12 ' HG3' ' A' ' 44' ' ' ARG . 60.6 mt -55.15 -52.99 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.784 -0.189 . . . . 0.0 111.07 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 54' ' ' LEU . 80.5 mt -61.07 -33.76 73.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 75' ' ' VAL . 1.3 t -65.75 -36.49 83.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 50.0 mt-10 -68.42 -40.15 81.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.796 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD13 ' CB ' ' A' ' 41' ' ' ALA . 18.0 tp -72.38 -46.42 55.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.17 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 91' ' ' PHE . 8.9 tp -56.22 -38.34 54.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.544 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -62.11 -36.81 82.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.359 . . . . 0.0 110.325 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.4 mmtt -64.32 -51.07 65.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.315 0.579 . . . . 0.0 110.306 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.784 HD22 ' HB1' ' A' ' 131' ' ' ALA . 69.1 mt -66.25 -33.21 75.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.877 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.457 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -140.21 115.19 7.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.552 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.89 131.45 46.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.912 2.408 . . . . 0.0 113.267 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.53 48.17 66.44 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.787 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 73.4 m -73.98 -59.62 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.969 0.385 . . . . 0.0 110.98 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.537 HG21 ' SG ' ' A' ' 61' ' ' CYS . 89.0 t -83.43 141.01 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.401 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.32 -46.62 85.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.382 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -170.98 134.32 0.95 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.963 0.411 . . . . 0.0 111.276 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 61' ' ' CYS . 48.0 t -73.21 138.27 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.274 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -127.88 130.58 48.78 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.638 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 29.9 m-20 -64.58 123.78 84.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.661 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' A' ' 58' ' ' VAL . 8.3 Cg_exo -71.6 120.75 7.13 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.528 2.152 . . . . 0.0 111.919 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 85.9 t -152.67 -61.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.038 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -78.11 -130.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.013 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -141.56 52.69 1.53 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.813 0.34 . . . . 0.0 111.395 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -160.43 -32.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.723 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -54.56 -47.22 73.51 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 109.928 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 94.9 mttt -62.24 -44.76 95.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.952 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -54.98 -36.23 65.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.447 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -76.08 -45.59 33.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -60.19 -41.07 92.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.63 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.561 HG21 ' HA ' ' A' ' 108' ' ' ALA . 62.7 mt -67.81 -41.44 85.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.049 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -57.3 -50.2 66.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' HG13 ' A' ' 72' ' ' VAL . 75.7 m-20 -61.78 -40.68 96.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.907 0.384 . . . . 0.0 110.963 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.546 ' O ' HG23 ' A' ' 95' ' ' ILE . 34.0 t80 -59.74 -49.87 76.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.555 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HA ' HG12 ' A' ' 95' ' ' ILE . 89.7 mt -67.51 -46.58 72.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.948 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 49.6 mtp85 -58.56 -43.14 89.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.168 0.509 . . . . 0.0 110.161 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -65.44 -44.62 86.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.88 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG12 ' HA ' ' A' ' 92' ' ' LEU . 39.2 pt -71.0 -37.46 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.659 ' HG2' HD12 ' A' ' 105' ' ' ILE . 56.6 mtpt -58.58 -40.8 84.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.981 0.42 . . . . 0.0 110.602 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -85.68 -34.65 21.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.664 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 44.2 t80 -51.69 -43.49 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.215 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.77 -44.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.03 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.8 t -58.29 127.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.863 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 28.5 mtpp -70.31 140.53 87.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.113 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.495 ' C ' ' H ' ' A' ' 104' ' ' ASP . 71.7 Cg_exo -52.73 -42.47 62.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.136 2.558 . . . . 0.0 113.954 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -70.86 20.69 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 102' ' ' PRO . 1.0 OUTLIER -150.35 40.4 0.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.659 HD12 ' HG2' ' A' ' 96' ' ' LYS . 70.0 mt -147.68 133.77 12.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.205 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.5 p90 -71.39 143.35 50.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.401 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 50.3 mp0 -89.8 152.65 21.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.561 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.68 -38.63 15.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.213 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -69.06 -36.2 77.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 11.6 m-20 -63.75 -50.45 69.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.261 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' LEU . 57.2 tp -69.81 -40.12 76.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.275 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -69.34 -48.2 62.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.826 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 115' ' ' THR . 95.3 mt-10 -80.71 -13.19 59.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.406 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.678 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 3.7 m120 64.24 37.29 8.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.941 0.4 . . . . 0.0 110.329 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 113' ' ' GLU . 67.8 p -81.05 -55.34 4.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.299 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 6.8 m-80 -73.98 -50.61 19.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.678 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 36.3 m170 66.97 -75.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.714 0.292 . . . . 0.0 111.359 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.9 m -59.93 -42.78 94.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.602 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.2 tp60 -51.26 -37.86 49.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.02 0.438 . . . . 0.0 110.514 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.58 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.5 t -61.71 -43.36 97.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.175 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -63.52 -47.5 81.4 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.571 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -60.88 -41.56 96.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.476 HG21 HG23 ' A' ' 105' ' ' ILE . 87.7 m -56.32 -43.93 79.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.454 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 90.9 mt -54.98 -43.12 73.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.043 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.8 mt -60.71 -44.25 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.13 98.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.223 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.613 HD13 ' O ' ' A' ' 127' ' ' LEU . 3.0 tm? -65.6 -42.99 91.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -53.27 -45.88 69.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.696 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.799 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 80.0 p -59.1 -35.95 74.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.156 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.548 HE21 HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -66.55 -52.28 47.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.01 0.433 . . . . 0.0 111.644 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.784 ' HB1' HD22 ' A' ' 67' ' ' LEU . . . -59.58 -43.91 93.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.023 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 65.7 pttt -78.22 39.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.597 0.237 . . . . 0.0 111.227 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -160.24 -44.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.71 0.291 . . . . 0.0 111.23 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 47.4 mmtm . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.708 0.289 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.5 136.66 55.73 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.497 2.131 . . . . 0.0 112.24 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -66.92 -137.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.608 ' HB ' HD11 ' A' ' 125' ' ' ILE . 6.9 t -174.12 49.09 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.808 0.337 . . . . 0.0 111.48 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -172.12 -54.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.303 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -77.31 -50.39 12.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.282 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.21 -37.08 83.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.557 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD22 ' HB3' ' A' ' 124' ' ' LEU . 93.0 mt -55.69 -46.13 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.477 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -63.67 -52.01 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.49 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.99 -38.59 77.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 111.508 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.683 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.16 -66.54 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.97 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 124' ' ' LEU . 92.3 mt -61.9 -50.3 80.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.1 mt-10 -60.25 -35.41 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.36 -41.32 99.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.85 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.26 -70.4 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.909 ' HB ' ' HD3' ' A' ' 44' ' ' ARG . 72.6 p -70.31 -39.81 74.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.002 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.33 -20.57 45.5 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.909 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -68.26 127.68 33.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.491 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 45' ' ' ARG . 20.8 mmt85 -78.36 130.17 35.84 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 71.3 mt -54.95 -41.86 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.681 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.09 141.34 0.16 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.311 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.36 -145.1 0.49 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.8 0.333 . . . . 0.0 111.394 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . 5.2 m120 -61.41 141.64 57.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.222 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.3 t80 -64.53 -47.68 77.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.092 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.0 mmm -70.69 -52.13 23.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.051 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' ASN . 1.5 m-20 -58.92 -40.76 85.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.561 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.01 -40.32 91.08 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.674 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.636 ' HB2' HD11 ' A' ' 111' ' ' LEU . 96.5 mt -55.24 -27.98 50.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' O ' HD11 ' A' ' 88' ' ' ILE . 48.6 mtmt -48.77 -39.32 24.63 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 2.8 p30 -54.44 -38.46 66.32 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.564 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 58' ' ' VAL . . . 76.56 -46.21 2.24 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.302 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.702 HG21 ' HD3' ' A' ' 78' ' ' PRO . 60.2 t -27.34 -55.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.479 HG23 ' OG1' ' A' ' 42' ' ' THR . 19.9 mt -60.19 -50.14 81.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.096 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.566 HD21 HD13 ' A' ' 38' ' ' ILE . 83.4 mt -61.02 -43.74 98.45 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 57.9 m -57.72 -40.62 80.0 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' OE2' HG21 ' A' ' 75' ' ' VAL . 47.5 mm-40 -67.77 -34.7 77.32 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.801 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD21 ' NE1' ' A' ' 37' ' ' TRP . 30.3 tp -69.28 -47.96 63.07 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.965 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD11 HE21 ' A' ' 68' ' ' GLN . 7.5 tp -61.02 -39.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.467 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -52.36 -26.4 12.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.52 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -69.46 -52.31 27.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.406 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.41 -59.1 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.745 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.593 HE21 HD11 ' A' ' 64' ' ' ILE . 8.0 tt0 -90.49 131.7 37.43 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.077 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 134.27 22.69 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.128 2.552 . . . . 0.0 112.871 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 51.63 42.04 51.12 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.859 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 64' ' ' ILE . 27.4 m -63.11 -45.88 89.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 111.198 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.88 134.87 48.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.996 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -68.3 -136.05 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.593 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -60.59 124.11 19.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG11 HG13 ' A' ' 58' ' ' VAL . 61.0 t -75.44 128.89 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.375 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -93.96 131.43 39.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.987 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -68.22 138.4 91.98 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.423 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.702 ' HD3' HG21 ' A' ' 58' ' ' VAL . 71.6 Cg_endo -74.56 37.34 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.475 2.116 . . . . 0.0 112.752 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.9 -55.65 9.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.854 0.359 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -72.58 -126.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -145.01 -48.7 0.24 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.604 0.24 . . . . 0.0 111.205 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -68.85 -18.19 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.119 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -57.46 -45.81 84.36 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.379 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 98.1 mttt -60.77 -41.25 95.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' CE2' ' A' ' 112' ' ' PHE . 88.6 mt -53.84 -36.03 62.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.329 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -73.86 -46.44 44.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.785 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.426 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 3.7 m120 -59.17 -42.74 91.48 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 55' ' ' LYS . 62.8 mt -67.54 -43.47 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.358 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.48 -48.54 85.48 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.789 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -69.01 -41.12 78.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.6 0.238 . . . . 0.0 111.381 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.8 t80 -59.68 -52.73 64.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HA ' HG12 ' A' ' 95' ' ' ILE . 96.3 mt -64.52 -44.04 92.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.905 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -59.37 -39.16 82.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.064 0.459 . . . . 0.0 110.38 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.87 -44.95 65.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.945 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 105' ' ' ILE . 33.0 pt -70.73 -38.96 75.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.688 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.5 mtpt -59.05 -39.67 82.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.915 0.388 . . . . 0.0 110.714 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -86.5 -33.99 20.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.708 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.95 -44.44 63.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.156 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.0 -44.06 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.891 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 105' ' ' ILE . 19.7 t -57.4 127.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.948 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 105' ' ' ILE . 51.7 mtmt -65.65 139.41 97.06 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.156 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.688 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 49.9 Cg_exo -54.72 -41.58 76.54 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.692 2.262 . . . . 0.0 111.964 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -58.04 -24.01 56.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.68 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -108.63 36.57 2.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.265 0.555 . . . . 0.0 109.562 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.732 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.2 mt -146.3 130.37 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.213 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 92' ' ' LEU . 41.1 p90 -71.72 144.83 49.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.615 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -83.37 161.42 21.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -52.0 -26.09 9.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.029 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.27 -37.25 16.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.726 0.298 . . . . 0.0 111.376 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.759 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 29.0 m-20 -53.12 -42.22 65.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.78 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.6 tp -85.36 -49.55 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.674 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' CE2' HD21 ' A' ' 85' ' ' LEU . 34.3 t80 -61.71 -58.91 6.19 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.592 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.93 2.03 4.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.774 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 p30 44.45 28.16 0.29 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.185 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 116' ' ' ASN . 6.0 t -74.99 -46.23 36.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.759 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 31.2 t-20 -99.71 135.81 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.506 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 47.9 m170 -117.96 -45.55 2.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.45 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.6 p -58.86 -48.25 82.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.858 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.3 tp60 -57.78 -42.27 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.462 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 97.3 t -59.09 -46.91 91.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -64.0 -45.45 88.91 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.1 m -62.06 -38.75 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.402 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' HD23 ' A' ' 127' ' ' LEU . 90.4 m -53.58 -46.19 70.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.461 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.683 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 93.1 mt -52.48 -42.97 64.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.117 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 30' ' ' THR . 58.4 mt -63.01 -39.88 86.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.011 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.478 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -59.65 -48.1 82.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.395 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 123' ' ' THR . 4.0 mm? -59.16 -41.19 87.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.85 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.17 75.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.818 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -61.24 -40.44 94.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.772 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.596 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -68.33 -53.5 23.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.349 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.35 -37.33 72.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.524 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.627 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 4.2 ttmp? -58.17 -49.78 75.83 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.394 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.2 p -69.06 -43.54 74.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.453 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 34.7 mmtp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.929 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.3 ptm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.715 0.293 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.616 ' HG2' ' HA ' ' A' ' 125' ' ' ILE . 33.5 Cg_exo -58.13 -46.14 27.26 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.565 2.177 . . . . 0.0 112.225 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.588 HE21 HG22 ' A' ' 30' ' ' THR . 16.5 pt20 39.31 -137.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.588 HG22 HE21 ' A' ' 29' ' ' GLN . 8.1 t -56.45 152.17 12.0 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.841 0.353 . . . . 0.0 111.28 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HA ' HD12 ' A' ' 34' ' ' LEU . 40.7 mp0 -51.26 -23.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.461 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 30' ' ' THR . 41.4 ttt85 -49.68 -45.44 48.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 3.3 mm100 -75.44 -33.78 60.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.032 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 31' ' ' GLU . 90.3 mt -56.52 -50.38 72.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.567 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 36' ' ' VAL . 38.7 ptt180 -63.84 -49.3 73.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.578 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.408 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 90.9 t -58.17 -39.11 71.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.966 0.412 . . . . 0.0 111.099 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.679 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.55 -67.2 0.44 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.797 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.856 HG22 HH12 ' A' ' 44' ' ' ARG . 62.5 mt -55.84 -47.53 79.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -57.28 -43.15 82.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.896 0.379 . . . . 0.0 110.627 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.78 -32.07 83.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.374 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -50.11 -38.14 37.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.555 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.502 ' OG1' ' NE ' ' A' ' 44' ' ' ARG . 61.7 p -125.73 -61.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.514 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.97 -40.28 0.8 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.392 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.888 ' CZ ' HG23 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -56.54 140.09 47.5 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.288 0.566 . . . . 0.0 112.119 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -85.81 138.49 32.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.749 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.3 mt -58.31 -52.31 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.865 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.74 -147.93 19.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.469 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.57 -57.36 3.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.569 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.816 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.3 m-20 -89.7 135.07 33.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 24.2 t80 -67.63 -49.31 63.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.199 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.569 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 58.8 mmm -68.86 -50.02 53.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.999 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.816 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 64.6 t0 -56.99 -41.46 78.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.863 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.75 97.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.5 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 50' ' ' PHE . 90.2 mt -61.59 -27.66 68.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.759 0.314 . . . . 0.0 111.22 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 52' ' ' ASP . 56.7 mtpt -50.47 -34.09 23.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.987 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 55.3 p-10 -55.52 -32.32 62.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.686 0.279 . . . . 0.0 110.937 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 77.79 -39.14 1.75 Allowed Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.054 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.968 HG21 ' HD3' ' A' ' 78' ' ' PRO . 42.8 t -50.56 -50.97 20.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.888 HG23 ' CZ ' ' A' ' 44' ' ' ARG . 64.0 mt -54.36 -53.94 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.134 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 54' ' ' LEU . 78.5 mt -61.02 -34.95 75.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 87' ' ' ASN . 56.0 m -65.18 -34.77 79.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 56.2 mt-10 -69.99 -42.17 73.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.601 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD22 HG12 ' A' ' 38' ' ' ILE . 19.4 tp -67.03 -54.56 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.302 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 67' ' ' LEU . 10.9 tp -50.71 -30.69 8.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.81 -40.75 56.32 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.953 0.406 . . . . 0.0 110.288 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -67.41 -48.27 67.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.799 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -59.81 -29.69 68.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.121 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.6 tt0 -154.54 130.39 5.41 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.894 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -79.91 44.66 1.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.151 2.567 . . . . 0.0 113.309 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.709 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 54.8 m -88.82 -46.96 8.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.76 0.314 . . . . 0.0 111.272 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' SG ' ' A' ' 61' ' ' CYS . 48.6 t -142.42 125.82 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.985 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.87 -43.86 5.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.675 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -78.62 52.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.211 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 58' ' ' VAL . 37.9 t -72.61 64.42 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -65.14 135.98 56.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.214 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.77 140.09 95.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.353 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.968 ' HD3' HG21 ' A' ' 58' ' ' VAL . 48.4 Cg_endo -68.63 123.74 10.79 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.267 1.978 . . . . 0.0 112.196 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.412 ' HB ' ' CE1' ' A' ' 83' ' ' HIS . 55.3 t -153.3 -63.7 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.81 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -85.62 -128.16 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.74 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -128.4 -41.4 1.55 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 44.6 p-90 -69.12 -21.57 64.02 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.911 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 79' ' ' VAL . 28.7 m170 -56.86 -54.21 49.03 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.059 0.457 . . . . 0.0 110.13 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.2 mttt -63.99 -43.91 94.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' TRP . 91.9 mt -54.41 -32.89 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -77.26 -49.65 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 61' ' ' CYS . 77.5 m-20 -59.78 -43.17 94.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 55' ' ' LYS . 64.4 mt -64.1 -42.35 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.3 94.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.93 -41.11 83.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.528 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.5 t80 -59.86 -52.84 63.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.631 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.583 ' HA ' HG12 ' A' ' 95' ' ' ILE . 93.2 mt -65.69 -44.09 87.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.397 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -60.87 -37.91 83.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.151 0.5 . . . . 0.0 110.33 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.07 -43.66 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.786 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.9 pt -70.73 -36.93 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.659 0.266 . . . . 0.0 111.672 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 54.8 mtpt -58.51 -41.74 86.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.049 0.452 . . . . 0.0 110.458 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -84.06 -35.41 23.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.561 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -50.92 -43.55 59.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.919 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.61 -46.25 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.743 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.4 t -61.87 128.35 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 34.8 mmtp -72.67 136.79 80.37 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.753 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 5.7 Cg_endo -51.27 -35.22 52.39 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.628 2.219 . . . . 0.0 112.186 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -55.21 -32.43 62.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.133 0.492 . . . . 0.0 110.119 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.09 37.2 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.16 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.552 HD13 HG13 ' A' ' 95' ' ' ILE . 81.8 mt -143.71 132.47 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.216 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 41.7 p90 -74.12 143.4 45.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.305 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.654 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 10.0 mp0 -86.37 157.29 19.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.817 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.27 -36.89 14.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.412 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -72.13 -34.69 68.75 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.625 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.2 m-20 -59.55 -51.16 71.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.736 0.303 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 65.0 tp -74.69 -47.65 30.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.488 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -58.77 -58.07 10.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.293 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -81.36 14.87 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 37.43 36.96 0.09 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.717 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 78.9 p -74.22 -54.58 7.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.828 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.7 m120 -98.96 124.61 44.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.769 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -101.49 -49.45 4.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.0 m -63.46 -42.4 98.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.008 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 70.3 tp60 -57.53 -38.89 75.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.597 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.7 t -57.16 -52.11 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.394 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.766 ' HA ' HD13 ' A' ' 124' ' ' LEU . 69.5 mt-30 -60.53 -43.42 97.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.454 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -47.59 -39.22 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.469 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 92.2 m -60.83 -42.71 98.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.674 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 121' ' ' GLN . 6.2 mp -58.32 -45.15 88.61 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.616 ' HA ' ' HG2' ' A' ' 28' ' ' PRO . 2.0 mp -59.66 -49.2 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 111.376 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.39 89.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.284 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -58.82 -40.94 85.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.259 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.45 98.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.153 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.885 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . 53.3 m -58.41 -37.63 75.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.024 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 95.9 mm-40 -65.49 -40.75 93.45 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.432 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.513 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -76.06 37.73 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.885 ' HE3' ' HA ' ' A' ' 129' ' ' SER . 21.9 pttp -167.21 -40.02 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.782 0.325 . . . . 0.0 110.74 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 84.8 m -65.96 -38.11 87.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.05 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 35.2 mmtp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.943 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.451 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 50.8 ttm . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.597 0.237 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.505 ' HB2' HG23 ' A' ' 125' ' ' ILE . 32.5 Cg_exo -58.27 135.36 67.63 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.611 2.207 . . . . 0.0 112.157 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.734 ' HG3' ' HE ' ' A' ' 32' ' ' ARG . 12.4 mm100 -61.03 135.12 57.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.617 ' HB ' ' NE2' ' A' ' 121' ' ' GLN . 80.1 p -78.94 34.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? 179.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.753 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.734 ' HE ' ' HG3' ' A' ' 29' ' ' GLN . 57.6 ttp180 -84.02 159.78 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 50.0 tt0 74.74 -35.27 0.29 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.734 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.591 ' O ' HG12 ' A' ' 38' ' ' ILE . 79.9 mt -59.94 -51.88 67.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.307 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' NH2' ' HB2' ' A' ' 50' ' ' PHE . 45.4 ttm-85 -59.94 -47.58 85.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.75 -39.0 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.764 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.658 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -67.43 -63.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.583 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.2 mm -48.72 -50.31 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.749 0.309 . . . . 0.0 111.621 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 95.1 mt-10 -67.19 -44.47 79.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.273 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.03 -35.72 88.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.151 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.0 -67.96 0.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 62' ' ' GLU . 80.5 p -87.4 -57.46 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.564 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.93 43.33 0.34 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 59' ' ' ILE . 34.0 mmt180 -131.61 129.84 41.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.299 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.0 mmt-85 -74.21 130.69 40.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.265 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 53' ' ' GLY . 45.1 mm -53.88 -53.41 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.029 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.86 -144.82 14.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.396 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.92 -55.24 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.379 . . . . 0.0 110.588 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.851 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 26.4 t-20 -97.68 136.88 37.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.446 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 23.5 t80 -66.12 -49.43 67.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.9 mmm -72.16 -54.05 10.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.851 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 34.5 m-20 -59.42 -34.52 72.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.546 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 46' ' ' ILE . . . -75.23 35.88 1.11 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.638 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 60' ' ' LEU . 89.3 mt -133.29 -22.38 1.99 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.954 0.407 . . . . 0.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' O ' HD11 ' A' ' 88' ' ' ILE . 43.1 mtmt -51.47 -36.44 44.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 11.6 p-10 -56.43 -38.38 71.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.553 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.699 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 62.12 36.57 93.14 Favored Glycine 0 C--N 1.33 0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.029 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.825 HG13 HG11 ' A' ' 75' ' ' VAL . 59.7 t -106.27 -54.7 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.845 0.355 . . . . 0.0 110.546 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 44' ' ' ARG . 44.1 mt -62.41 -43.33 98.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.826 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 54' ' ' LEU . 92.5 mt -65.42 -43.3 90.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.828 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.681 ' HB2' HG21 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -57.74 -39.2 76.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HB3' HG21 ' A' ' 42' ' ' THR . 5.5 mm-40 -68.38 -35.42 77.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.005 178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.658 HD11 ' HE1' ' A' ' 37' ' ' TRP . 26.8 tp -56.21 -61.46 2.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.572 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.2 tp -65.88 -32.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 26.4 t-20 -50.55 -31.03 14.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.633 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -79.26 -51.86 8.9 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.193 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.7 mt -66.72 -59.13 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.185 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -90.52 120.69 68.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.09 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 125.96 19.06 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.994 2.462 . . . . 0.0 112.633 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.96 49.07 56.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.411 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' HG13 ' A' ' 64' ' ' ILE . 65.6 m -63.83 -44.08 94.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.921 0.391 . . . . 0.0 111.048 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 61' ' ' CYS . 58.5 t -137.07 133.54 47.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.923 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -68.03 -138.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.661 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.88 119.16 8.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.696 0.284 . . . . 0.0 110.343 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.825 HG11 HG13 ' A' ' 58' ' ' VAL . 43.9 t -77.91 122.69 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.165 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 HD21 ' CD ' ' A' ' 86' ' ' GLU . 69.5 m-20 -82.53 132.34 35.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.738 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -67.12 121.7 79.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.295 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.597 ' HD3' HG21 ' A' ' 58' ' ' VAL . 55.6 Cg_endo -68.22 117.33 4.87 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.412 2.075 . . . . 0.0 112.2 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 84.2 t -152.9 -61.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.98 -132.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.065 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -138.74 48.92 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.811 0.338 . . . . 0.0 111.145 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.568 ' HA ' HD12 ' A' ' 85' ' ' LEU . 35.2 p-90 -158.5 -32.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -54.91 -45.21 74.73 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.118 0.485 . . . . 0.0 109.747 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 93.8 mttt -64.11 -37.95 89.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 82' ' ' TRP . 93.4 mt -54.31 -40.61 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.235 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' CD ' HD21 ' A' ' 76' ' ' ASN . 40.2 tt0 -77.59 -42.81 33.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.485 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 3.9 m120 -56.79 -39.42 74.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.852 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 55' ' ' LYS . 73.6 mt -73.94 -44.05 51.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.329 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 93' ' ' ARG . . . -55.89 -53.12 44.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.197 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -59.18 -41.15 87.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.761 0.315 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.3 t80 -63.22 -53.04 59.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.954 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 95' ' ' ILE . 88.8 mt -65.94 -44.44 85.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 89' ' ' GLY . 81.1 mtp180 -59.38 -43.98 92.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.498 . . . . 0.0 110.102 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -63.87 -47.21 81.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.593 HD11 HD23 ' A' ' 92' ' ' LEU . 28.4 pt -71.26 -39.56 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.781 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 59.7 tttm -56.37 -40.58 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.093 0.473 . . . . 0.0 110.641 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -88.98 -28.68 20.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 30.5 t80 -53.51 -42.73 67.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.09 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.29 -42.23 0.12 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.476 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.613 ' HB ' HD11 ' A' ' 105' ' ' ILE . 28.1 t -53.26 131.12 15.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.849 0.356 . . . . 0.0 111.065 -179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.23 137.4 94.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.232 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.781 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 44.8 Cg_exo -56.1 -42.64 64.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.671 2.247 . . . . 0.0 112.335 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -73.92 22.38 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.152 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.522 ' HA ' HE22 ' A' ' 119' ' ' GLN . 1.9 m-20 -149.47 39.34 0.8 Allowed 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.033 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.613 HD11 ' HB ' ' A' ' 100' ' ' VAL . 68.3 mt -148.73 133.26 9.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.357 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 44.8 p90 -74.99 143.34 43.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.158 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 56.2 mt-10 -87.74 168.89 12.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.87 -23.33 4.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -90.43 -37.95 13.61 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.7 m-20 -55.49 -41.24 72.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.786 0.327 . . . . 0.0 110.699 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 54' ' ' LEU . 56.2 tp -82.57 -49.9 9.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.456 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -65.14 -62.33 1.61 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.509 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -72.65 -7.82 52.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.596 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.533 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 74.5 m-20 59.09 37.11 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.133 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' ASN . 71.8 p -87.12 15.62 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.03 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 19.4 t-20 -179.96 68.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.685 0.279 . . . . 0.0 111.328 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.533 ' NE2' ' HB3' ' A' ' 114' ' ' ASN . 24.5 m80 -59.17 -42.58 91.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.766 0.317 . . . . 0.0 111.421 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.3 m -48.64 -47.21 40.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.118 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 104' ' ' ASP . 3.8 tp-100 -61.89 -39.41 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.608 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 91.5 t -54.9 -44.79 74.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.617 ' NE2' ' HB ' ' A' ' 30' ' ' THR . 40.3 tt0 -66.45 -47.11 74.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.706 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.4 t -65.86 -36.11 82.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.028 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.9 m -51.93 -45.1 64.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.482 ' HB3' HD22 ' A' ' 34' ' ' LEU . 87.8 mt -58.42 -43.78 88.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.505 HG23 ' HB2' ' A' ' 28' ' ' PRO . 61.6 mt -58.19 -42.87 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.037 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.85 85.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.297 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 tp -61.52 -38.61 88.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.86 -37.51 71.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.685 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.9 m -54.21 -36.25 63.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.676 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.587 ' NE2' HG23 ' A' ' 100' ' ' VAL . 45.4 mt-30 -66.35 -46.95 75.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -74.75 37.31 0.11 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.684 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 130' ' ' GLN . 60.3 pttt -76.61 -47.23 23.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.903 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 133' ' ' THR . 20.1 m -164.54 45.43 0.1 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.069 0.461 . . . . 0.0 110.656 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 130' ' ' GLN . 75.0 mmtt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.941 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 2.7 tpt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 74.0 Cg_endo -76.8 45.59 1.69 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.306 2.004 . . . . 0.0 112.629 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -59.39 -32.76 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.019 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 33' ' ' GLN . 85.8 m -43.05 101.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.681 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -67.99 -28.17 67.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.068 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -53.39 -43.32 67.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.476 ' H ' HG22 ' A' ' 30' ' ' THR . 73.8 mt-30 -61.29 -37.08 81.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD21 HD13 ' A' ' 125' ' ' ILE . 96.2 mt -55.7 -46.31 77.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.145 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' HG2' ' A' ' 35' ' ' ARG . 46.3 mtp85 -64.38 -53.67 44.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.453 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -57.15 -37.95 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.379 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -61.57 -65.84 0.63 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.065 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.724 HD11 HD22 ' A' ' 124' ' ' LEU . 82.7 mt -63.9 -50.2 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -58.37 -44.42 88.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.361 . . . . 0.0 110.779 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.53 91.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.69 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -54.58 -62.81 1.41 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.728 0.299 . . . . 0.0 111.579 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -91.0 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.955 0.407 . . . . 0.0 111.373 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.41 -23.81 0.37 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.852 ' HG3' HG12 ' A' ' 59' ' ' ILE . 22.0 mmm180 -53.0 132.8 38.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.101 -0.55 . . . . 0.0 111.555 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -101.39 119.04 38.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.365 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 46' ' ' ILE . 58.5 mt -79.91 48.04 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.9 -45.7 95.39 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.262 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -66.1 -149.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.751 0.31 . . . . 0.0 111.171 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.945 ' HB3' ' HB3' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -65.68 138.25 57.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.411 179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.595 ' H ' HD22 ' A' ' 49' ' ' ASN . 17.2 t80 -58.53 -35.08 71.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.479 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 117' ' ' HIS . 16.8 mmt -95.9 -53.53 3.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.418 . . . . 0.0 111.44 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.945 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 35.6 t70 -52.9 -34.66 55.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.367 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.01 -47.55 45.59 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.604 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -63.38 -13.79 43.32 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 52.4 mtpt -49.8 -41.12 43.79 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 78' ' ' PRO . 10.4 p-10 -53.62 -37.87 63.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.893 0.378 . . . . 0.0 110.735 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.88 -39.96 2.25 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.857 HG21 ' HD3' ' A' ' 78' ' ' PRO . 58.3 t -35.13 -43.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 122.522 0.329 . . . . 0.0 111.654 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.852 HG12 ' HG3' ' A' ' 44' ' ' ARG . 18.7 mt -62.67 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 91' ' ' PHE . 88.8 mt -63.07 -44.64 95.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -55.7 -46.14 77.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' OE2' HG11 ' A' ' 75' ' ' VAL . 31.6 mm-40 -62.45 -32.9 73.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.125 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.537 HD22 HG12 ' A' ' 38' ' ' ILE . 25.0 tp -70.37 -52.81 19.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.17 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.648 HD11 HE21 ' A' ' 68' ' ' GLN . 9.0 tp -59.34 -39.56 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.641 0.257 . . . . 0.0 111.483 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -53.87 -27.47 30.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.371 . . . . 0.0 110.534 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 66' ' ' LYS . 11.0 mmpt? -78.95 -52.61 8.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 131' ' ' ALA . 71.3 mt -67.68 -60.61 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.648 HE21 HD11 ' A' ' 64' ' ' ILE . 8.0 tt0 -99.14 113.0 64.33 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.602 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.4 129.13 30.38 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.212 2.608 . . . . 0.0 113.709 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.33 50.61 28.86 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.241 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 55.4 m -75.62 -61.76 1.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.204 0.502 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.517 HG21 ' SG ' ' A' ' 61' ' ' CYS . 59.0 t -83.37 138.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.838 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -53.52 -46.07 69.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 74' ' ' LYS . 13.0 tmtt? -176.28 121.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.08 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.605 ' CG2' HG13 ' A' ' 58' ' ' VAL . 3.4 p -69.17 126.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -112.73 144.2 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.096 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -56.31 141.58 69.99 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.372 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.857 ' HD3' HG21 ' A' ' 58' ' ' VAL . 74.3 Cg_endo -73.43 37.7 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.577 2.184 . . . . 0.0 113.157 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.85 -58.69 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 110.957 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 83' ' ' HIS . 11.6 mm100 -83.77 146.32 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.949 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -57.49 -42.23 82.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.327 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.53 ' HA ' HD12 ' A' ' 85' ' ' LEU . 51.3 p-90 -68.35 -25.71 65.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.358 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 44.9 m170 -57.5 -51.58 68.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.8 0.334 . . . . 0.0 110.506 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 96.1 mttt -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.454 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 82' ' ' TRP . 83.2 mt -56.57 -35.06 67.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.302 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -72.03 -47.75 49.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.816 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.46 93.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.882 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.8 mt -69.53 -42.54 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.72 89.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.811 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 72' ' ' VAL . 77.5 m-20 -67.22 -41.89 84.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.645 0.26 . . . . 0.0 111.255 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.504 ' O ' HG23 ' A' ' 95' ' ' ILE . 36.2 t80 -58.59 -53.28 60.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.243 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HA ' HG12 ' A' ' 95' ' ' ILE . 88.3 mt -65.3 -44.28 88.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -59.1 -39.24 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 0.0 110.318 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.53 -45.19 66.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.788 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 92' ' ' LEU . 34.0 pt -70.53 -37.95 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.1 mtpt -58.35 -41.52 84.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.628 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -85.84 -34.1 21.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 25.0 t80 -51.56 -43.08 62.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.972 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.46 -45.0 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.918 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' HB ' HD11 ' A' ' 105' ' ' ILE . 21.6 t -59.81 128.62 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.873 0.368 . . . . 0.0 110.924 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.588 ' NZ ' ' HB2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -71.28 142.19 86.76 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.15 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.6 Cg_exo -53.08 -38.01 79.98 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.0 112.221 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -55.18 -29.76 58.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.555 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.85 37.91 2.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.268 0.556 . . . . 0.0 109.618 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.605 HD11 ' HB ' ' A' ' 100' ' ' VAL . 70.3 mt -144.83 129.58 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.074 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 43.2 p90 -74.83 143.89 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.854 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' HB2' ' OD2' ' A' ' 110' ' ' ASP . 1.6 mp0 -85.67 148.92 25.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.683 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -48.02 -35.8 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.312 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -70.33 -37.89 74.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.699 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.63 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 62.7 m-20 -60.97 -45.32 95.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 111.309 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.2 tp -75.35 -43.97 47.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.318 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.484 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.2 t80 -68.84 -59.85 2.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.951 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 115' ' ' THR . 69.1 mm-40 -73.65 -8.31 55.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.384 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.48 30.13 17.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.648 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.63 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.0 p -71.75 -35.34 70.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -138.58 122.11 17.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.416 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.532 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 42.4 m170 -102.29 -48.37 4.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.577 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 57.0 m -50.01 -42.29 48.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.639 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 116' ' ' ASN . 70.2 tp60 -57.45 -38.88 75.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.55 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 95.3 t -59.92 -46.86 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.318 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -62.29 -45.06 94.96 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.183 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 t -63.36 -39.79 95.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.5 m -55.39 -45.29 76.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.19 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 38' ' ' ILE . 86.9 mt -57.44 -37.81 73.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.552 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -59.98 -47.8 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.58 -47.49 78.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.2 tp -56.21 -33.24 65.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -60.09 -45.81 91.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.527 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.6 p -59.56 -37.61 78.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.133 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.53 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 6.1 mp0 -63.99 -52.01 61.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 111.744 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.97 -47.22 84.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.412 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 14.8 ptmm? -62.75 -47.72 82.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.685 0.279 . . . . 0.0 111.372 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.425 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 86.2 m -68.6 -36.93 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 15.3 tppt? . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.303 -0.856 . . . . 0.0 111.027 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 66.3 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.556 0.217 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 32.3 Cg_exo -58.51 134.72 62.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.602 2.201 . . . . 0.0 112.327 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -173.59 -170.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.289 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.8 p 42.04 -121.18 0.55 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.572 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pm0 -147.42 -23.75 0.38 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 0.0 110.616 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 36' ' ' VAL . 39.4 ttm180 -55.62 -43.44 76.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.023 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.75 -37.98 79.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD22 ' HB3' ' A' ' 124' ' ' LEU . 95.8 mt -60.48 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.731 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.593 HH21 HH22 ' A' ' 45' ' ' ARG . 7.7 ptm180 -62.18 -47.31 85.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.618 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 32' ' ' ARG . 92.2 t -63.19 -38.51 82.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.264 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.645 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -62.47 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.946 -179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 97.8 mt -60.23 -52.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -60.44 -38.51 84.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.567 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.59 -34.53 87.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.839 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.57 -70.56 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.79 0.329 . . . . 0.0 111.722 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.5 p -81.1 -39.42 25.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.439 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 97.39 43.86 2.88 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.863 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 25.2 mmt180 -133.86 134.47 42.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.593 HH22 HH21 ' A' ' 35' ' ' ARG . 27.3 mmm180 -75.73 124.03 26.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.28 -55.28 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.687 0.279 . . . . 0.0 111.152 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.03 -144.47 11.62 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.84 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -74.05 141.0 45.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.64 0.257 . . . . 0.0 110.867 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.97 -124.1 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.704 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 29.5 t80 -160.22 -50.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.686 0.279 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.474 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 61.7 mmm -67.49 -50.02 60.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.178 0.513 . . . . 0.0 109.893 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.634 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 8.1 t70 -63.74 -32.37 73.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.488 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.67 -43.94 97.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.53 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.012 HD22 HD11 ' A' ' 60' ' ' LEU . 78.5 mt -58.31 -27.87 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.787 0.327 . . . . 0.0 111.571 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 47.0 mtpt -48.93 -45.55 41.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.8 p30 -58.07 -34.7 70.42 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.471 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 58.85 91.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.3 t -150.28 -57.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.854 0.359 . . . . 0.0 110.472 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mm -69.6 -42.23 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.429 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD11 HD22 ' A' ' 54' ' ' LEU . 83.1 mt -56.93 -46.02 82.32 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.588 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.7 OUTLIER -56.59 -43.65 80.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.592 178.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 65.6 mm-40 -63.65 -35.84 81.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.081 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 41' ' ' ALA . 33.3 tp -68.62 -50.67 49.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.822 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.3 tp -59.96 -36.88 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.339 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -58.45 -30.4 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 0.0 110.575 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.2 mmtt -68.81 -51.87 36.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 131' ' ' ALA . 47.7 mt -69.0 -55.72 10.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.8 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.85 135.44 19.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.06 135.1 24.54 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.09 2.527 . . . . 0.0 112.94 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 55.19 46.38 79.06 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' HG13 ' A' ' 64' ' ' ILE . 52.1 m -70.22 -45.76 65.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.655 0.264 . . . . 0.0 111.475 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.3 t -139.75 -34.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.193 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 84.5 mt-30 70.06 -126.55 0.09 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.004 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -52.95 132.5 37.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.929 0.395 . . . . 0.0 111.3 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG22 ' SG ' ' A' ' 61' ' ' CYS . 44.8 t -106.53 128.62 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.296 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 HD21 ' HG2' ' A' ' 86' ' ' GLU . 75.5 m-20 -82.21 132.0 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.765 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -63.55 134.37 95.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.516 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.06 43.05 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.513 2.142 . . . . 0.0 112.839 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.15 -60.64 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.958 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -85.51 -112.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.857 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -148.26 -41.95 0.16 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.585 0.231 . . . . 0.0 111.542 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -60.49 -31.02 70.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.083 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -52.85 -46.22 67.74 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 0.0 110.51 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.9 mttt -58.2 -43.58 87.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 112' ' ' PHE . 95.6 mt -54.79 -32.08 59.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.462 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 76' ' ' ASN . 5.5 tp10 -70.87 -53.35 15.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -61.78 -40.79 96.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.957 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.627 HD11 ' O ' ' A' ' 55' ' ' LYS . 61.3 mt -67.59 -43.95 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.85 -49.31 79.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.826 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.59 -40.75 89.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.62 0.247 . . . . 0.0 111.384 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' O ' HG23 ' A' ' 95' ' ' ILE . 21.4 t80 -59.5 -53.76 54.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.311 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 95' ' ' ILE . 74.9 mt -68.17 -40.43 82.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.456 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -61.6 -40.61 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.338 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.86 -45.19 68.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.918 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.592 HD11 HD23 ' A' ' 92' ' ' LEU . 30.4 pt -71.22 -38.15 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 102' ' ' PRO . 5.8 ttpm? -61.8 -38.53 88.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 0.0 110.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -85.66 -34.58 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.257 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 52.1 t80 -49.89 -45.21 50.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.228 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.06 -43.36 0.12 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.954 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 105' ' ' ILE . 24.8 t -55.91 128.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.755 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 105' ' ' ILE . 67.0 mttm -62.57 136.19 95.91 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.675 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 50.4 Cg_exo -55.24 -40.11 87.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.714 2.276 . . . . 0.0 112.086 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -57.9 -24.45 57.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.634 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.57 35.87 2.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.66 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 100' ' ' VAL . 75.9 mt -147.71 130.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.286 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 52.8 p90 -75.96 144.07 41.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.86 153.58 25.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.588 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -50.71 -25.15 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.293 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.83 -39.01 36.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.119 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 29.9 m-20 -59.56 -48.03 83.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.36 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 54' ' ' LEU . 62.8 tp -72.17 -46.78 54.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.528 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' CD2' HD21 ' A' ' 85' ' ' LEU . 33.6 t80 -62.36 -54.42 40.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.553 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.444 ' HB2' HG23 ' A' ' 115' ' ' THR . 4.9 mm-40 -75.48 -13.29 60.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.538 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 73.8 m-20 64.97 31.28 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 82.1 p -71.46 -50.06 35.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.771 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.572 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -105.43 119.86 40.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.988 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -99.14 -48.74 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.621 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 77.8 p -62.52 -42.19 99.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.023 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -56.76 -41.93 78.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.044 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.599 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 70.2 t -60.43 -46.2 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.38 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.71 -45.25 90.83 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.314 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -62.58 -40.6 97.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.4 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.5 m -54.77 -44.44 73.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.442 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.645 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -58.81 -44.43 90.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.61 -44.73 90.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.38 98.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 127' ' ' LEU . 2.4 tm? -58.67 -46.4 87.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.47 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.15 -43.91 78.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 52.4 m -61.22 -35.65 77.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.687 ' NE2' ' HE3' ' A' ' 134' ' ' LYS . 57.8 tp60 -65.48 -52.88 49.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.36 35.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.51 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -77.36 -72.55 0.35 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.195 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 41.1 p -156.59 45.89 0.42 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.015 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.687 ' HE3' ' NE2' ' A' ' 130' ' ' GLN . 75.6 mmtt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.657 0.265 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' MET . 31.1 Cg_exo -58.99 133.27 52.39 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.58 2.186 . . . . 0.0 112.205 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -64.03 131.25 47.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.947 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.556 ' HB ' HD11 ' A' ' 125' ' ' ILE . 3.7 t -69.23 120.93 15.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' THR . 4.5 tp10 176.18 -127.77 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.51 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 39.4 ttm180 -57.84 -36.63 72.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.642 0.258 . . . . 0.0 111.226 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -49.99 -41.6 47.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.984 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.737 HD21 HD13 ' A' ' 125' ' ' ILE . 73.2 mt -62.16 -46.6 88.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.525 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -65.05 -58.01 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.435 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -52.56 -38.5 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.864 0.364 . . . . 0.0 111.555 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.554 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -60.87 -71.11 0.15 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.239 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.642 HG21 HD23 ' A' ' 60' ' ' LEU . 56.7 mt -66.18 -49.67 74.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 95.9 mt-10 -56.92 -44.67 82.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.805 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.19 -33.18 86.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.639 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.06 -60.83 2.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 111.6 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.2 p -89.75 -56.64 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.524 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 44' ' ' ARG . . . 127.68 42.96 0.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.898 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB2' HG12 ' A' ' 59' ' ' ILE . 35.3 mmm-85 -134.28 132.06 39.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.633 0.254 . . . . 0.0 110.675 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 45' ' ' ARG . 44.6 mmt-85 -82.19 40.45 0.63 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.461 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.506 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 63.3 mt 64.86 -71.79 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.14 -48.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.693 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.32 143.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.581 0.229 . . . . 0.0 110.568 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.13 -123.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.142 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.567 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 27.9 t80 -160.6 -44.37 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.662 ' HE2' ' HB3' ' A' ' 117' ' ' HIS . 58.9 mmm -85.77 -44.29 12.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.023 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.6 m-20 -61.18 -38.84 87.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.172 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -63.18 -30.97 79.14 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.617 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.064 HD22 HD11 ' A' ' 60' ' ' LEU . 53.9 mt -73.06 -28.8 62.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.774 0.321 . . . . 0.0 111.24 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -44.08 -58.0 3.07 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.551 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 5.5 p-10 -58.23 -38.74 77.42 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.501 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 110.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.423 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 59.0 t -158.33 -61.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.039 0.447 . . . . 0.0 109.947 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 44' ' ' ARG . 1.2 mp -64.17 -43.33 97.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.064 HD11 HD22 ' A' ' 54' ' ' LEU . 73.8 mt -58.99 -43.7 91.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.457 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.836 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.3 p -64.06 -37.67 88.27 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 49.9 mt-10 -68.28 -38.75 82.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.254 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.565 HD22 HG12 ' A' ' 38' ' ' ILE . 33.7 tp -56.58 -60.41 3.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.842 0.353 . . . . 0.0 111.01 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.556 HD11 HE21 ' A' ' 68' ' ' GLN . 8.4 tp -60.73 -33.19 54.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.167 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.2 t-20 -56.78 -31.04 64.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.089 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.8 mmtt -76.44 -53.26 8.38 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.888 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.22 -60.08 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.986 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 64' ' ' ILE . 7.6 tt0 -88.57 135.27 32.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 130.82 18.29 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.993 2.462 . . . . 0.0 112.534 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 56.37 43.31 89.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.892 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 49.0 m -66.3 -43.8 85.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.836 HG21 ' HB2' ' A' ' 61' ' ' CYS . 46.9 t -139.55 143.18 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.537 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.88 -145.21 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.862 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.69 -18.47 62.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.544 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.469 HG22 ' CG1' ' A' ' 72' ' ' VAL . 61.5 t 68.68 123.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -86.98 132.83 33.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 56.8 m-20 -69.99 131.12 89.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.189 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ASP . 31.5 Cg_exo -59.53 118.18 5.03 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 76.5 t -153.8 -58.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.548 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -81.8 -127.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.777 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -130.34 -46.64 1.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 0.0 111.237 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -68.68 -17.66 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.29 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.8 m170 -55.46 -49.55 72.18 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.952 0.406 . . . . 0.0 110.755 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.551 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.7 mttt -63.18 -43.3 98.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.296 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.488 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.7 mt -55.82 -31.29 62.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.359 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -76.1 -52.42 10.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.209 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.445 ' OD1' HG13 ' A' ' 75' ' ' VAL . 75.2 m-20 -59.24 -44.91 92.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 55' ' ' LYS . 59.4 mt -67.76 -42.2 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.26 -46.38 93.93 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.952 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -63.53 -40.27 96.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.73 0.3 . . . . 0.0 111.183 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 95' ' ' ILE . 19.7 t80 -60.52 -51.46 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.254 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.64 HD23 HD11 ' A' ' 95' ' ' ILE . 83.3 mt -67.23 -42.89 83.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.349 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.7 tmt_? -58.35 -41.18 84.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.068 0.461 . . . . 0.0 109.871 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB1' ' NE2' ' A' ' 68' ' ' GLN . . . -66.03 -45.39 81.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.57 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.657 HG13 HD13 ' A' ' 105' ' ' ILE . 31.1 pt -71.81 -27.69 28.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.782 0.325 . . . . 0.0 111.541 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.5 mtpt -76.82 27.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.183 0.516 . . . . 0.0 111.03 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 95' ' ' ILE . 78.0 t60 -165.24 -33.63 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.053 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.451 ' OH ' ' HG2' ' A' ' 134' ' ' LYS . 24.8 t80 -57.08 -43.5 82.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.833 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -176.16 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.621 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 105' ' ' ILE . 27.1 t -64.74 128.4 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.898 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.3 mtpp -68.88 138.16 90.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 50.5 Cg_exo -52.98 -39.32 79.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.582 2.188 . . . . 0.0 112.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -57.01 -28.43 62.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.548 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -104.63 35.91 2.59 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.657 HD13 HG13 ' A' ' 95' ' ' ILE . 77.8 mt -142.53 128.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.085 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB3' ' CG ' ' A' ' 119' ' ' GLN . 33.6 p90 -73.93 -156.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' N ' ' HD1' ' A' ' 106' ' ' PHE . 81.6 mt-10 -137.18 149.58 47.34 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.435 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -49.35 -16.95 0.22 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.06 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -76.51 -36.51 57.71 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 24.3 p-10 -59.99 -34.62 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.934 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.61 HD21 ' C ' ' A' ' 54' ' ' LEU . 59.0 tp -85.11 -43.37 13.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.94 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CD2' HD21 ' A' ' 85' ' ' LEU . 30.2 t80 -76.85 -59.99 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.96 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -78.86 -1.4 34.86 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 58.39 41.01 23.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.196 0.522 . . . . 0.0 109.723 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 113' ' ' GLU . 80.9 p -86.76 -30.6 21.47 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.509 ' C ' ' HB2' ' A' ' 110' ' ' ASP . 21.6 t-20 -160.24 65.42 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.197 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.662 ' HB3' ' HE2' ' A' ' 51' ' ' MET . 79.7 m-70 -61.05 -33.75 73.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.673 0.273 . . . . 0.0 111.131 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -49.58 -43.48 46.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.278 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.526 ' CG ' ' HB3' ' A' ' 106' ' ' PHE . 70.7 tp60 -65.78 -33.0 74.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.012 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.579 ' HB ' ' HE1' ' A' ' 51' ' ' MET . 66.3 t -53.38 -48.07 57.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.569 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -64.27 -48.72 74.66 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.796 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 79.5 p -61.33 -39.81 91.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.536 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.423 ' OG1' ' HD2' ' A' ' 106' ' ' PHE . 97.4 m -56.82 -44.25 81.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.431 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD22 HD11 ' A' ' 38' ' ' ILE . 70.5 mt -53.53 -39.29 64.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.823 0.344 . . . . 0.0 110.498 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.737 HD13 HD21 ' A' ' 34' ' ' LEU . 47.8 mm -57.27 -45.13 84.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.19 81.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.315 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.5 tp -54.5 -33.79 60.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.22 74.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.857 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -56.91 -38.05 72.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.78 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.624 ' O ' ' HD3' ' A' ' 134' ' ' LYS . 12.1 mp0 -66.79 -56.16 11.7 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.413 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.62 -31.24 66.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.371 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -56.73 -55.35 35.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.545 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.675 HG23 ' HD2' ' A' ' 134' ' ' LYS . 3.4 t -69.69 -43.84 71.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.329 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.675 ' HD2' HG23 ' A' ' 133' ' ' THR . 4.9 mptp? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.851 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.596 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 1.6 mpt? . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 27' ' ' MET . 43.6 Cg_endo -66.88 133.15 30.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.21 1.94 . . . . 0.0 112.217 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 30' ' ' THR . 17.9 pt20 -64.04 -48.99 74.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.702 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 33' ' ' GLN . 10.2 t 36.23 42.25 0.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.833 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -69.03 -47.93 64.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.484 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HA ' HH12 ' A' ' 35' ' ' ARG . 39.5 ttm180 -68.82 -42.52 77.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.275 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.56 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 84.5 mt-30 -60.48 -18.85 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.842 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 30' ' ' THR . 88.1 mt -51.62 -48.66 63.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.568 HH12 ' HA ' ' A' ' 32' ' ' ARG . 4.4 ptp85 -62.56 -50.79 69.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.64 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 92.5 t -57.55 -39.13 67.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.308 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -63.74 -70.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.116 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.658 HG23 HD22 ' A' ' 63' ' ' LEU . 63.6 mt -55.27 -48.67 76.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 45' ' ' ARG . 54.5 mt-10 -58.11 -40.47 81.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.36 -37.92 95.14 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.183 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.16 -66.02 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.836 0.309 . . . . 0.0 111.836 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -79.59 -48.99 12.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.392 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 112.29 42.09 1.01 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.6 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.593 ' HB2' HD13 ' A' ' 59' ' ' ILE . 31.1 mmt180 -131.56 131.28 43.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.662 0.268 . . . . 0.0 110.873 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLY . 38.3 mmt180 -83.82 35.11 0.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.571 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 76.6 mt 60.63 -73.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.495 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 170.46 -50.27 0.2 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.247 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -177.98 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.964 0.411 . . . . 0.0 110.293 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -74.41 -126.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.464 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 19.7 t80 -165.16 -50.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.742 0.305 . . . . 0.0 110.576 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.497 ' O ' HD11 ' A' ' 111' ' ' LEU . 17.2 mmt -85.64 -50.52 7.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.289 0.566 . . . . 0.0 110.261 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.544 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 1.5 m-20 -52.21 -43.64 64.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.471 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.41 96.77 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.876 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -61.37 -33.4 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 84' ' ' LYS . 42.3 mtmt -48.61 -37.91 19.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 56.0 p-10 -51.32 -33.23 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 67.83 68.67 1.58 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.239 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLU . 46.1 t -146.72 -56.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 110.614 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 44' ' ' ARG . 69.8 mt -67.32 -43.43 87.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.511 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 54' ' ' LEU . 84.0 mt -66.63 -45.34 79.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.54 ' HB2' HG11 ' A' ' 72' ' ' VAL . 7.6 p -58.66 -38.02 77.27 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' VAL . 45.7 mm-40 -67.99 -33.98 75.66 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.839 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.658 HD22 HG23 ' A' ' 38' ' ' ILE . 25.6 tp -69.21 -48.89 60.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.369 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.572 HD13 HG22 ' A' ' 95' ' ' ILE . 8.0 tp -55.9 -37.96 50.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -52.27 -27.89 16.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 3.8 mmmp? -71.49 -50.84 27.57 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.28 -58.0 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.451 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 7.7 tt0 -102.71 133.87 20.2 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.62 136.1 22.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.217 2.612 . . . . 0.0 113.268 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.88 44.16 81.72 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.315 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.8 m -79.41 -46.29 17.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.942 0.401 . . . . 0.0 111.069 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG11 ' HB2' ' A' ' 61' ' ' CYS . 40.6 t -144.29 143.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.491 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -139.97 -40.78 0.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.48 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -55.99 -55.14 36.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.049 0.452 . . . . 0.0 110.98 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.0 t 49.92 61.59 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.397 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.599 ' HB2' HD21 ' A' ' 87' ' ' ASN . 69.4 m-80 -53.65 134.64 41.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.48 130.18 93.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.523 ' HB3' ' HB2' ' A' ' 56' ' ' ASP . 44.4 Cg_endo -66.72 106.17 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.297 1.998 . . . . 0.0 112.528 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.8 t -153.83 -56.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.053 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 83' ' ' HIS . 11.6 mm100 -86.54 145.95 26.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.47 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -52.61 -44.12 65.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.432 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -71.48 -28.24 63.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.811 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.453 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 38.8 m170 -57.59 -53.64 55.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.999 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 88' ' ' ILE . 97.3 mttt -62.58 -46.55 87.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.006 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 112' ' ' PHE . 96.6 mt -57.05 -36.72 70.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.5 -45.85 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.849 0.357 . . . . 0.0 110.652 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.599 HD21 ' HB2' ' A' ' 76' ' ' ASN . 78.5 m-20 -63.06 -39.42 94.67 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HG21 ' HA ' ' A' ' 108' ' ' ALA . 63.7 mt -65.51 -41.71 91.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.757 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -56.43 -43.79 90.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.568 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.6 -42.93 95.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.663 0.268 . . . . 0.0 111.228 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -60.13 -52.98 63.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.294 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HD11 ' A' ' 95' ' ' ILE . 76.4 mt -67.93 -40.19 83.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.509 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -60.46 -40.14 90.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.302 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -70.84 -46.35 62.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.097 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 92' ' ' LEU . 28.7 pt -72.04 -40.59 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.574 ' HG3' HD12 ' A' ' 105' ' ' ILE . 5.8 ttpm? -61.15 -36.81 80.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.953 0.406 . . . . 0.0 110.505 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -87.0 -34.36 19.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.54 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 28.5 t80 -52.18 -43.86 64.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.316 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -179.66 -44.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.22 -0.99 . . . . 0.0 113.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.638 ' HB ' HD11 ' A' ' 105' ' ' ILE . 18.8 t -56.45 123.05 6.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.576 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HE3' ' OD1' ' A' ' 104' ' ' ASP . 52.6 pttt -66.51 136.21 94.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.306 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.511 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . 53.9 Cg_exo -54.15 -34.27 77.87 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.891 2.394 . . . . 0.0 112.506 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -62.56 -0.91 0.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.073 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.544 ' OD1' ' HE3' ' A' ' 101' ' ' LYS . 1.0 OUTLIER -138.85 41.6 2.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.144 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.638 HD11 ' HB ' ' A' ' 100' ' ' VAL . 69.1 mt -149.03 134.49 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.146 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 120' ' ' VAL . 53.4 p90 -71.49 -155.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.065 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HA ' HD13 ' A' ' 92' ' ' LEU . 48.6 mt-10 -150.68 158.55 44.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.78 -24.91 2.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.978 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 109' ' ' ASN . 2.6 m120 -79.07 -43.9 23.23 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.746 0.308 . . . . 0.0 111.316 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 30.6 m-20 -60.0 -46.12 90.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.084 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.542 HD11 ' HB2' ' A' ' 54' ' ' LEU . 59.9 tp -71.86 -47.36 53.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD2' HD21 ' A' ' 85' ' ' LEU . 35.3 t80 -61.49 -54.55 41.8 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.743 0.306 . . . . 0.0 111.244 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 115' ' ' THR . 50.5 mt-10 -71.27 -13.11 61.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 110.089 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.418 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 76.1 m-80 62.28 29.22 17.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 113' ' ' GLU . 75.6 p -71.64 -53.1 14.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 119' ' ' GLN . 5.5 m120 -94.33 123.18 37.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.846 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -101.84 -58.15 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.937 0.398 . . . . 0.0 110.773 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 p -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.004 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.821 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 69.9 tp60 -51.94 -39.45 59.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.609 ' HA ' ' CD1' ' A' ' 106' ' ' PHE . 78.6 t -59.98 -49.59 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.883 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.731 ' HA ' HD13 ' A' ' 124' ' ' LEU . 27.3 mt-30 -61.62 -36.86 81.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.96 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.3 t -51.43 -40.56 59.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.171 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 105' ' ' ILE . 86.6 m -57.67 -46.68 83.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.07 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 121' ' ' GLN . 5.9 mp -55.79 -41.83 74.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.365 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.0 -49.04 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.387 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.46 89.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.248 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 54.2 tp -61.82 -31.52 71.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.139 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' O ' ' HE2' ' A' ' 132' ' ' LYS . . . -53.23 -47.02 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.456 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 p -59.29 -33.38 71.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.985 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.626 HE21 HG22 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -65.26 -44.28 88.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.198 179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.07 42.56 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.981 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' NZ ' ' HB3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -167.7 -41.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 110.766 179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.0 m -63.47 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 75.4 mmtt . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.953 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.829 0.347 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 125' ' ' ILE . 25.8 Cg_endo -61.96 -49.56 6.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.39 2.06 . . . . 0.0 112.346 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -177.46 130.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.442 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.9 t -91.38 135.92 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 66.6 mm-40 65.49 145.47 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.391 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 79.2 ttt180 75.47 -51.15 0.64 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.629 HE22 ' HB2' ' A' ' 28' ' ' PRO . 54.2 tt0 -68.25 -43.89 76.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.734 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.51 HD22 ' HB3' ' A' ' 124' ' ' LEU . 86.0 mt -61.51 -43.76 98.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 ttm105 -61.2 -55.63 29.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.67 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.74 -38.04 79.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.773 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.622 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.5 OUTLIER -58.51 -69.94 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 74.6 mt -63.89 -47.14 91.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.04 -45.84 89.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.82 0.343 . . . . 0.0 110.506 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.51 -33.53 86.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.289 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -51.11 58.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.849 0.356 . . . . 0.0 111.413 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.1 p -97.51 -92.09 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.323 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 164.55 41.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' CG1' ' A' ' 59' ' ' ILE . 33.3 mmt180 -137.31 130.11 30.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.702 0.287 . . . . 0.0 110.685 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HG3' HH11 ' A' ' 45' ' ' ARG . 20.6 mmt85 -84.55 132.84 34.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.661 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 53' ' ' GLY . 93.9 mt -56.91 -39.41 65.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.722 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.5 -142.1 17.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.474 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -65.37 133.07 50.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.843 0.354 . . . . 0.0 111.655 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.747 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 75.1 m-20 61.3 132.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.66 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 26.8 t80 -75.79 -43.88 44.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.891 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.482 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 52.8 mmm -72.67 -48.36 39.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.359 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.747 ' HB3' ' HB2' ' A' ' 49' ' ' ASN . 34.8 t70 -53.2 -31.12 41.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -76.56 -41.67 24.09 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.041 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.671 HD22 HD11 ' A' ' 60' ' ' LEU . 75.7 mt -63.21 -44.04 96.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.669 ' O ' HD11 ' A' ' 88' ' ' ILE . 11.5 ptmm? -53.41 -43.03 67.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' HE2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -56.06 -38.15 70.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 110.423 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.88 108.03 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.998 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 49.1 t -158.1 -62.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.649 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.2 mp -74.14 -38.33 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.239 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 38' ' ' ILE . 72.1 mt -58.01 -45.21 87.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.345 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.828 ' HB2' HG21 ' A' ' 72' ' ' VAL . 1.9 p -59.83 -36.07 76.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 55.6 mt-10 -71.23 -37.08 72.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.043 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? -56.8 -56.61 19.4 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.42 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.559 HD11 HE21 ' A' ' 68' ' ' GLN . 8.1 tp -65.94 -31.3 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.257 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 71' ' ' SER . 27.0 t-20 -56.47 -32.64 65.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.671 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -74.42 -52.73 11.21 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.074 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.55 -58.44 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.962 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.559 HE21 HD11 ' A' ' 64' ' ' ILE . 8.1 tt0 -89.76 119.04 69.46 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.979 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.81 127.8 26.07 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.965 2.443 . . . . 0.0 113.04 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.62 49.2 53.97 Favored Glycine 0 C--N 1.332 0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 113.849 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 65' ' ' ASN . 69.6 m -68.57 -44.6 74.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.369 . . . . 0.0 110.809 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.828 HG21 ' HB2' ' A' ' 61' ' ' CYS . 48.9 t -142.83 138.68 27.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.763 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -117.04 -42.89 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.685 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 74' ' ' LYS . 3.8 mptp? -60.99 -60.6 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 111.691 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 75' ' ' VAL . 20.5 t 51.01 51.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.634 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -61.39 136.52 58.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.248 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -61.61 139.83 95.15 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.27 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 64.4 Cg_endo -72.72 38.25 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.534 2.156 . . . . 0.0 112.989 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.0 t -74.04 -54.97 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.43 ' C ' HD22 ' A' ' 81' ' ' ASN . 99.0 mm-40 -79.61 -143.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.807 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 80' ' ' GLN . 4.6 m120 -118.08 -48.49 2.54 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.77 0.319 . . . . 0.0 111.029 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -65.52 -26.15 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.391 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -55.44 -46.53 76.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.915 0.388 . . . . 0.0 110.906 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.549 ' O ' HG13 ' A' ' 88' ' ' ILE . 93.0 mttt -61.56 -48.48 80.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.781 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.458 HD21 ' CG ' ' A' ' 112' ' ' PHE . 92.8 mt -59.33 -32.59 70.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -64.9 -49.67 69.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 75' ' ' VAL . 75.7 m-20 -63.44 -38.0 89.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.837 HG21 ' HA ' ' A' ' 108' ' ' ALA . 64.8 mt -64.95 -43.59 96.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.884 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.39 -48.7 84.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.648 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.48 -40.37 85.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.849 0.357 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' O ' HG23 ' A' ' 95' ' ' ILE . 17.8 t80 -60.85 -51.34 69.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.0 mt -66.44 -42.88 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.011 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -59.87 -39.36 84.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.133 0.492 . . . . 0.0 110.083 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 68' ' ' GLN . . . -69.47 -43.88 72.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.67 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 92' ' ' LEU . 32.1 pt -71.05 -40.4 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 111.484 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 50.0 mtmt -61.79 -40.17 94.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.058 0.456 . . . . 0.0 110.203 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -79.15 -36.51 40.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.336 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -53.92 -45.39 71.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.107 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.08 -45.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.891 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 96' ' ' LYS . 26.4 t -58.39 123.64 10.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.722 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -70.02 136.48 87.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.746 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' HB ' ' A' ' 105' ' ' ILE . 71.4 Cg_exo -51.8 -30.89 39.85 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.719 2.28 . . . . 0.0 112.329 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -55.69 -32.58 63.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.487 . . . . 0.0 110.205 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.85 35.72 2.69 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' A' ' 102' ' ' PRO . 71.8 mt -146.04 136.12 18.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.003 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 39.0 p90 -69.49 -156.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.439 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HA ' HD13 ' A' ' 92' ' ' LEU . 91.4 mt-10 -148.95 164.73 33.7 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 120.999 0.428 . . . . 0.0 110.859 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -51.47 -25.9 7.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.234 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -80.48 -36.0 34.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.588 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 72.0 m-20 -58.06 -49.79 75.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.686 0.279 . . . . 0.0 111.175 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 9.1 mt -75.17 -50.53 15.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.885 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CG ' HD21 ' A' ' 85' ' ' LEU . 24.5 t80 -57.18 -57.75 11.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.654 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -79.11 6.75 8.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 38.91 33.81 0.08 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.209 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.56 HG23 ' OD1' ' A' ' 116' ' ' ASN . 4.7 t -78.45 -46.89 18.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.084 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.8 m120 -94.57 123.49 38.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.829 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 51' ' ' MET . 44.1 m170 -107.57 -47.79 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.612 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.4 m -66.11 -40.22 90.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.222 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.603 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 68.5 tp60 -60.07 -47.29 86.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.497 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 54.3 t -58.86 -43.34 88.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.782 0.325 . . . . 0.0 111.028 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.53 -45.6 86.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.6 m -60.83 -40.73 93.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.368 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -54.2 -41.95 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.373 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.635 HD22 HD11 ' A' ' 38' ' ' ILE . 96.2 mt -61.26 -46.76 89.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.21 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.783 HG23 ' HD2' ' A' ' 28' ' ' PRO . 61.1 mt -58.92 -43.54 88.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.04 93.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.043 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.66 -40.96 93.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.057 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -55.77 -46.82 77.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.994 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 131' ' ' ALA . 47.4 t -61.41 -38.21 86.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.567 ' NE2' ' HE3' ' A' ' 134' ' ' LYS . 51.8 tp60 -71.67 22.85 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.688 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 129' ' ' SER . . . -146.07 -52.86 0.25 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.307 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 61.7 pttt -73.52 -47.03 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 110.813 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.408 ' N ' ' HG3' ' A' ' 132' ' ' LYS . 77.4 m -70.16 -46.44 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.133 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.567 ' HE3' ' NE2' ' A' ' 130' ' ' GLN . 72.8 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.982 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.6 mmt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.571 0.224 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HE22 ' A' ' 33' ' ' GLN . 36.3 Cg_exo -57.63 135.06 67.18 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.544 2.163 . . . . 0.0 112.273 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.555 HE22 ' HD2' ' A' ' 32' ' ' ARG . 25.9 mt-30 -69.27 -143.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.738 HG22 HD11 ' A' ' 125' ' ' ILE . 57.5 p -152.43 136.36 16.35 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.323 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' H ' HD12 ' A' ' 34' ' ' LEU . 4.8 mm-40 73.39 -52.46 0.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.015 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.555 ' HD2' HE22 ' A' ' 29' ' ' GLN . 39.2 ttm180 -63.81 -52.54 59.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.566 HE22 ' HA ' ' A' ' 28' ' ' PRO . 25.3 mt-30 -77.84 -37.94 47.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.563 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 31' ' ' GLU . 98.1 mt -56.27 -49.45 74.17 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.17 -52.92 56.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.722 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.9 t -59.19 -36.9 65.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.551 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.647 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -61.39 -66.61 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.178 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.641 HD11 HD22 ' A' ' 124' ' ' LEU . 85.1 mt -65.47 -50.03 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.13 -45.72 90.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.864 0.364 . . . . 0.0 110.487 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.7 -29.27 72.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.33 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.03 -56.01 12.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.753 0.311 . . . . 0.0 111.53 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.789 HG21 ' HB3' ' A' ' 62' ' ' GLU . 66.8 p -105.83 -50.53 3.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.079 0.466 . . . . 0.0 111.124 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 123.7 42.51 0.38 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 34.1 mmt180 -129.78 127.7 40.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.861 0.362 . . . . 0.0 111.345 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 45' ' ' ARG . 43.1 mmm-85 -79.31 133.22 36.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.16 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.694 HG22 ' HA3' ' A' ' 53' ' ' GLY . 66.0 mt -54.48 -51.87 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.928 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.18 -148.47 19.88 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.405 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.44 -56.93 4.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.24 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.966 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 25.6 t-20 -93.19 142.02 27.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.129 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 30.0 t80 -59.54 -52.14 66.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.482 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.522 ' HE3' ' O ' ' A' ' 117' ' ' HIS . 15.8 mmt -76.82 -53.65 7.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.92 0.39 . . . . 0.0 111.556 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.966 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 26.9 m-20 -50.34 -42.52 53.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 46' ' ' ILE . . . -63.16 -41.57 99.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.374 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 HD11 ' A' ' 60' ' ' LEU . 98.0 mt -57.32 -30.19 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.3 mtmt -47.49 -30.7 3.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 7.9 p-10 -53.57 -40.8 65.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.685 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.75 -27.42 2.23 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.852 HG13 HG11 ' A' ' 75' ' ' VAL . 58.0 t -53.2 -60.64 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 49.6 mt -57.1 -50.3 76.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.484 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.705 HD11 HD22 ' A' ' 54' ' ' LEU . 74.8 mt -59.6 -39.56 84.6 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -59.62 -38.8 82.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.142 177.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.789 ' HB3' HG21 ' A' ' 42' ' ' THR . 95.1 mt-10 -67.44 -39.26 85.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.854 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.641 HD21 ' HE1' ' A' ' 37' ' ' TRP . 3.3 tm? -60.59 -58.43 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.649 HD11 HE21 ' A' ' 68' ' ' GLN . 9.0 tp -63.63 -31.92 54.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.649 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 61' ' ' CYS . 25.2 t-20 -56.01 -34.07 65.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.73 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 75.7 mmtt -77.98 -51.9 9.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.245 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' ALA . 57.7 mt -64.23 -58.2 7.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.931 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.649 HE21 HD11 ' A' ' 64' ' ' ILE . 7.8 tt0 -95.4 135.62 23.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.069 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 133.59 22.98 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.017 2.478 . . . . 0.0 112.724 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.3 38.56 57.31 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.776 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 48.4 m -60.62 -42.0 95.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.95 137.09 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.89 -138.52 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.458 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 10.7 mmpt? -62.87 124.01 19.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.8 0.333 . . . . 0.0 110.567 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.852 HG11 HG13 ' A' ' 58' ' ' VAL . 59.1 t -77.83 127.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.403 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -89.78 132.86 35.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -65.26 135.41 96.09 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.405 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.834 ' HD3' HG21 ' A' ' 58' ' ' VAL . 79.5 Cg_endo -75.38 37.7 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.526 2.15 . . . . 0.0 112.769 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.69 -55.59 9.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.112 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -72.46 -128.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.962 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -140.68 -48.29 0.42 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.605 0.24 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -68.73 -20.32 64.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -57.64 -45.01 86.0 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.909 0.385 . . . . 0.0 110.413 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 96.6 mttt -61.09 -41.76 97.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.626 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.5 mt -53.38 -37.36 62.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.432 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -68.5 -53.64 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -54.6 -38.26 66.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.569 HD11 ' O ' ' A' ' 55' ' ' LYS . 55.5 mt -71.82 -42.55 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.153 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.581 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -60.18 -56.77 22.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.045 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -61.58 -40.34 94.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 0.0 111.227 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 22.3 t80 -58.54 -50.15 74.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.403 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HA ' HG12 ' A' ' 95' ' ' ILE . 98.5 mt -67.11 -47.97 69.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.693 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 31.1 mmt180 -57.45 -36.24 71.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.341 0.591 . . . . 0.0 110.133 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.35 -45.3 69.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.694 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 92' ' ' LEU . 31.5 pt -72.55 -39.33 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.611 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 56.8 mtpt -58.82 -41.76 87.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -82.04 -34.86 29.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.578 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 31.9 t80 -51.73 -42.96 62.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.885 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.23 -44.37 0.19 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.285 -0.96 . . . . 0.0 113.121 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' HB ' HD11 ' A' ' 105' ' ' ILE . 25.6 t -57.85 130.17 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 111.107 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.583 ' HD2' ' N ' ' A' ' 101' ' ' LYS . 3.3 mptp? -69.37 140.07 89.95 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.611 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 51.2 Cg_exo -53.56 -39.33 83.01 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.692 2.262 . . . . 0.0 112.163 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.8 t-160 -56.17 -28.84 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -107.11 37.08 2.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.309 0.575 . . . . 0.0 109.602 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.588 HD11 ' HB ' ' A' ' 100' ' ' VAL . 78.1 mt -144.43 130.17 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.295 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 49.8 p90 -73.27 143.05 47.18 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.803 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.642 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.2 mp0 -86.41 152.71 22.47 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.28 -37.25 23.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.592 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -72.39 -36.43 68.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.602 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.642 ' OD1' ' HB2' ' A' ' 107' ' ' GLU . 1.6 m-20 -60.5 -47.23 87.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.695 0.283 . . . . 0.0 111.08 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.2 tp -74.43 -48.52 27.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.67 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -60.59 -56.37 22.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.326 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 115' ' ' THR . 68.3 mm-40 -72.54 -12.56 61.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.975 0.417 . . . . 0.0 110.433 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 55' ' ' LYS . 75.8 m-20 63.28 30.45 15.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.562 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 77.9 p -72.95 -45.25 59.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.882 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.5 OUTLIER -118.8 124.18 46.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.313 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.531 ' N ' HD22 ' A' ' 116' ' ' ASN . 43.0 m170 -108.35 -46.49 3.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.584 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.6 m -50.99 -44.77 60.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -59.75 -40.39 87.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.928 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.568 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 94.4 t -59.38 -46.46 92.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.406 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -63.01 -45.89 90.25 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -62.2 -39.98 94.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.9 m -55.12 -42.36 72.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.493 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.647 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 89.3 mt -56.35 -46.29 80.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.124 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.738 HD11 HG22 ' A' ' 30' ' ' THR . 63.0 mt -57.88 -41.45 79.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.85 -45.02 95.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.81 -40.31 92.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.817 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -59.49 -41.17 89.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.907 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 52.0 m -55.18 -36.01 65.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.74 -47.0 76.78 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -79.69 43.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.621 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 21.9 ptmt -169.41 44.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.058 0.456 . . . . 0.0 110.742 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.0 t -171.63 -36.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.952 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.883 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.632 ' HB3' ' HD3' ' A' ' 28' ' ' PRO . 27.8 ttt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 27' ' ' MET . 35.5 Cg_exo -59.63 -47.2 17.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.194 1.929 . . . . 0.0 112.18 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.692 ' HG3' ' H ' ' A' ' 30' ' ' THR . 60.0 tp60 -175.23 -135.27 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.943 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.692 ' H ' ' HG3' ' A' ' 29' ' ' GLN . 9.6 t 178.88 38.02 0.0 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.901 0.381 . . . . 0.0 110.974 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -176.57 -54.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HG3' HH21 ' A' ' 35' ' ' ARG . 79.1 ttt180 -77.48 -45.86 24.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.217 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 99.2 mm-40 -68.62 -40.55 80.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.622 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.66 -49.5 77.52 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 38.8 ptt180 -63.21 -50.44 70.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 98.5 t -62.45 -39.53 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.901 0.381 . . . . 0.0 111.599 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.633 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -61.21 -70.59 0.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.437 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.648 HD11 HD22 ' A' ' 124' ' ' LEU . 98.7 mt -61.02 -53.07 54.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 50.8 mt-10 -58.8 -44.0 90.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.865 0.364 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.91 -31.78 72.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.66 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.66 -70.23 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.791 0.329 . . . . 0.0 111.57 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.3 p -78.74 -51.19 10.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.448 ' O ' ' HD3' ' A' ' 44' ' ' ARG . . . 121.26 40.43 0.54 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 20.5 mmt85 -128.62 126.93 41.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.058 0.456 . . . . 0.0 111.445 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.43 133.86 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.297 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' HA3' ' A' ' 53' ' ' GLY . 97.4 mt -54.41 -38.64 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.663 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.25 -135.8 14.7 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.603 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -52.08 143.65 13.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.008 0.433 . . . . 0.0 111.84 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 58.65 -134.69 0.97 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.894 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.538 ' O ' HD23 ' A' ' 54' ' ' LEU . 29.9 t80 -163.48 -53.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.679 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 63.5 mmm -77.72 -46.45 21.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.219 0.533 . . . . 0.0 110.345 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.631 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 56.1 m-20 -55.65 -30.97 61.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.333 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' HA3' HG23 ' A' ' 46' ' ' ILE . . . -61.33 -43.35 99.47 Favored Glycine 0 C--O 1.228 -0.247 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.816 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 60' ' ' LEU . 1.7 mm? -61.94 -26.84 68.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.533 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.4 mtpt -50.67 -40.44 53.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.961 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.575 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 57.6 p-10 -53.33 -30.83 41.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.673 0.273 . . . . 0.0 111.574 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 87' ' ' ASN . . . 61.97 39.68 97.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.27 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.597 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 41.3 t -107.35 -55.19 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 44' ' ' ARG . 19.2 mt -63.96 -44.6 97.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 54' ' ' LEU . 65.7 mt -63.71 -46.8 83.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -55.05 -43.31 73.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.422 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 93.1 mt-10 -67.43 -33.17 74.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.582 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.9 tm? -65.96 -53.34 40.33 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.605 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.588 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.7 tp -59.06 -39.16 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.622 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -54.83 -28.0 46.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -73.76 -52.39 13.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.704 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 131' ' ' ALA . 59.9 mt -70.15 -58.9 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.706 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.556 HE21 HD11 ' A' ' 64' ' ' ILE . 8.3 tt0 -95.35 112.17 57.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.508 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.39 127.23 21.63 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 123.036 2.491 . . . . 0.0 113.239 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 52.06 53.46 30.46 Favored Glycine 0 C--N 1.332 0.347 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.768 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.588 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.6 m -72.01 -80.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.021 0.41 . . . . 0.0 110.762 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 47.8 t -88.94 127.36 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.661 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -96.52 130.46 43.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.665 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt 51.05 64.65 1.75 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.569 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 3.2 p -56.39 124.04 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 111.023 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -81.77 137.68 35.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.314 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -68.01 148.57 98.37 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.986 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.587 ' HD3' HG21 ' A' ' 58' ' ' VAL . 59.3 Cg_endo -72.32 47.41 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.576 2.184 . . . . 0.0 112.61 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.88 -36.92 78.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' HIS . 84.7 mt-30 -139.52 -144.29 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.288 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 -99.21 -47.63 5.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -59.01 -33.02 70.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.617 0.246 . . . . 0.0 110.883 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.445 ' HD2' ' N ' ' A' ' 80' ' ' GLN . 95.6 m-70 -54.81 -49.02 72.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.445 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 56' ' ' ASP . 95.6 mttt -64.7 -45.39 86.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.475 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.7 mt -51.68 -33.52 34.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.617 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 86' ' ' GLU . 5.5 tp10 -73.58 -51.6 16.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.237 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 57' ' ' GLY . 73.5 m-80 -60.55 -40.59 92.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.2 mt -63.71 -42.71 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.005 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.23 96.85 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.562 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 76.3 m-20 -65.38 -42.37 92.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.83 0.348 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.6 t80 -62.01 -49.51 75.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.646 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.557 ' HA ' HG12 ' A' ' 95' ' ' ILE . 97.7 mt -66.71 -47.17 73.2 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.407 ' HG2' ' HA ' ' A' ' 90' ' ' ASN . 39.1 ptt180 -59.57 -39.36 83.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.104 0.478 . . . . 0.0 110.14 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -67.59 -43.78 79.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.851 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 91' ' ' PHE . 38.2 pt -71.48 -39.59 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.727 0.299 . . . . 0.0 111.548 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 9.2 mtpm? -60.64 -39.28 87.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.5 . . . . 0.0 110.198 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -81.57 -35.96 29.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.514 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 32.2 t80 -54.23 -44.71 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.235 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 172.29 -43.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.136 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 105' ' ' ILE . 13.3 t -56.61 127.01 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 105' ' ' ILE . 31.9 mmmt -69.39 142.02 91.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.298 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.536 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.8 Cg_exo -54.08 -39.81 84.11 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.702 2.268 . . . . 0.0 112.2 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -56.39 -25.47 49.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -111.51 37.73 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.647 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.78 HD11 ' HB ' ' A' ' 100' ' ' VAL . 63.5 mt -146.44 129.95 9.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.353 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HB3' ' HG3' ' A' ' 119' ' ' GLN . 32.4 p90 -76.09 143.55 41.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.586 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 9.8 mp0 -84.54 159.56 20.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -47.48 -35.22 8.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.277 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 22.8 p30 -74.15 -36.65 64.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.7 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 1.3 m-20 -54.31 -47.07 72.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.851 0.357 . . . . 0.0 110.834 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.447 HD21 ' C ' ' A' ' 54' ' ' LEU . 68.3 tp -79.93 -48.43 13.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -65.14 -64.09 0.95 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.274 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 109' ' ' ASN . 71.3 mm-40 -68.53 0.88 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 53.56 30.42 10.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 109.607 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 110' ' ' ASP . 4.3 m -67.47 -40.56 85.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.961 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.682 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 5.6 m120 -127.97 120.07 26.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -94.86 -50.24 5.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.6 m -60.55 -40.04 90.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 106' ' ' PHE . 70.3 tp60 -58.02 -35.18 70.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.992 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 55.4 t -56.57 -48.76 79.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -73.26 -41.07 64.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.224 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 51.0 m -55.61 -44.69 77.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.417 HG23 HG12 ' A' ' 105' ' ' ILE . 85.2 m -60.45 -43.31 96.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.648 HD22 HD11 ' A' ' 38' ' ' ILE . 93.5 mt -57.37 -44.95 84.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.962 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.11 -43.56 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.104 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.72 96.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.131 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.61 -33.16 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.3 -41.05 71.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.7 m -55.54 -37.76 68.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.48 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -66.53 -48.88 68.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.247 179.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.706 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -78.08 40.13 0.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.447 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -68.53 -43.82 75.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 132' ' ' LYS . 8.4 t -176.07 42.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.858 179.84 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.622 0.249 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HB2' ' H ' ' A' ' 29' ' ' GLN . 43.1 Cg_endo -67.58 -137.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.543 2.162 . . . . 0.0 112.25 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.474 ' H ' ' HB2' ' A' ' 28' ' ' PRO . 17.9 pt20 -171.78 -139.77 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.774 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.606 ' HA ' ' HG ' ' A' ' 34' ' ' LEU . 69.2 p -147.8 -149.13 0.28 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.944 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 32' ' ' ARG . 88.4 tt0 54.48 -110.76 0.58 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.655 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.535 HH11 ' NH2' ' A' ' 35' ' ' ARG . 30.0 tpt180 -56.9 -40.34 76.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.792 0.329 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -58.34 -48.27 81.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.24 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.606 ' HG ' ' HA ' ' A' ' 30' ' ' THR . 97.5 mt -62.15 -45.94 91.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.525 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.535 ' NH2' HH11 ' A' ' 32' ' ' ARG . 52.3 ttp180 -61.17 -52.54 64.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.771 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.72 -39.15 83.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.782 0.325 . . . . 0.0 111.709 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -59.14 -72.19 0.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 HD22 ' A' ' 63' ' ' LEU . 82.6 mt -59.9 -50.77 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 93.5 mt-10 -58.5 -44.01 89.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 0.0 110.929 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.7 -31.92 79.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.671 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 63' ' ' LEU . . . -55.5 -71.47 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 111.736 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.3 p -84.7 -55.09 4.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.378 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.69 36.99 0.42 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 40.7 mmm-85 -120.16 130.53 54.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.618 0.247 . . . . 0.0 110.797 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.6 mmt85 -81.56 32.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.413 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 76.6 mt 58.53 -76.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.564 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . 153.17 -133.99 4.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.226 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -67.65 -125.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.531 HD22 ' H ' ' A' ' 52' ' ' ASP . 47.4 t30 -54.23 147.18 13.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.72 0.295 . . . . 0.0 110.365 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -55.5 -45.9 76.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.355 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.429 ' HE1' ' HB ' ' A' ' 120' ' ' VAL . 56.3 mmm -72.46 -51.5 19.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 111.079 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 1.3 m-20 -58.33 -29.61 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA3' ' CG2' ' A' ' 46' ' ' ILE . . . -66.81 -44.81 88.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.782 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 60' ' ' LEU . 85.0 mt -60.15 -24.2 64.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 111.472 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 46.6 mtpt -49.1 -38.07 23.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.927 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HA ' ' HG2' ' A' ' 84' ' ' LYS . 50.0 p-10 -54.12 -38.21 65.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.592 0.234 . . . . 0.0 111.417 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' A' ' 56' ' ' ASP . . . 75.82 -35.89 1.23 Allowed Glycine 0 C--O 1.226 -0.345 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.429 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.847 HG21 ' HD3' ' A' ' 78' ' ' PRO . 53.8 t -49.61 -56.93 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.6 mt -56.69 -51.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.114 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 HD22 ' A' ' 54' ' ' LEU . 88.5 mt -59.24 -36.27 75.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 72' ' ' VAL . 29.9 m -64.75 -37.05 86.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.431 178.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.5 mt-10 -65.9 -35.31 80.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.38 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD13 ' CB ' ' A' ' 41' ' ' ALA . 30.5 tp -68.77 -48.66 63.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.961 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.565 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.5 tp -60.35 -37.68 75.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.433 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -56.77 -29.63 62.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.333 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -70.26 -52.95 19.11 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 131' ' ' ALA . 62.7 mt -68.45 -56.95 6.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.514 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 8.3 tt0 -101.86 114.84 65.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.539 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.75 127.85 24.35 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.124 2.549 . . . . 0.0 113.367 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 49.37 52.49 23.37 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.706 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.565 ' OG ' HG13 ' A' ' 64' ' ' ILE . 61.1 m -68.28 -64.9 0.77 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.945 0.372 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG21 ' SG ' ' A' ' 61' ' ' CYS . 77.3 t -93.63 137.57 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.312 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -68.13 -136.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.485 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.42 124.14 20.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.872 0.368 . . . . 0.0 110.574 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 58' ' ' VAL . 61.8 t -82.58 128.5 38.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.411 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.406 HD21 ' CD ' ' A' ' 86' ' ' GLU . 72.5 m-20 -98.36 134.21 41.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.779 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.53 130.83 94.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 58' ' ' VAL . 81.0 Cg_endo -74.92 42.3 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.532 2.155 . . . . 0.0 112.763 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.09 -62.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.919 0.39 . . . . 0.0 110.958 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.24 -116.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.743 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -148.17 -39.97 0.17 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -62.29 -31.35 71.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.051 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -53.64 -47.13 70.61 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.006 0.431 . . . . 0.0 110.322 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.3 mttt -57.95 -41.32 82.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.045 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.9 mt -53.72 -36.9 62.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.894 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.406 ' CD ' HD21 ' A' ' 76' ' ' ASN . 39.9 tt0 -76.61 -48.24 19.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.694 0.283 . . . . 0.0 110.998 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -58.4 -43.7 88.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.754 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 55' ' ' LYS . 66.4 mt -63.21 -41.08 91.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.3 -45.79 94.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.429 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.07 -41.96 81.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.731 0.3 . . . . 0.0 111.051 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 95' ' ' ILE . 25.6 t80 -58.86 -51.69 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.109 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.571 ' HA ' HG12 ' A' ' 95' ' ' ILE . 86.4 mt -66.51 -44.61 82.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.0 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -57.7 -39.25 76.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.101 0.477 . . . . 0.0 110.246 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -68.99 -44.68 72.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.791 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.616 HG13 HD13 ' A' ' 105' ' ' ILE . 32.0 pt -69.91 -38.6 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 102' ' ' PRO . 55.7 mtpt -57.33 -46.06 83.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -81.23 -31.62 33.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.929 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.526 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 33.8 t80 -52.63 -41.59 63.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.564 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.48 -42.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.755 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 105' ' ' ILE . 22.0 t -58.45 128.72 19.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.96 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -67.78 140.23 94.04 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.142 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.597 ' HB3' ' HE3' ' A' ' 96' ' ' LYS . 53.1 Cg_exo -54.14 -39.14 87.22 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.605 2.203 . . . . 0.0 112.166 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.2 m170 -56.55 -26.25 54.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.853 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.17 36.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.289 0.566 . . . . 0.0 109.573 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 100' ' ' VAL . 71.6 mt -146.35 128.48 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.015 -179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 34.5 p90 -76.09 142.71 41.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.454 ' N ' ' OE1' ' A' ' 107' ' ' GLU . 1.2 mp0 -80.52 157.13 26.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.662 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.09 -37.8 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.079 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 113' ' ' GLU . 12.4 p30 -70.65 -33.85 71.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.453 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' A' ' 116' ' ' ASN . 70.3 m-20 -60.71 -51.95 67.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 111.458 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 54' ' ' LEU . 60.4 tp -70.95 -43.38 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.655 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -64.17 -46.82 82.33 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.961 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 109' ' ' ASN . 50.2 mt-10 -78.98 -9.57 59.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.427 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m120 62.01 38.06 14.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.905 0.383 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.1 p -92.01 -53.66 4.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.882 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 110' ' ' ASP . 4.8 m120 -87.93 61.64 6.48 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -55.95 -46.54 78.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.827 0.346 . . . . 0.0 110.976 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -61.36 -46.28 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.435 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 4.0 tp60 -60.44 -41.03 93.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.386 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 77.3 t -56.92 -44.67 82.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.488 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -65.94 -46.83 76.78 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.563 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 53.3 m -64.01 -40.66 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.568 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 85.1 m -54.66 -41.54 70.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.291 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 37' ' ' TRP . 94.3 mt -55.34 -40.66 71.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.8 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.07 -44.92 96.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.39 93.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.265 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.38 -42.35 91.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 132' ' ' LYS . . . -63.02 -42.02 99.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -56.75 -39.45 74.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 9.3 mm100 -63.37 -51.08 67.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.449 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -49.97 -34.77 21.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.773 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 128' ' ' ALA . 70.8 mmtt -67.57 -58.56 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.0 111.493 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 134' ' ' LYS . 2.4 t -67.63 -50.3 58.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.138 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 130' ' ' GLN . 48.0 mmtm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.878 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 28' ' ' PRO . 51.0 ttm . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 27' ' ' MET . 50.5 Cg_endo -68.39 -138.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.235 1.957 . . . . 0.0 112.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.692 HE22 ' HG2' ' A' ' 31' ' ' GLU . 70.8 tp60 -173.05 127.47 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.641 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 t -179.82 44.08 0.0 OUTLIER 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.298 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.692 ' HG2' HE22 ' A' ' 29' ' ' GLN . 65.7 mm-40 -60.76 -54.55 43.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.667 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.616 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 79.7 ttt180 -81.12 -45.14 16.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.839 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -55.95 -12.43 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.142 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 124' ' ' LEU . 47.0 tp -61.87 -49.18 77.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.956 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptp180 -64.83 -47.17 78.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.962 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.39 -40.08 76.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.962 0.41 . . . . 0.0 110.74 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -66.08 -65.79 0.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.516 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 124' ' ' LEU . 73.3 mt -56.95 -51.06 73.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HB2' ' A' ' 35' ' ' ARG . 50.5 mt-10 -61.06 -48.19 82.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.58 87.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.773 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 63' ' ' LEU . . . -54.14 -63.26 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.804 0.335 . . . . 0.0 111.484 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.2 p -84.4 -61.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.0 111.119 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.24 -32.69 0.94 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HB2' HD13 ' A' ' 59' ' ' ILE . 24.0 mmt180 -64.85 132.25 48.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.994 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.489 ' C ' ' H ' ' A' ' 47' ' ' GLY . 27.4 mmm180 -89.15 25.55 1.83 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.942 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 64.5 mt 67.82 -31.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.168 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 45' ' ' ARG . . . 85.91 -138.7 16.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.008 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -65.81 143.55 57.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.974 0.416 . . . . 0.0 111.745 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m120 61.6 -136.6 0.54 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.746 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' HZ ' HD23 ' A' ' 34' ' ' LEU . 28.3 t80 -160.97 -48.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.014 0.435 . . . . 0.0 110.194 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.466 ' CE ' ' HB ' ' A' ' 120' ' ' VAL . 56.5 mmm -83.46 -43.11 16.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.027 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 33.2 m-20 -56.06 -40.4 73.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.317 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.63 95.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.963 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 60' ' ' LEU . 57.1 mt -62.56 -31.3 72.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.0 111.302 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.687 ' O ' HD11 ' A' ' 88' ' ' ILE . 47.1 mtpt -47.26 -48.35 24.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.005 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 78' ' ' PRO . 1.3 m-20 -59.9 -36.73 77.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.341 . . . . 0.0 111.168 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 94.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.435 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG13 HG11 ' A' ' 75' ' ' VAL . 58.5 t -155.23 -53.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.199 0.523 . . . . 0.0 109.936 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 44' ' ' ARG . 56.4 mt -67.61 -44.39 86.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.773 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 54' ' ' LEU . 67.8 mt -59.66 -45.31 92.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.561 ' SG ' ' HB ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -54.96 -43.11 73.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' VAL . 95.7 mt-10 -66.1 -35.83 81.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.748 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 63' ' ' LEU . 2.7 tm? -66.42 -51.45 56.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.646 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.592 HG13 ' OG ' ' A' ' 71' ' ' SER . 8.1 tp -60.84 -38.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.423 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 61' ' ' CYS . 64.5 m-20 -54.54 -28.96 49.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.929 0.395 . . . . 0.0 110.671 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -70.64 -51.73 26.01 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.6 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.789 HD13 ' HB2' ' A' ' 131' ' ' ALA . 46.0 mt -72.39 -58.54 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.75 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.487 HE21 HD11 ' A' ' 64' ' ' ILE . 7.5 tt0 -96.27 134.53 23.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.016 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.0 133.3 19.55 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.155 2.57 . . . . 0.0 112.687 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 54.12 45.81 71.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.81 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.592 ' OG ' HG13 ' A' ' 64' ' ' ILE . 48.4 m -68.45 -47.05 68.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.766 0.317 . . . . 0.0 111.362 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.561 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 30.0 t -140.55 137.07 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.66 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.589 ' HG2' ' H ' ' A' ' 74' ' ' LYS . 42.0 tt0 -69.12 -133.73 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.562 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.589 ' H ' ' HG2' ' A' ' 73' ' ' GLN . 96.7 mttt -71.46 129.7 39.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.746 0.308 . . . . 0.0 110.962 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.833 HG11 HG13 ' A' ' 58' ' ' VAL . 48.3 t -76.76 125.75 36.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.98 134.04 34.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -63.01 136.33 96.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.364 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.576 ' HB3' ' HB3' ' A' ' 56' ' ' ASP . 66.3 Cg_endo -73.07 38.12 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.5 2.134 . . . . 0.0 112.943 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.24 -55.87 10.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.417 ' C ' HD22 ' A' ' 81' ' ' ASN . 3.4 mm100 -78.66 -143.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.417 HD22 ' C ' ' A' ' 80' ' ' GLN . 4.8 m120 -118.44 -49.61 2.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.256 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -68.22 -22.65 64.78 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.615 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -54.71 -46.69 74.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.868 0.366 . . . . 0.0 110.658 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' O ' HG13 ' A' ' 88' ' ' ILE . 95.7 mttt -63.18 -47.11 83.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.445 HD21 ' CD2' ' A' ' 112' ' ' PHE . 93.0 mt -57.98 -31.01 66.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.411 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -65.08 -51.87 58.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 0.0 110.634 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.8 m-80 -62.47 -39.19 92.62 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.896 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.687 HD11 ' O ' ' A' ' 55' ' ' LYS . 63.3 mt -66.3 -42.59 91.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.247 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 93' ' ' ARG . . . -59.4 -50.73 64.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.748 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -61.57 -41.4 97.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.769 0.318 . . . . 0.0 111.025 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 95' ' ' ILE . 24.2 t80 -60.8 -47.94 84.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.465 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 95' ' ' ILE . 95.8 mt -67.56 -48.47 66.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.795 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 30.7 mmt180 -58.52 -36.65 74.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.291 0.567 . . . . 0.0 110.218 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 98' ' ' TYR . . . -69.15 -44.75 71.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.61 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.585 HG13 HD13 ' A' ' 105' ' ' ILE . 43.4 pt -71.68 -36.03 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 102' ' ' PRO . 9.2 mtpm? -59.0 -42.06 89.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.014 0.435 . . . . 0.0 110.613 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -85.08 -34.89 22.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.688 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 94' ' ' ALA . 27.5 t80 -51.52 -43.99 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.174 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -44.46 0.15 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.02 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.744 ' HB ' HD11 ' A' ' 105' ' ' ILE . 15.8 t -58.33 127.9 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.758 0.313 . . . . 0.0 110.844 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' ILE . 28.2 mtpp -66.27 138.59 96.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.147 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.672 ' HB3' ' HE2' ' A' ' 96' ' ' LYS . 52.2 Cg_exo -53.85 -42.11 69.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.626 2.217 . . . . 0.0 112.15 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -58.09 -23.82 56.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.677 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -109.06 36.5 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.591 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.744 HD11 ' HB ' ' A' ' 100' ' ' VAL . 67.4 mt -144.69 128.64 12.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.632 ' CD2' ' HA ' ' A' ' 120' ' ' VAL . 51.7 p90 -78.58 144.67 35.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.805 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.504 ' HB2' ' OD1' ' A' ' 110' ' ' ASP . 60.0 mp0 -83.25 159.87 21.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.517 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' ILE . . . -49.05 -34.27 13.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.507 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -70.05 -35.1 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.608 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 116' ' ' ASN . 1.5 m-20 -57.81 -48.19 80.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 111.136 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 55' ' ' LYS . 66.5 tp -75.93 -47.15 26.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.554 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.445 ' CD2' HD21 ' A' ' 85' ' ' LEU . 28.8 t80 -63.2 -61.51 2.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 115' ' ' THR . 56.8 mm-40 -73.37 -7.72 52.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.338 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.559 HD21 ' NZ ' ' A' ' 55' ' ' LYS . 73.7 m-20 60.77 27.99 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.504 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 110' ' ' ASP . 74.5 p -72.99 -30.22 63.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.125 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 110' ' ' ASP . 0.7 OUTLIER -145.18 51.38 1.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.727 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.491 ' O ' ' HB ' ' A' ' 120' ' ' VAL . 7.9 p80 -59.39 -34.6 72.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.624 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 HG22 HD22 ' A' ' 116' ' ' ASN . 10.9 t -54.4 -41.79 69.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 110.277 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.422 ' N ' HG23 ' A' ' 118' ' ' THR . 67.7 tp60 -59.05 -32.09 69.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.544 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.632 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . 78.6 t -56.25 -47.02 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.45 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -60.97 -46.98 88.54 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.267 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.2 p -65.4 -39.11 91.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.497 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -57.33 -47.27 81.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.628 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.689 ' HB3' HD11 ' A' ' 34' ' ' LEU . 89.7 mt -55.75 -40.08 72.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.71 -43.69 95.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.263 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.8 94.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.341 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 tp -56.94 -33.63 67.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.024 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.01 72.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.676 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . 53.2 m -57.47 -34.99 69.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -74.08 -48.53 29.16 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.642 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.789 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -60.71 -43.63 97.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.303 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' A' ' 129' ' ' SER . 66.0 pttt -57.06 -41.32 78.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.854 0.359 . . . . 0.0 110.482 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.44 ' HB ' ' HD3' ' A' ' 134' ' ' LYS . 91.0 m -64.87 -35.78 82.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.901 179.87 . . . . . . . . 2 2 . 1 stop_ save_